UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
|
|
|
þ
|
|
ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the fiscal year ended December 31, 2008
OR
|
|
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from _________ to _________
Commission file number: 333-123081
HEALTH BENEFITS DIRECT CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
|
|
|
Delaware
|
|
98-0438502
|
|
|
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
150 N. Radnor-Chester Road
Suite B-101
Radnor, Pennsylvania
|
|
19087
|
|
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
(484) 654-2200
Registrants telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: None.
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, par value $0.001 per share
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of
the Securities Act.
o
Yes
þ
No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or
Section 15(d) of the Act.
o
Yes
þ
No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes
þ
No
o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§
229.405) is not contained herein, and will not be contained, to the best of registrants knowledge,
in definitive proxy or information statements incorporated by reference in Part III of this Form
10-K or any amendment to this Form 10-K.
o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated
filer
o
|
Accelerated
filer
o
|
Non-accelerated
filer
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
þ
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Act).
Yes
o
No
þ
The aggregate market value of common stock, par value $0.001 per share, held by non-affiliates at
June 30, 2008 (the last business day of the registrants most recently completed second fiscal
quarter) was $14,773,055. Such aggregate market value was computed by reference to the closing
price of the common stock of the registrant on the Over-the-Counter Bulletin Board on June 30,
2008.
As of March 20, 2009, there were 41,279,645 shares of the registrants common stock, par value
$0.001 per share, outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
None.
CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS
Certain of the statements contained in this Annual Report on Form 10-K, including in the Business
description, the Managements Discussion and Analysis of
Financial Condition and Results of Operation and elsewhere in this
report are forward-looking statements within the meaning of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These
statements are based on managements current expectations and are subject to uncertainty and
changes in circumstances. Actual results may vary materially from the expectations contained in the
forward-looking statements. The forward-looking statements herein include, among others, statements
addressing managements views with respect to future financial and operating results and costs
associated with the Companys operations and other similar statements. Various factors, including
competitive pressures, market interest rates, changes in insurance carrier mix, regulatory changes,
customer and insurance carrier defaults or insolvencies, litigation, acquisition of businesses that
do not perform as we expect or that are difficult for us to integrate or control, adverse
resolution of any contract or other disputes with customers and insurance carriers, or the loss of
one or more key insurance carrier relationships, could cause actual outcomes and results to differ
materially from those described in forward-looking statements.
The words may, will, expect, intend, anticipate, estimate, believe, continue and
similar expressions may identify forward-looking statements, but the absence of these words does
not necessarily mean that a statement is not forward-looking. While we believe that we have a
reasonable basis for each forward-looking statement contained in this Annual Report on Form 10-K,
we caution you that these statements are based on a combination of facts and factors currently
known by us and projections of the future about which we cannot be certain. Many factors, including
general business and economic conditions, affect our ability to achieve our objectives. As a result
of these factors, we cannot assure you that the forward-looking statements in this Annual Report on
Form 10-K will prove to be accurate. In addition, if our forward-looking statements prove to be
inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these
forward-looking statements, you should not regard these statements as a representation or warranty
by us or any other person that we will achieve our objectives and plans in any specified time
frame, if at all. We may not update these forward-looking statements, even though our situation may
change in the future.
3
PART I
ITEM 1. BUSINESS.
Overview
We were originally incorporated under the laws of the state of Nevada on October 21, 2004 as
Darwin Resources Corp., an exploration stage company engaged in mineral exploration. On November
22, 2005, Darwin Resources Corp. merged with and into its newly-formed wholly-owned subsidiary,
Darwin Resources Corp., a Delaware corporation, solely for the purpose of changing its state of
incorporation from Nevada to Delaware. On November 23, 2005, HBDC II, Inc., a newly-formed
wholly-owned subsidiary of Darwin Resources Corp., was merged with and into Health Benefits Direct
Corporation, a privately-held Delaware corporation, and the name of the resulting entity was
changed from Health Benefits Direct Corporation to HBDC II, Inc. Following the merger, Darwin
Resources Corp. changed its name to Health Benefits Direct Corporation and we began operations in
our current form.
We operate though three distinct businesses in two business segments: our Telesales business
segment, which is comprised of our Telesales business and our Insurint business, and the Atiam
business segment.
Telesales specializes in the direct marketing of health and life insurance and related
products to individuals and families. Telesales has developed proprietary technologies and
processes to connect prospective insurance customers with Telesales agents and service personnel
using an integrated on-line platform with call center follow up. Telesales employs licensed agents
supported by tele-application, customer service and technology employees for the purpose of
providing immediate information to prospective customers and selling insurance products. Telesales
receives commission and other fees from the insurance companies on behalf of which it sells
insurance products for the sale of such products. During the first quarter of 2009 we ceased
marketing and selling activities in Telesales and sold the majority of our call center-produced
agency business to eHealth Insurance Services, Inc. (eHealth).
Insurint is a proprietary, professional-grade, web-based agent portal that aggregates
real-time quotes and underwriting information from multiple highly-rated carriers of health and
life insurance and related products. We market Insurint using a Software as a Service (SaaS) model
instead of software licensing model, which offers easy web-based distribution and pay-as-you-go
pricing. We market primarily to insurance agents, agencies, and other organizations selling health
insurance products to families and individuals. Unlike existing health insurance quote engines,
Insurint also enables an agent to input responses to a set of questions about the health of
proposed insureds to place an insurance policy faster and more accurately. In addition, Insurint
offers a suite of sales tools that agents can use to increase their overall sales production.
Atiam is a provider of comprehensive, web-based insurance administration software
applications. Atiams flagship software product is InsPro, which was introduced 2004. Atiams
clients include insurance carriers and third party administrators. Atiam realizes revenue from the
sale of software licenses, application service provider fees, software maintenance fees and
consulting and implementation services. We acquired Atiam on October 1, 2007.
4
Telesales
Telesales is an independent agency, selling health and life insurance and related products on
behalf of a number of nationally-branded, highly-rated insurance carriers. The primary product we
sell on behalf of insurance carriers is major medical health insurance for individuals and
families. We also sell short-term medical policies (term shorter than one year), health savings
accounts and term life insurance. We believe these additional products represent significant
cross-sell opportunities to our existing client base with minimal acquisition cost.
Our service is free to consumers and our principal source of revenue is commissions paid to us
by our insurance carrier partners as compensation for policies sold. Our commissions are based on
a percentage of the premium amount collected by a carrier during the period that a customer
maintains coverage under a policy. These commissions include first year commissions and renewal
commissions. First year commission rates are significantly higher than renewal commission rates.
We also are eligible for incentive bonuses based on our ability to meet pre-determined criteria
established by our insurance carriers. The amounts of commissions and incentive bonuses for which
we are eligible vary, often significantly, by carrier and product. Our licensed agents assist
consumers in sorting through the complicated process of selecting and obtaining health or life
insurance or related products.
During the first quarter of 2009, we ceased the direct marketing and sale of health and life
insurance and related products to individuals and families in our Telesales call center. We
continue to sell health and life insurance and related products to individuals and families through
our non employee Insurance Specialist Group, Inc. (ISG) agents. Our Telesales business segment
eliminated 43 positions, including all of our licensed employee sales agents and certain of our
Telesales service and support personnel, and we eliminated another 20 positions in Telesales
through attrition.
On February 20, 2009, we completed the sale of our Telesales call center-produced agency
business to eHealth, an unaffiliated third party.
Pursuant to the terms of the sale, we transferred to eHealth broker of record status and the
right to receive commissions on certain of the in-force individual and family major medical health
insurance policies and ancillary dental, life and vision insurance policies issued by Aetna, Inc.,
Golden Rule, Humana, PacifiCare, Inc., Assurant and United Healthcare Insurance Co. on which we
were designated as broker of record. We still retain of the right to receive commission of certain
policies and products, including the agency business generated through our ISG agents, all short
term medical products and all business produced through carriers other than the specified carriers
mentioned above. In addition, we also transferred to eHealth certain lead information relating to
health insurance prospects. Going forward, eHealth has agreed to pay us a portion of each
commission payment received by eHealth relating to the transferred policies for the duration of
each policy, for so long as eHealth remains broker of record on such policy.
In addition, we will continue to receive a portion of all first year and renewal commissions
received by eHealth from policies sold through certain referral sites that result from leads
delivered by us to eHealth. We are entitled to receive these payments under the terms of a
Marketing and Referral Agreement, with eHealth, which is scheduled to terminate on August 20, 2010.
5
As a result of the above transactions, management anticipates a significant decline in future
Telesales revenues as a result of the cessation of direct marketing and sales in Telesales and the
eHealth transaction. Revenue from the five insurance carriers subject to the eHealth transactions
accounted for 66% of the Companys total revenue for the year ended December 31, 2008. We believe
the reduction in future revenues will be mitigated by significant reductions in future expenses.
Insurint
Principal Products and Services
Insurint is a web based tool that provides insurance agents and brokers with an all-in-one,
real time quoting engine and on-demand customer relationship management, or CRM, platform. It helps
insurance agents and brokers streamline their sales and marketing activities and increases agent
productivity, which ultimately strengthens the customer relationship. Insurint utilizes a Software
as a Service (SaaS) model instead of software licensing model, which offers easy web-based access
and pay-as-you-go pricing. Currently, we recognize revenue based on both one time setup and
recurring monthly access fees.
During 2008 we earned $97,177 in revenue from Insurint.
There are more than one million independent insurance agents licensed to sell health and life
insurance to individuals and groups in the United States. The vast majority of these agents use a
combination of manual quoting methods (such as rating tables from different carriers), legacy
software tools (such as stand-alone CRM software) and hard copies of underwriting guides to address
their customers needs and manage their business. While Insurint is designed for the use of
independent insurance agents, it may also be used by insurance companys direct sales departments,
or captive agents. We believe there is a significant opportunity for Insurint, based on this
tools unique strengths as described below, to provide a large number of these agents with a
comprehensive, end-to-end solution that meets all of their quoting, underwriting, CRM and marketing
needs, allowing them to improve their efficiency and maximize their productivity:
|
|
|
Insurint is a one-stop platform from which an agent may choose from a variety of
health and life insurance products and carriers. Insurint allows the insurance sales
agent to cross sell products or bundle quotes across different product lines.
|
|
|
|
|
Insurint provides real-time information and underwriting intelligence to help agents
build their business, while saving time and taking the hassle out of quoting and comparing
individual plans.
|
|
|
|
|
Insurint provides seamless integration of the quoting engine with CRM features, which
helps an agent to be more efficient with his or her sales, marketing and customer
management activities. Insurint can also enable an agent to make service calls to his or
her customers, thus improving customer service and providing another selling opportunity
for the agent.
|
|
|
|
|
Insurint provides an integrated web sharing tool, InsurintConnect, which allows the
agent to share the sales process and presentation with the client, thereby involving the
client in the sale, and helping them move from multiple plan choices to a logical
conclusion to meet their coverage needs.
|
6
|
|
|
Insurint provides a brandable, flexible technology framework, which can be customized
to the needs of agencies of all sizes, and may integrate with any existing telephony
and/or CRM solution they may already employ.
|
Marketing, Sales and Operations
Insurints marketing utilizes aggregator and affinity relationships, which seeks co-marketing
opportunities that create synergies between products and organizations, email promotions and
presentations at important industry events. Insurints marketing message and graphical treatment
is centered on an evolutionary concept, and is positioning itself as the Next Stage in the
Evolution of Insurance Technology. Insurints sales team provides both personalized and group
demonstrations to agents, agencies and carriers looking to learn more about Insurint.
Insurint currently has several key vendor agreements and relationships, which provide
functionality for portions of Insurints quoting engine. The unanticipated loss of the
functionality of portions of Insurints quoting engine, which are provided by key vendors, would
result in an interruption of Insurints product delivery to its customers until such time that
Insurint integrated replacement functionality from alternative vendors or sources. The loss of
such functionality could result in the loss of existing customers and revenue. To mitigate the
negative impact of the potential loss of such functionality Insurint has contractual agreements
with key vendors, which include performance standards and minimum contractual time periods.
Insurint monitors these key vendor relationships, their performance of services and periodically
evaluates alternative vendors and services.
Insurint depends on various hosting and technology vendors, which provide services critical to
Insurints delivery of products and services to Insurints customers. Such hosting and technology
services can be replaced with comparable services from other vendors on short notice.
Atiam Business Segment
We acquired Atiam Technologies, L.P. on October 1, 2007 and now operate this business as our
Atiam business segment. Atiam and its predecessor Systems Consulting Associates, Inc. (SCA) was
founded in 1986 by Robert J. Oakes as a programming and consulting services company. In 1988 SCA
entered into a long-term contract with Provident Mutual Insurance Company to develop, maintain,
install, support, and enhance IMACS, which was an insurance direct marketing and administration
software system. IMACS was the precursor of InsPro. Atiam dedicated four years, from 2001 to
2005, to developing Atiams principal product InsPro, which is a comprehensive, scalable, and
modular web-based insurance marketing, claims administration, and policy servicing platform.
Principal Products and Services
Our Atiam business segment offers InsPro on a licensed and an ASP (Application Service
Provider) basis. InsPro is an insurance administration and marketing system that supports group
and individual business lines, and efficiently processes agent, direct market, worksite and web
site generated business.
During 2008, we earned 87% of Atiams revenues from our four largest Atiam clients as follows;
client #1 $2,885,388, client #2 $786,740, client #3 $576,399 and client #4 $552,138.
7
InsPro incorporates a modular design, which enables the customer to purchase only the
functionality needed, thus minimizing the customers implementation cost and time necessary to
implement InsPro. InsPro can be rapidly tailored to the requirements of a wide range of customers
from the largest insurance companies and marketing organizations to the smallest third party
administrators, operating in environments ranging from a single server environment to the mainframe
installations. InsPro currently supports a wide range of distribution channels, including the
Internet, traditional direct marketing, agent-booked, individual and group plans, worksite, and
association booked business, and supports underwritten as well as guaranteed products including
long term care, Medicare supplement, critical illness, long and short term disability, whole and
term life, comprehensive major, hospital indemnity accidental death and dismemberment.
An InsPro software license entitles the purchaser a perpetual license to a copy of the InsPro
software installed at a single client location, which may be used to drive a production and model
office instance of the application. The ASP Hosting Service enables a client to lease the InsPro
software, paying only for that capacity required to support their business. ASP clients access an
instance of InsPro installed on Atiam owned servers located at Atiams offices or at a third
partys site.
Software maintenance fees apply to both licensed and ASP clients. Maintenance fees cover
periodic updates to the application and the InsPro Help Desk.
Consulting and implementation services are generally associated with the implementation of an
InsPro instance for either an ASP or licensed client, and cover such activity as InsPro
installation, configuration, modification of InsPro functionality, client insurance plan set-up,
client insurance document design, and system documentation.
Sales, Marketing and Operations
Atiam markets its products and services directly to prospective insurance carriers and third
party administrators via trade shows, advertising in industry publications and direct mail.
Atiam delivers services to its clients, which include InsPro system implementation, legacy
system migration to InsPro, InsPro application management, web development, InsPro help desk and
24x7 hosting service support.
Competition
Telesales
The individual health and life insurance agency market is highly competitive and has few
barriers to entry. We anticipate that competition in this market will continue to intensify. We are
not aware of any insurance sales agency that utilizes an interactive insurance marketplace
substantially similar to ours. However, significant competition exists from companies engaging in
traditional and Internet-only sales. These competitors include large and small insurance carriers,
agencies that operate on a national and regional basis and individual agents. We also anticipate
substantial new competition in this market, including from competitors with an interactive
insurance marketplace substantially similar to ours.
8
Many of our competitors are more established than we are, and have significantly greater
financial, technical, marketing, and other resources than we do. Many of our competitors have
greater name recognition and a larger customer base than we do. These competitors may be able to
respond more quickly to new or changing opportunities and customer requirements and may be able to
undertake more extensive promotional activities and offer more attractive terms to insurance
carriers.
During the first quarter of 2009 we ceased marketing and selling activities in Telesales and
sold our call center-produced agency business to eHealth Insurance Services, Inc.
Insurint
The life and health insurance field agent tool market is fragmented, but also very
competitive, and is characterized by rapidly changing consumer demand and technological change. We
believe Insurints competitors fall into three categories, which are:
|
|
|
Direct competitors, who provide web based tools targeting the life and health
insurance agents desktop, which includes Norvax, Quotit and HealthConnect;
|
|
|
|
|
The insurance agents insurance agencies and their technology partners, who
provide internally developed web based tools;
|
|
|
|
|
Indirect competitors, who provide web based tools targeting insurance agents
selling insurance products other than primarily health insurance, such as
Agencyworks InsureSocket Brokerage, Connectures InsureConnect, iPipeline, which
all target life insurance agents, Ebix (for Life and Property and casualty
insurance agents), and iBommerang, which provides co-browsing for insurance
agents.
|
Insurints major competitors in the agent quoting and sales software market for individual
major medical products are Norvax, which was founded in 2001 and has created a recognized brand,
and Quotit, which was founded in 1999 and has strong relationships with more than 120 insurance
carriers in health, life, dental and vision insurance markets.
Atiam
The market for insurance policy administration systems and services are very competitive,
rapidly evolving, highly fragmented and subject to rapid technological change. Many of our
competitors are more established than we are and have greater name recognition, a larger customer
base and greater financial, technical and marketing resources than Atiams.
Atiam is focused on the senior health, disability, affinity and association segments. Atiam
competes with such concerns as International Business Machines Corporation (Genelco Software),
Computer Sciences Corporation (FutureFirst), LifePro, and Fiserv Inc. (ID3), as well as with such
smaller enterprises as Management Data, Inc. To compete we use best practice technologies and
methods incorporated into InsPro, which provides customers with a user-friendly, flexible, modular
and cost-effective insurance administrative software system. We also compete on price with a
typical InsPro software license fee ranging from $500,000 to $750,000, compared to $800,000 to
$900,000 from our competitors. InsPros modular design, scalability and ASP hosting service option
makes it a compelling insurance administrative system from
9
small third party administrators to the largest insurance carriers.
Employees
As of December 31, 2008, we had 120 employees, which included 118 full-time and 2 part-time
employees. None of our employees are members of any labor union and we are not a party to any
collective bargaining agreement. We believe that the relationship between our management and our
employees is good.
Intellectual Property and Proprietary Rights
We rely on a combination of trademark, copyright and trade secret laws in the United States
and other jurisdictions as well as confidentiality procedures and contractual provisions to protect
our proprietary technology and our brand. We also have filed patent applications that relate to
certain of our technologies and business processes.
Governmental Regulation
Our Telesales activities are subject to governmental regulation at both the state and federal
level. Our non-insurance activities are subject to governmental regulation much like many other
non-insurance companies. Our Telesales insurance carrier partners also are subject to governmental
regulation at both the state and federal level. In addition, there are still relatively few laws or
regulations specifically addressing our Internet activities. As a result, the manner in which
existing laws and regulations could be applied to the Internet in general, and how they relate to
our businesses in particular, is unclear in many cases. Such uncertainty arises under existing laws
regulating matters including user privacy, defamation, pricing, advertising, taxation, gambling,
sweepstakes, promotions, content regulation, quality of products and services, and intellectual
property ownership and infringement.
We expect to post privacy policy and practices concerning the use and disclosure of any user
data on our websites. Failure to comply with posted privacy policies, Federal Trade Commission
requirements, or other domestic or international privacy-related laws and regulations could result
in governmental proceedings. There are multiple legislative proposals before federal and state
legislative bodies regarding privacy issues. It is not possible to predict whether or when such
legislation may be adopted, and certain proposals, if adopted, could harm our business through a
decrease in use and revenue.
Our Telesales direct marketing operations are or may become subject to additional federal and
state do not call laws and requirements. In January 2003, the Federal Trade Commission amended
its rules to provide for a national do not call registry. Under these federal regulations,
consumers may have their phone numbers added to the national do not call registry. Generally, we
are prohibited from calling any consumer whose telephone number is listed in the registry unless
the consumer has requested or initiated the contact or given his or her prior consent. Enforcement
of the Federal do not call provisions began in the fall of 2003, and the rule provides for fines
of up to $11,000 per violation and other possible penalties. Our current business model relies
heavily on outbound calls from our contact centers to consumers. The federal regulations and
similar state laws may restrict our ability to effectively market to new consumers the products we
sell on behalf of our insurance carrier partners. Furthermore, compliance with these rules may
prove difficult, and we may incur penalties for improperly conducting our marketing activities.
10
Corporate Information
We were incorporated under the laws of the state of Nevada on October 21, 2004 as Darwin
Resources Corp., or Darwin-NV, an exploration stage company engaged in mineral exploration. On
November 22, 2005, Darwin-NV merged with and into its newly-formed wholly-owned subsidiary, Darwin
Resources Corp., a Delaware corporation, or Darwin-DE, solely for the purpose of changing the
companys state of incorporation from Nevada to Delaware. On November 23, 2005, HBDC II, Inc., a
newly-formed wholly-owned subsidiary of Darwin-DE, was merged with and into Health Benefits Direct
Corporation, a privately-held Delaware corporation engaged in direct marketing and distribution of
health and life insurance and related products primarily over the Internet, and the name of the
resulting entity was changed from Health Benefits Direct Corporation to HBDC II, Inc. Following
this merger, Darwin-DE changed its name to Health Benefits Direct Corporation and, as a result,
HBDC II, Inc. became our wholly-owned subsidiary.
Our principal executive offices are located at 150 N. Radnor-Chester Road, Suite B-101,
Radnor, Pennsylvania 19087. Our telephone number is (484) 654-2200. Our website address is
www.healthbenefitsdirect.com. The principal offices of our wholly-owned subsidiary, HBDC II, Inc.,
are located at 2200 S.W. 10th Street, Deerfield Beach, Florida 33442. The principal offices of our
wholly-owned subsidiary, Insurint Corporation are located at 2200 S.W. 10th Street, Deerfield
Beach, Florida 33442 and its web site is
www.insurint.com
. The principal offices of our
wholly-owned subsidiary, Atiam, are located at 130 Baldwin Tower, Eddystone, PA 19022 and its web
site is
www.atiam-tech.com
.
Investor Information
All periodic and current reports, registration statements and other material that we are
required to file with the Securities and Exchange Commission (SEC), including our annual report
on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those
reports filed or furnished pursuant to Section 13(a) of the Securities Exchange Act of 1934, are
available free of charge through our investor relations page at
www.healthbenefitsdirect.com
. Such
documents are available as soon as reasonably practicable after electronic filing of the material
with the SEC. Our Internet websites and the information contained therein or connected thereto are
not intended to be incorporated into this Annual Report on Form 10-K.
The public may also read and copy any materials filed by the Company with the SEC at the SECs
Public Reference Room at 100 F Street, NE, Washington, DC 20549. The public may obtain information
on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC
maintains an Internet site, www.sec.gov, which contains reports, proxy and information statements,
and other information regarding issuers that file electronically with the SEC.
Executive Officers of the Registrant
The following table sets forth the name, age, and title of persons currently serving as our
executive officers. Our executive officers are appointed by, and serve at the discretion of, our
board of directors.
11
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
Anthony R. Verdi
|
|
|
60
|
|
|
Acting Principal Executive Officer, Chief
Financial Officer and Chief Operating Officer
|
Robert J. Oakes
|
|
|
50
|
|
|
President and Chief Executive Officer of Atiam
Technologies, LLC
|
Anthony R. Verdi has served as our Chief Financial Officer and Assistant Secretary since
November 2005, as our Chief Operating Officer since April 2008 and from June 20, 2008 as acting
Principal Executive Officer. From 2001 until November 2005, Mr. Verdi has provided consulting
services to life, health and property and casualty insurance company agency and venture capital
clients. From December 1998 until March 2001, Mr. Verdi served as Chief Operating Officer of
Provident and Chief Financial Officer of HealthAxis. From January 1990 until December 1998 Mr.
Verdi served as Chief Financial Officer of Provident American Corporation. From July 1986 until
January 1990, he was the Vice President and Controller of InterCounty Hospitalization and Health
Plans, a nonprofit group medical insurer. From April 1971 until July 1986, he served in various
finance and accounting capacities for the Academy Insurance Group, ultimately serving as the
Assistant Controller.
Robert Oakes has served as the President and Chief Executive Officer of our Atiam Technologies
LLC subsidiary since our acquisition of the subsidiary on October 1, 2007. From 1986 until 2007
Mr. Oakes was President and Chief Executive Officer of the general partner of Atiam Technologies
L.P., a software development and servicing company that developed, expanded and serviced products
to serve the insurance and financial services markets. Mr. Oakes founded Atiam in 1986 and led the
companys effort to design and develop its flagship product,
InsPro
.
ITEM 2. PROPERTIES.
We do not own any real property. We currently lease approximately 50,000 square feet of
office space in Deerfield Beach, Florida under a lease agreement with 2200 Deerfield Florida LLC.
The lease expires on March 31, 2016 and we have the option to extend the term for two additional
36-month periods, as well as the right to terminate the lease within the first five years. The
monthly rent increases every 12 months, starting at $62,500 and ending at approximately $81,550.
We also lease 7,414 square feet of office space in Radnor, Pennsylvania. We lease this office
space under a lease agreement with Radnor Properties-SDC, L.P. The term of the lease commenced on
November 1, 2006, and will expire on March 31, 2017. The monthly base rent increases every 12
months, starting at approximately $13,466 and ending at approximately $21,531. Under the terms of
the lease agreement, rent is waived for the first five months of the lease term with respect to
5,238 square feet and for the first 12 months for the remaining 2,176 square feet.
We also sublease approximately 14,000 square feet of office space located in New York, New
York. We sublease this office space under a sublease agreement with World Travel Partners I, LLC.
The initial term of the sublease terminates on December 30, 2010. The monthly base rent increases
every 12 months, starting at approximately $25,250 and ending at approximately $28,420.
We also lease approximately 13,600 square feet of space in Eddystone, Pennsylvania. We lease
this office space under a lease agreement with BPG Officer VI Baldwin Tower L.P.
12
The term of this lease commenced on August 1, 2007, and will expire on December 31, 2012. The
monthly rent increases every 12 months, starting at approximately $8,500 and ending at
approximately $23,900.
ITEM 3. LEGAL PROCEEDINGS.
On August 7, 2008, a former employee of the Company (the Plaintiff) filed a putative
collective action in the United States District Court for the Southern District of Florida, case
no. 08-CV-61254-Ungaro-Simonton, alleging that the Company and a co-defendant, who is an officer of
the Company, unlawfully failed to pay overtime to its insurance sales agents in violation of the
Fair Labor Standards Act (FLSA). Plaintiff purported to bring claims on behalf of a class of
current and former insurance sales agents who were classified as non-exempt by the Company and
compensated at an hourly rate, plus commissions (Agents). On October 16, 2008, the Court
conditionally certified a collective action under the FLSA covering all Agents who worked for the
Company within the last three years. Plaintiff and all Agents who opt to participate in the
collective action seek payment from the Company of compensation for all overtime hours worked at
the rate of one and one-half times their regular rate of pay, liquidated damages, attorneys fees,
costs, and interest. On March 2, 2009, the parties reached an agreement to settle this case. That
settlement will be submitted to the Court for necessary approval.
On August 28, 2008, a former employee of the Company (the Plaintiff) filed a national class
action complaint in the Seventeenth Judicial Circuit of Florida, Broward County, case no. 062008 CA
042798 XXX CE, alleging that the Company breached a contract with employees by failing to provide
certain commissions and/or bonuses. The complaint also contains claims for an accounting and for
declaratory relief relating to the alleged compensation agreement. Plaintiff purports to bring
these claims on behalf of a class of current and former insurance sales agents. Plaintiff seeks
payment from the Company of all commissions allegedly owed to him and the putative class, triple
damages, attorneys fees, costs, and interest. The Company filed a motion to dismiss the
complaint, which has not yet been heard by the court. The Company believes that these claims are
without merit and intends to vigorously defend the litigation.
We are also involved in various investigations, claims and lawsuits arising in the normal
conduct of our business, none of which, in our opinion, will harm our business. We cannot assure
that we will prevail in any litigation. Regardless of the outcome, any litigation may require us to
incur significant litigation expense and may result in significant diversion of our attention.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
We held our annual meeting of shareholders on October 2, 2009. The following nominees were
elected to our board of directors at our annual meeting. The number of votes for each nominee is
set forth below:
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
Shares Voted in
|
|
Number of Shares
|
|
|
Favor
|
|
Withheld
|
Donald R. Caldwell
|
|
|
26,730,713
|
|
|
|
217,597
|
|
Alvin H. Clemens
|
|
|
26,524,713
|
|
|
|
423,597
|
|
John Harrison
|
|
|
26,876,713
|
|
|
|
71,597
|
|
Warren V. Musser
|
|
|
26,798,713
|
|
|
|
149,597
|
|
Robert J. Oakes
|
|
|
26,881,713
|
|
|
|
66,597
|
|
Sanford Rich
|
|
|
26,826,713
|
|
|
|
121,597
|
|
L.J. Rowell
|
|
|
26,831,713
|
|
|
|
116,597
|
|
Paul Soltoff
|
|
|
26,708,713
|
|
|
|
239,597
|
|
Frederick C. Tecce
|
|
|
26,703,713
|
|
|
|
244,597
|
|
Anthony R. Verdi
|
|
|
26,878,713
|
|
|
|
69,597
|
|
Edmond Walters
|
|
|
26,831,713
|
|
|
|
116,597
|
|
13
In addition, each of the following two proposals was approved at the annual meeting. The
number of votes for each proposal is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
Proposal to ratify the appointment of
Sherb & Co., LLP as the Companys
independent registered public
accountants for the fiscal year
ending December 31, 2008
|
|
|
26,527,029
|
|
|
|
358,148
|
|
|
|
63,133
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposal to approve the adoption of
the Health Benefits Direct
Corporation 2008 Equity Compensation
Plan
|
|
|
15,208,466
|
|
|
|
499,015
|
|
|
|
191,289
|
|
There were no broker non-votes with respect to the election of directors and the proposal to ratify
the appointment of Sherb & Co., LLP as the Companys independent registered public accountants for
the fiscal year ending December 31, 2008. There were 9,874,540 broker non-votes with respect to the
proposal to approve the adoption of the Health Benefits Direct Corporation 2008 Equity Compensation
Plan
.
14
PART II
ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market Information
The following table sets forth the high and low bid prices for our common stock for the
periods indicated, as reported by the OTCBB. The prices state inter-dealer quotations, which do not
include retail mark-ups, mark-downs or commissions. Such prices do not necessarily represent actual
transactions.
|
|
|
|
|
|
|
|
|
|
|
High
|
|
Low
|
2007:
|
|
|
|
|
|
|
|
|
First quarter, ended March 31, 2007
|
|
$
|
3.26
|
|
|
$
|
2.55
|
|
Second quarter, ended June 30, 2007
|
|
$
|
2.93
|
|
|
$
|
2.20
|
|
Third quarter, ended September 30, 2007
|
|
$
|
2.40
|
|
|
$
|
1.75
|
|
Fourth quarter, ended December 31, 2007
|
|
$
|
2.60
|
|
|
$
|
1.65
|
|
|
|
|
|
|
|
|
|
|
2008:
|
|
|
|
|
|
|
|
|
First quarter, ended March 31, 2008
|
|
$
|
1.90
|
|
|
$
|
0.70
|
|
Second quarter, ended June 30, 2008
|
|
$
|
1.02
|
|
|
$
|
0.41
|
|
Third quarter, ended September 30, 2008
|
|
$
|
0.70
|
|
|
$
|
0.21
|
|
Fourth quarter, ended December 31, 2008
|
|
$
|
0.40
|
|
|
$
|
0.06
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
|
|
|
|
|
|
First
quarter through March 30, 2009
|
|
$
|
0.16
|
|
|
$
|
0.05
|
|
Holders of Record
Based on information furnished by our transfer agent, as of December 31, 2008, we had
approximately 137 holders of record of our common stock.
Our common stock has been quoted on the OTCBB since December 13, 2005 under the symbol
HBDT.OB. Prior to that date, there was no active market for our common stock. Based on information
furnished by our transfer agent, as of February 6, 2009, we had approximately 132 holders of record
of our common stock. We have not declared any cash dividends on our common stock during the last
two fiscal years.
15
ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
OVERVIEW
Health Benefits Direct Corporation operates through two business segments.
The Atiam business segment, or Atiam, is a provider of comprehensive, web-based insurance
administration software applications. Atiams flagship software product is InsPro, which was
introduced in 2004. Atiams clients include insurance carriers and third party administrators.
Atiam realizes revenue from the sale of software licenses, application service provider fees,
software maintenance fees and consulting and implementation services.
The Telesales business segment, or Telesales, specializes in the direct marketing of health and
life insurance and related products to individuals and families. Telesales has developed
proprietary technologies and processes to connect prospective insurance customers with Telesales
agents and service personnel using an integrated on-line platform with call center follow up.
Telesales employs licensed agents supported by tele-application, customer service and technology
employees for the purpose of providing immediate information to prospective customers and selling
insurance products. Telesales receives commission and other fees from the insurance companies for
the sale of their products.
During the first quarter of 2009, we ceased the direct marketing and sale of health and life
insurance and related products to individuals and families in our Telesales call center. We
continue to sell health and life insurance and related products to individuals and families through
our non-employee ISG agents. Our Telesales business segment eliminated 43 positions, including all
of its licensed employee sales agents along with other Telesales service and support personnel, and
eliminated another 20 positions in Telesales through attrition.
On February 20, 2009, we entered into a Client Transition Agreement with eHealth, pursuant to which
we transferred to eHealth certain lead information relating to health insurance prospects and
broker of record status and the right to receive commissions on certain of the in-force individual
and family major medial health insurance policies and ancillary dental, life and vision insurance
policies issued by Aetna, Inc., Golden Rule Insurance Company, Humana, Inc., PacifiCare, Inc., Time
Insurance Company (marketed under the name Assurant Health) and United Healthcare Insurance Co. on
which we were designated as the broker of record as of that date. Certain policies and products
were excluded from the transaction, including our agency business generated through our ISG agents,
all short term medical products and all business produced through carriers other than the specified
carriers. As consideration for such transfer, eHealth agreed to pay us approximately $1,280,000 in
cash and to assume certain of our liabilities relating to historical commission advances on the
transferred policies in an aggregate amount of approximately $1,385,000. eHealth has also agreed
to pay us a portion of each commission payment received by eHealth relating to a transferred policy
for the duration of the policy, provided that eHealth remains broker of record on such policy.
Additionally, eHealth agreed to construct one or more websites for the purpose of selling health
insurance products and to pay us a portion of all first year and renewal commissions received by
eHealth from policies sold through such websites that result from marketing to prospects using
leads that we delivered to eHealth.
16
Management anticipates a significant decline in future Telesales revenues as a result of the
cessation of direct marketing and sales in Telesales and the eHealth transaction. Revenue from the
five insurance carriers covered by the eHealth transaction accounted for 66% of our total revenue
for 2008 and 85% of our Telesales segment. Management believes the reduction in future revenues
will be mitigated by significant reductions in future expenses.
We have not yet completed a determination of the impairment of long term assets as a result of the
cessation of direct marketing and sales and eHealth transaction. The long term assets, which may
be impaired, and their net book value as of December 31, 2008, include property and equipment net
of depreciation of approximately $434,067, internet domain name
www.healthbenefitsdirect.com
of
$22,389, intangible assets net of accumulated amortization acquired from ISG, including the value
of purchased commission override revenue of $227,779 and value of acquired carrier contracts and
agent relationships of $1,032,294. We anticipate completing an impairment determination during the
first quarter of 2009.
CRITICAL ACCOUNTING POLICIES
The following is a discussion of our critical accounting policies and methods. Critical accounting
policies are defined as those that are both important to the portrayal of our financial condition
and results of operations and are reflective of significant judgments and uncertainties made by
management that may result in materially different results under different assumptions and
conditions. Note 2 to the consolidated financial statements for the year ended December 31, 2008
includes further information on the significant accounting policies and methods used in the
preparation of our consolidated financial statements.
The preparation of financial statements in conformity with U.S. generally accepted accounting
principals requires us to make estimates and judgments that affect the reported amounts of assets,
liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On
an on-going basis, we evaluate the application of these estimates, including those related to the
recoverability of investments, useful lives of intangible assets, valuation of goodwill, product
development costs, revenue recognition and deferred revenue and accounting for income taxes. We
base our estimates on historical experience and on various other assumptions that are believed to
be reasonable under the circumstances, the results of which form the basis for making judgments
about the carrying values of assets and liabilities that are not readily apparent from other
sources. Actual amounts could differ significantly from these estimates.
17
Revenue Recognition Policy
Our Telesales segment generates revenues primarily from the receipt of commissions paid to us by
insurance companies based upon the insurance policies sold to consumers through our service. These
revenues are in the form of first year, bonus and renewal commissions that vary by company and
product. We recognize commission revenue from the sale of primarily health insurance, after we
receive notice that the insurance company has received payment of the related premium. First year
commission revenues per policy can fluctuate due to changing premiums, commission rates, and types
or amount of insurance sold. We receive bonuses based upon individual criteria set by insurance
companies. We recognize bonus revenues when we receive notification from the insurance company of
the bonus due to us. Bonus revenues are typically higher in the fourth quarter of our fiscal year
due to the bonus system used by many health insurance companies, which pay greater amounts based
upon the achievement of certain levels of annual production. Revenues for renewal commissions are
recognized after we receive notice that the insurance company has received payment for a renewal
premium. Renewal commission rates are significantly less than first year commission rates and may
not be offered by every insurance company. We also generate revenue from the sale of leads to third
parties. Such revenues are recognized when we receive notification from those sources of the
revenue due to us. Our revenue recognition accounting policy has been applied to all periods
presented in this report. The timing between when we submit a consumers application for insurance
to the insurance company and when we generate revenues has varied over time. The type of insurance
product, the insurance companys premium billing and collection process, and the insurance
companys backlog are the primary factors that impact the length of time between submitted
applications and revenue recognition. Any changes in the amount of time between submitted
application and revenue recognition, which will be influenced by many factors not under our
control, will create fluctuations in our operating results and could affect our business, operating
results and financial condition.
The Company also generates revenue from the sub-lease of our leased New York City office and a
portion of our leased Deerfield Beach Florida office, which are both leased under operating leases.
The terms of the Companys sub-lease of our New York City office is under similar terms as our
lease. The Company sub-leases portions of our Deerfield Beach office to two unaffiliated parties
through January 31, 2010. Sub-lease revenue includes base rent, additional rent representing a
portion of occupancy expenses under the terms of the sub-leases and certain technology and facility
services provided. We recognize sub-lease revenue when lease rent payments are due in accordance
with the sub-lease agreements in accordance with SFAS No. 13 Accounting for Leases. Recognition
of sub-lease revenue commences when control of the facility has been given to the tenant. We record
a provision for losses on accounts receivable equal to the estimated uncollectible amounts. This
estimate is based on our historical experience and a review of the current status of the Companys
receivables.
Our Atiam business segment offers InsPro on a licensed and an application service provider, or ASP,
basis. An InsPro software license entitles the purchaser to a perpetual license to a copy of the
InsPro software installed at a single client location, which may be used to drive a production and
model office instance of the application. The ASP hosting service enables a client to lease the
InsPro software, paying only for that capacity required to support their business. ASP clients
access an instance of InsPro installed on Atiam owned servers located at Atiams offices or at a
third partys site.
Software maintenance fees apply to both licensed and ASP clients. Maintenance fees cover periodic
updates to the application and the InsPro Help Desk.
18
Consulting and implementation services are generally associated with the implementation of an
InsPro instance for either an ASP or licensed client, and cover such activity as InsPro
installation, configuration, modification of InsPro functionality, client insurance plan set-up,
client insurance document design, and system documentation.
The Company recognizes revenues in accordance with AICPA Statement of Position (SOP) 97-2,
Software
Revenue Recognition
, as amended by SOP 98-9 (Modification of SOP 97-2, Software Revenue
Recognition, With Respect to Certain Transactions). Revenue from software license agreements is
recognized when persuasive evidence of an agreement exists, delivery of the software has occurred,
the fee is fixed or determinable, and collectibility is probable. The Company considers fees
relating to arrangements with payment terms extending beyond one year to not be fixed or
determinable and revenue for these arrangements is recognized as payments become due from the
customer. In software arrangements that include more than one InsPro module, the Company allocates
the total arrangement fee among the modules based on the relative fair value of each of the
modules.
License revenue allocated to software products generally is recognized upon delivery of the
products or deferred and recognized in future periods to the extent that an arrangement includes
one or more elements to be delivered at a future date and for which fair values have not been
established. Revenue allocated to maintenance agreements is recognized ratably over the
maintenance term and revenue allocated to training and other service elements is recognized as the
services are performed.
The unearned portion of Atiam business segment revenue has been included in the consolidated
balance sheet as a liability for deferred revenue.
Under the criteria set forth in SOP 98-1, Accounting for the Costs of Computer Software Developed
or Obtained for Internal Use capitalization of software development costs begins upon the
establishment of technological feasibility of the software. The establishment of technological
feasibility and the ongoing assessment of the recoverability of these costs require considerable
judgment by management with respect to certain external factors, including, but not limited to,
anticipated future gross product revenues, estimated economic life, and changes in software and
hardware technology. Capitalized software development costs are amortized utilizing the
straight-line method over the estimated economic life of the software not to exceed three years. We
regularly review the carrying value of software development assets and a loss is recognized when
the unamortized costs are deemed unrecoverable based on the estimated cash flows to be generated
from the applicable software.
We review the carrying value of property and equipment and intangible assets for impairment at
least annually or whenever events or changes in circumstances indicate that the carrying amount of
an asset may not be recoverable. Recoverability of long-lived assets is measured by comparison of
its carrying amount to the undiscounted cash flows that the asset or asset group is expected to
generate. If such assets are considered to be impaired, the impairment to be recognized is measured
by the amount by which the carrying amount of the property, if any, exceeds its fair market value.
19
Effective January 1, 2006, we adopted the provisions of SFAS No. 123(R), Share-Based Payment,
under the modified prospective method. SFAS No. 123(R) eliminates accounting for share-based
compensation transactions using the intrinsic value method prescribed under APB Opinion No. 25,
Accounting for Stock Issued to Employees, and requires instead that such transactions be
accounted for using a fair-value-based method. Under the modified prospective method, we are
required to recognize compensation cost for share-based payments to employees based on their
grant-date fair value from the beginning of the fiscal period in which the recognition provisions
are first applied. For periods prior to adoption, the financial statements are unchanged, and the
pro forma disclosures previously required by SFAS No. 123, as amended by SFAS No. 148, will
continue to be required under SFAS No. 123(R) to the extent those amounts differ from those in the
Statement of Operations.
ACQUISITION OF ATIAM
We acquired Atiam on October 1, 2007. The results of Atiams operations prior to our October 1,
2007 acquisition have been excluded from our financial statements. The results of our Atiam
business segment have been included in the Companys statement of operations as of October 1, 2007.
Thus Atiam segments results from operations for years ended December 31, 2008 and 2007 are not
comparable. The Company accounted for the acquisition of Atiam using the purchase method of
accounting in accordance with Statement of Financial Accounting Standards No. 141 Business
Combinations. Our calculation for the consideration paid for Atiam in connection with the Bilenia
Agreement and the Atiam Merger Agreement in the aggregate was $3,080,744 and consisted of the
following:
|
|
|
|
|
Cash payments to sellers
|
|
$
|
1,350,000
|
|
Fair value of common stock issued to sellers
|
|
|
1,650,006
|
|
Estimated direct transaction fees and expenses
|
|
|
80,738
|
|
|
|
|
|
Estimated purchase price
|
|
$
|
3,080,744
|
|
|
|
|
|
We estimated the fair values of Atiams assets acquired and liabilities assumed at the date of
acquisition as follows:
|
|
|
|
|
Cash
|
|
$
|
608,534
|
|
Accounts receivable
|
|
|
643,017
|
|
Prepaid expenses & other assets
|
|
|
22,623
|
|
Property and equipment, net
|
|
|
158,819
|
|
Other assets
|
|
|
3,401
|
|
Intangible assets
|
|
|
2,097,672
|
|
Accounts payable
|
|
|
(34,278
|
)
|
Accrued expenses
|
|
|
(122,675
|
)
|
Income taxes payable
|
|
|
(157,288
|
)
|
Deferred revenue
|
|
|
(120,000
|
)
|
Long and short term capital lease obligations
|
|
|
(19,081
|
)
|
|
|
|
|
|
|
$
|
3,080,744
|
|
|
|
|
|
20
Intangible assets acquired from Atiam were assigned the following values: value of client contracts
and relationships other than license with an assigned value of $1,089,223 amortized straight line
over five years; value of purchased software for sale and licensing value with an assigned value of
$644,449 amortized straight line over five years; and employment and non-compete agreements
acquired with an assigned value of $364,000 amortized straight line over three years. Intangible
assets acquired from Atiam had the following unamortized values as of December 31, 2008: value of
client contracts and relationships other than license of $816,916; value of purchased software for
sale and licensing value of $483,337; and employment and non-compete agreements acquired of
$212,319.
RESULTS OF OPERATIONS FOR YEAR ENDED DECEMBER 31, 2008 COMPARED TO THE YEAR ENDED DECEMBER 31, 2007
Revenues
For the twelve months ended December 31, 2008, we earned revenues of $24,128,027 compared to
$20,709,750 for the twelve months ended December 31, 2007, an increase of $3,418,277 or 17%. The
increase in revenues is primarily attributable to an increase in Atiam segment revenues. We
acquired Atiam on October 1, 2007. The results of Atiams operations prior to our October 1, 2007
acquisition have been excluded from our financial statements. The results of our Atiam business
segment have been included in the Companys statement of operations as of October 1, 2007. Thus
Atiam segments results from operations for years ended December 31, 2008 and 2007 are not
comparable. Telesales segment revenues declined due to lower periodic bonus revenue from carriers,
which was caused by lower marketing and selling activity. Revenues include the following:
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months
|
|
|
|
Ended December 31
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
Commission revenue from carriers excluding periodic bonuses and ISG
|
|
$
|
16,078,942
|
|
|
$
|
16,043,563
|
|
Periodic bonus revenue from carriers
|
|
|
100,392
|
|
|
|
843,311
|
|
ISG commission revenue
|
|
|
1,404,244
|
|
|
|
1,821,958
|
|
Lead sale revenue
|
|
|
408,120
|
|
|
|
859,890
|
|
Insurint technology fees
|
|
|
97,177
|
|
|
|
|
|
Sub-lease and other revenue
|
|
|
460,640
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Telesales business segment
|
|
|
18,549,515
|
|
|
|
19,568,722
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consulting and implementation services
|
|
|
3,889,069
|
|
|
$
|
668,674
|
|
ASP revenue
|
|
|
1,123,943
|
|
|
|
244,854
|
|
Sales of software licenses
|
|
|
115,000
|
|
|
|
137,500
|
|
Maintenance revenue
|
|
|
450,500
|
|
|
|
90,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Atiam business segment
|
|
|
5,578,512
|
|
|
|
1,141,028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
24,128,027
|
|
|
$
|
20,709,750
|
|
|
|
|
|
|
|
|
21
|
|
|
In 2008, we earned commission revenue from carriers, excluding periodic bonuses and ISG
revenues, of $16,078,942 as compared to $16,043,563 in 2007.
|
|
|
|
We had 31 licensed insurance agent employees at December 31, 2008 as
compared to 118 at December 31, 2007. In March 2008, we closed our New York sales
office, which accounted for approximately 20% of our sales activity for 2007. We
also reduced sales and sales support staff in our Florida office. As a result of
the closure, we terminated 34 licensed sales agents and eliminated eight open
licensed sales positions, which were vacated subsequent to December 31, 2007. In
October 2008, we further reduced our Telesales sales and sales support staff in
our Florida office. In October 2008, we terminated 51 employees, including 22
agents. Management believes the reduction in future revenues will be mitigated by
significant reductions in future expenses.
|
|
|
|
|
Subsequent to December 31, 2008, we ceased the direct marketing and
sale of health and life insurance and related products to individuals and families
in our Telesales call center. We continue to sell health and life insurance and
related products to individuals and families through our non-employee ISG agents.
Our Telesales business segment eliminated 43 positions, which included all
Telesales licensed employee sales agents along with other Telesales service and
support personnel, and eliminated another 20 positions in Telesales through
attrition. Management believes these reductions will result in the reduced
expenses in excess of reduced revenue.
|
|
|
|
In 2008, we earned periodic bonuses from carriers of $100,392 as compared to $843,311
in 2007. The Telesales segment receives bonuses from certain carriers, which are based
primarily on the Telesales segments sales performance and criteria established by
carriers and generally do not extend beyond the current calendar year. Accordingly, we
cannot determine what criteria, if any, may be offered by its carriers pertaining to
bonuses beyond the current calendar year. As a result of the cessation of direct
marketing and sales in 2009, management does not anticipate receiving material periodic
bonuses from carriers in the future.
|
|
|
|
|
In 2008, we earned revenue of $1,404,244 relating to ISG as compared to $1,821,958 in
2007. ISG revenue declined as a result of reduced new sales, the lapse of inforce
business and reduced commission overrides earned on the Telesales segment on new and
inforce business. As a result of the transaction with eHealth in February 2009, management
anticipates a significant decline in ISG commission revenue as a result of the elimination
of commission overrides for all Telesales business.
|
22
|
|
|
In 2008, we earned revenues of $408,120 relating to the sale of leads to third parties
as compared to $859,890 in 2007. We re-sell certain leads that we purchase in order to
recoup a portion of our lead cost. The primary reason for the decrease in lead sales
revenue is a decrease in lead cost spending, which resulted in a reduced number of leads
available for sale. As a result of the cessation of direct marketing in the first quarter
of 2009, management does not anticipate receiving material lead revenue in the future.
|
|
|
|
|
In 2008, we earned revenues of $97,177 relating to Insurint technology fees. Our
Insurint subsidiary provides a proprietary, professional-grade, web based agent portal to
support and assist insurance agents in the business of marketing and selling health
insurance and related products. Insurints technology fees commenced in the second
quarter of 2008.
|
|
|
|
|
In 2008 we earned revenue of $460,640 relating to the sub-lease of a portion of our
Florida office and our former New York sales office. Sub-lease revenue includes base rent,
additional rent pertaining to utilities and occupancy costs and certain telephony,
technology and facility services provided by us to certain of our sub-tenants.
|
|
|
|
On February 21, 2008 the Company entered into a sub-lease agreement
with a third party whereby the third party sub-leased approximately 5,200 square
feet of our Deerfield Beach office space beginning March 1, 2008 through February
28, 2009. This sub-lease agreement was amended and restated on October 3, 2008 to
increase the sub-leased square footage to 13,900 and extend the lease term through
January 31, 2010.
|
|
|
|
|
On October 1, 2008 the Company entered into a sub-lease agreement
with a third party whereby the third party sub-leased approximately 8,000 square
feet of our Deerfield Beach office space beginning October 15, 2008 through
January 31, 2010. In accordance with this sub-lease agreement the Company
recognizes base rent, additional rent representing a portion of certain actual
occupancy expenses for our Deerfield Beach office and certain telephony,
technology and facility services provided to our sub-tenant.
|
|
|
|
|
On April 17, 2008 the Company entered into a sub-lease agreement with
a third party whereby the third party will sub-lease our New York office space for
the balance of the Companys Sublease Agreement and pay the Company sub-lease
payments essentially equal to the Companys costs under the Sublease Agreement.
The third party commenced paying sub-sublease payments to the Company in September
2008 however the third party failed to pay their December 2008, January and
February 2009 rent when due. The Company is a beneficiary to a letter of credit
in the amount of $151,503, which is available for the Company to draw against in
the event of the third partys failure to pay their rent when due. We have
notified the third party that they have breached their lease and that we will make
draws against the letter of credit for amounts past due.
|
23
Total Operating Expenses
Our total operating expenses in 2008 were $33,091,737 as compared to $35,037,791 for 2007, for a
decrease of $1,946,054 or 6%. Total operating expenses consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months
|
|
|
|
Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
Telesales business segment
|
|
$
|
26,781,420
|
|
|
$
|
34,219,253
|
|
Atiam business segment
|
|
|
6,310,318
|
|
|
|
943,538
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
33,091,738
|
|
|
$
|
35,162,791
|
|
|
|
|
|
|
|
|
Telesales operating expenses consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months
|
|
|
|
Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
Salaries, commission and related taxes
|
|
$
|
13,665,679
|
|
|
$
|
17,077,101
|
|
Lead, advertising and other marketing
|
|
|
4,375,466
|
|
|
|
8,478,643
|
|
Depreciation and amortization
|
|
|
1,922,438
|
|
|
|
2,154,916
|
|
Rent, utilities, telephone and communications
|
|
|
3,319,088
|
|
|
|
2,658,471
|
|
Professional fees
|
|
|
1,672,450
|
|
|
|
1,915,223
|
|
Loss on impairment of property and equipment
|
|
|
88,922
|
|
|
|
|
|
Loss on impairment of intangible asset
|
|
|
380,711
|
|
|
|
125,000
|
|
Other general and administrative
|
|
|
1,356,666
|
|
|
|
1,809,899
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
26,781,420
|
|
|
$
|
34,219,253
|
|
|
|
|
|
|
|
|
|
|
|
Salaries, commissions and related taxes declined in 2008 compared to 2007 as a result
of employee workforce reductions.
|
|
|
|
|
Our operating expenses for 2008 included approximately $3.0 million of non-recurring
charges pertaining to severance, acceleration of equity compensation, expenses related to
the closing of our New York office and litigation.
|
24
|
|
|
Loss on impairment of property and equipment pertains to the closure of our Telesales
New York sales office. During the first quarter of 2008 Telesales closed its sales office
located in New York. As of March 31, 2008, we determined that all furniture and
lease-hold improvements located at the New York sales office were impaired as a result of
the office closure. During the first quarter of 2008, we recorded $88,922 expense to
write-down the value of these assets to their net realizable value.
|
|
|
|
|
Loss on impairment of intangible assets pertains to the following:
|
|
|
|
During the first quarter of 2008, we determined that the portion of
license fee paid by Telesales for a commission system together with capitalized
costs incurred to implement the commission system was impaired as a result of the
absence of definitive plans to implement this system for internal use in
Telesales. We recorded a $295,633 expense in the first quarter of 2008 to
write-off the value of this asset.
|
|
|
|
|
As a result of Ivan Spinners termination of employment, we have
determined that the value of an employment and non-compete agreement acquired
pertaining to Mr. Spinner was impaired as of December 31, 2008 and recorded an
impairment charge of $85,078 in loss on impairment of intangible assets.
|
We acquired Atiam on October 1, 2007. The results of Atiams operations prior to our October 1,
2007 acquisition have been excluded from our financial statements. The results of our Atiam
business segment have been included in the Companys statement of operations as of October 1, 2007.
Thus Atiam segments results from operations for years ended December 31, 2008 and 2007 are not
comparable. Atiams operating expenses consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months
|
|
|
|
Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
Salaries, commission and related taxes
|
|
$
|
3,467,151
|
|
|
$
|
467,066
|
|
Lead, advertising and other marketing
|
|
|
15,017
|
|
|
|
11,052
|
|
Depreciation and amortization
|
|
|
645,707
|
|
|
|
131,851
|
|
Rent, utilities, telephone and communications
|
|
|
190,626
|
|
|
|
62,264
|
|
Professional fees
|
|
|
1,276,052
|
|
|
|
146,884
|
|
Other general and administrative
|
|
|
715,765
|
|
|
|
124,421
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
6,310,318
|
|
|
$
|
943,538
|
|
|
|
|
|
|
|
|
25
Other income (expenses)
Interest income was attributable to interest-bearing cash deposits resulting from the capital
raised in private placements. The decrease in interest income is the result of a decline in
interest rates and to a lesser extent a decline in cash balances.
Interest expense pertains to imputed interest on certain employee obligations.
Net loss
As a result of these factors described above, we reported a net loss of $8,976,084 or $0.23 loss
per share in 2008 as compared to a net loss of $14,136,599 or $0.43 loss per share in 2007.
Results of Operations for Telesales Business Segment
Revenues
In 2008, we earned revenues of $18,549,515 as compared to $19,568,722 in 2007, for a decrease of
$1,019,207or 5%. Telesales segment revenues declined due to lower periodic bonus revenue from
carriers, which was caused by lower marketing and selling activity. Revenues include the
following:
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months
|
|
|
|
Ended December 31
|
|
|
|
2008
|
|
|
2007
|
|
Commission revenue from carriers excluding periodic bonuses and ISG
|
|
$
|
16,078,942
|
|
|
$
|
16,043,563
|
|
Periodic bonus revenue from carriers
|
|
|
100,392
|
|
|
|
843,311
|
|
ISG commission revenue
|
|
|
1,404,244
|
|
|
|
1,821,958
|
|
Lead sale revenue
|
|
|
408,120
|
|
|
|
859,890
|
|
Insurint technology fees
|
|
|
97,177
|
|
|
|
|
|
Sub-lease and other revenue
|
|
|
460,640
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
18,549,515
|
|
|
$
|
19,568,722
|
|
|
|
|
|
|
|
|
|
|
|
In 2008, we earned commission revenue from carriers, excluding periodic bonuses and ISG
revenues, of $16,078,942 as compared to $16,043,563 in 2007.
|
|
|
|
We had 31 licensed insurance agent employees at December 31, 2008 as
compared to 118 at December 31, 2007. In March 2008, we closed our New York sales
office, which accounted for approximately 20% of our sales activity for 2007. We
also reduced sales and sales support staff in our Florida office. As a result of
the closure, we terminated 34 licensed sales agents and eliminated eight open
licensed sales positions, which were vacated subsequent to December 31, 2007. In
October 2008, we further reduced our Telesales sales and sales support staff in
our Florida office and terminated 51 employees, including 22 agents. Management
believes these reductions will result in the reduced expenses in excess of reduced
revenue.
|
26
|
|
|
Subsequent to December 31, 2008, we ceased the direct marketing and
sale of health and life insurance and related products to individuals and families
in our Telesales call center. We continue to sell health and life insurance and
related products to individuals and families through our non-employee ISG agents.
Our Telesales business segment eliminated 43 positions including all of its
licensed employee sales agents, along with other Telesales service and support
personnel, and eliminated another 20 positions in Telesales through attrition.
Management believes these reductions will result in the reduced expenses in excess
of reduced revenue.
|
|
|
|
In 2008, we earned periodic bonuses from carriers of $100,392 as compared to $843,311
in 2007. The Telesales segment receives bonuses from certain carriers, which are based
primarily on the Telesales segments sales performance and other criteria established by
carriers and generally do not extend beyond the current calendar year. Accordingly, we
cannot determine what criteria, if any, may be offered by its carriers pertaining to
bonuses beyond the current calendar year. As a result of the cessation of direct
marketing and sales in the first quarter of 2009, management does not anticipate receiving
material periodic bonuses from carriers in the future.
|
|
|
|
|
In 2008, we earned revenue of $1,404,244 relating to ISG as compared to $1,821,958 in
2007. ISG revenue declined as a result of reduced new sales, the lapse of inforce
business and reduced commission overrides earned on the Telesales segment on new and
inforce business. As a result of the transactions with eHealth in February 2009,
management anticipates a significant decline in ISG commission revenue as a result of the
elimination of commission overrides for all Telesales business.
|
27
|
|
|
In 2008, we earned revenues of $408,120 relating to the sale of leads to third parties
as compared to $859,890 in 2007. We re-sell certain leads that we purchase in order to
recoup a portion of our lead cost. The primary reason for the decrease in lead sales
revenue is a decrease in lead cost spending, which results in a reduced number of leads
available for sale. As a result of the cessation of direct marketing in the first quarter
of 2009, management does not anticipate receiving material lead revenue in the future.
|
|
|
|
|
In 2008, we earned revenues of $97,177 relating to Insurint technology fees. Our
Insurint subsidiary provides a proprietary, professional-grade, web based agent portal to
support and assist insurance agents in the business of marketing and selling health
insurance and related products. Insurints technology fees commenced in the second
quarter of 2008.
|
|
|
|
|
In 2008, we earned revenue of $460,640 relating to the sub-lease of a portion of our
Florida office and our former New York sales office. Sub-lease revenue includes base rent,
additional rent pertaining to utilities and occupancy costs and certain telephony,
technology and facility services provided by us to certain of our sub-tenants.
|
|
|
|
On February 21, 2008 the Company entered into a sub-lease agreement
with a third party whereby the third party sub-leased approximately 5,200 square
feet of our Deerfield Beach office space beginning March 1, 2008 through February
28, 2009. This sub-lease agreement was amended and restated on October 3, 2008 to
increase the sub-leased square footage to 13,900 and extend the lease term through
January 31, 2010.
|
|
|
|
|
On October 1, 2008 the Company entered into a sub-lease agreement
with a third party whereby the third party sub-leased approximately 8,000 square
feet of our Deerfield Beach office space beginning October 15, 2008 through
January 31, 2010. In accordance with this sub-lease agreement the Company
recognizes base rent, additional rent representing a portion of certain actual
occupancy expenses for our Deerfield Beach office and certain telephony,
technology and facility services provided to our sub-tenant.
|
|
|
|
|
On April 17, 2008 the Company entered into a sub-lease agreement with
a third party whereby the third party will sub-lease our New York office space for
the balance of the Companys Sublease Agreement and pay the Company sub-lease
payments essentially equal to the Companys costs under the Sublease Agreement.
The third party commenced paying sub-sublease payments to the Company in September
2008 however the third party failed to pay their December 2008, January and
February 2009 rent when due. The Company is a beneficiary to a letter of credit
in the amount of $151,503, which is available for the Company to draw against in
the event of the third partys failure to pay their rent when due. We have
notified the third party that they have breached their lease and that we will make
draws against the letter of credit for amounts past due.
|
28
Total Operating Expenses
Our Telesales segments total operating expenses in 2008 were $26,781,420 as compared to
$34,219,253 in 2007, for a decrease of $7,437,833 or 22%. Total operating expenses consisted of
the following:
|
|
|
Salaries, commission and related taxes consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
Salaries, wages and bonuses
|
|
$
|
8,192,550
|
|
|
$
|
10,462,015
|
|
Share based employee and director compensation
|
|
|
1,516,686
|
|
|
|
1,751,556
|
|
Commissions to employees
|
|
|
1,928,889
|
|
|
|
2,634,257
|
|
Commissions to non-employees
|
|
|
371,441
|
|
|
|
398,900
|
|
Employee benefits
|
|
|
347,011
|
|
|
|
433,099
|
|
Payroll taxes
|
|
|
726,659
|
|
|
|
920,957
|
|
Severance and other compensation
|
|
|
505,610
|
|
|
|
365,651
|
|
Directors compensation
|
|
|
76,833
|
|
|
|
110,666
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
13,665,679
|
|
|
$
|
17,077,101
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and wages were $8,192,550 in 2008 as compared to $10,462,015 in 2007,
for a decrease of $2,269,465 or 22%.
|
|
|
|
This decrease is the result of the reduced personnel employed by the
Telesales segment.
|
|
|
|
|
The Telesales segment had 89 employees at December 31, 2008 as
compared to 253 at December 31, 2007.
|
|
|
|
In March 2008, we closed our New York sales office, which
accounted for approximately 20% of our sales activity for 2007.
We also reduced sales and sales support staff in our Florida
office. As a result of the closure, we terminated 34 licensed
sales agents and eliminated eight open licensed sales positions,
which were vacated subsequent to December 31, 2007. In October
2008, we further reduced our Telesales sales and sales support
staff in our Florida office and terminated 51 employees,
including 22 agents. Management believes these reductions will
result in the reduced expenses in excess of reduced revenue.
|
29
|
|
|
Subsequent to December 31, 2008, we ceased the direct marketing and
sale of health and life insurance and related products to individuals
and families in our Telesales call center. We continue to sell health
and life insurance and related products to individuals and families
through our non-employee ISG agents. Our Telesales business segment
eliminated 43 positions including all of its licensed employee sales
agents along with other Telesales service and support personnel and
eliminated another 20 positions in Telesales through attrition.
Management believes these reductions will result in the reduced expenses
in excess of reduced revenue.
|
|
|
|
Share-based employee and director compensation expense was $1,516,686 in 2008 as
compared to $1,751,556 in 2007.
|
|
|
|
The decrease in 2008 as compared to 2007 was in part the result of an
expense in 2007 pertaining to the modification of the expiration dates and
vesting of two former executives options in the amount of $212,426 and
vesting schedules of stock options issued in 2006.
|
|
|
|
|
Share-based employee and director compensation consists of stock option and
restricted stock grants, which are valued at fair-value on the date of the
grant and expensed over the stock options vesting period or the duration of
employment, whichever is shorter.
|
|
|
|
Commissions to employees were $1,928,889 in 2008 as compared to $2,634,257 in
2007. This decrease was the result of a decrease in sales that resulted in lower
sales commission expense.
|
|
|
|
|
Commissions to non-employees were $371,441 in 2008 as compared to $398,900 in
2007. We pay commissions to non-employee ISG agents.
|
|
|
|
|
Employee benefits expense was $347,011 in 2008 as compared to $433,099 in 2007.
This decrease is the result of the reduced personnel employed by the Telesales
segment. Our employee benefit cost consists of the company-paid portion of group
medical, dental and life insurance coverage and partial matching of employee
contributions to our 401(k) plan.
|
|
|
|
|
Payroll taxes expense was $726,659 in 2008 as compared to $920,957 in 2007. The
decrease was the result of lower salaries, wages, bonuses and commissions to
employees.
|
|
|
|
|
Severance and other compensation expense was $505,610 in 2008 as compared to
$365,651 in 2007. The increase was the result of severance expense as a result of
the termination of Ivan Spinner.
|
30
|
|
|
Lead, advertising and other marketing was $4,375,466 in 2008 as compared to
$8,478,643 in 2007, a decrease of $4,103,177 or 48%, due primarily to a decrease in
the number of leads purchased in 2008 compared to 2007. Subsequent to December 31,
2008, we ceased the direct marketing and sale of health and life insurance and
related products to individuals and families in its Telesales call center, which
will result in the elimination of lead cost in the future.
|
|
|
|
Depreciation and amortization expense consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
Amortization of intangibles acquired as a
result of the ISG acquisition
|
|
$
|
1,045,119
|
|
|
$
|
1,287,397
|
|
Amortization of software and website development
|
|
|
198,181
|
|
|
|
223,081
|
|
Amortization of internet domain name
|
|
|
53,733
|
|
|
|
53,733
|
|
Depreciation expense
|
|
|
625,405
|
|
|
|
590,705
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,922,438
|
|
|
$
|
2,154,916
|
|
|
|
|
|
|
|
|
|
|
|
In 2008, we incurred amortization expense of $1,045,119 as compared to $1,287,397 for
the intangible assets acquired from ISG. The intangible assets acquired from ISG represent
the value of purchased commission override revenue with an assigned value of $1,411,594
amortized over five years in proportion to expected future value, the value of acquired
carrier contracts and agent relationships with an assigned value of $2,752,143 amortized
over five years in proportion to expected future value and the value of employment and
non-compete agreement acquired with an assigned value of $800,593 amortized on a straight
line basis over a weighted average useful life of 3.2 years.
|
|
|
|
As a result of Ivan Spinners termination of employment, we have determined the
value of an employment and non-compete agreement acquired pertaining to Mr. Spinner
impaired as of December 31, 2008 and recorded an impairment charge of $85,078 in
loss of impairment of intangible asset.
|
|
|
|
In 2008, we incurred depreciation expense of $625,405 as compared to $590,705 in 2007.
The increase pertains to the impairment of furniture and equipment located at the Companys
former New York sales office.
|
31
|
|
|
Rent, utilities, telephone and communications expenses consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
Rent, utilities and other occupancy
|
|
$
|
2,609,673
|
|
|
$
|
1,848,632
|
|
Telephone and communications
|
|
|
709,415
|
|
|
|
809,839
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
3,319,088
|
|
|
$
|
2,658,471
|
|
|
|
|
|
|
|
|
|
|
|
In 2008, we incurred rent, utilities and other occupancy expense of $2,609,673 as
compared to $1,848,632 in 2007. The increase was primarily attributable to a
$629,326 accrual for the non-terminable lease for Telesales New York sales office.
In March 2008, we closed our sales office located in New York. On April 17, 2008, we
entered into a sub-lease agreement with a third party, whereby the third party will
sub-lease our New York office space for the balance of our lease and pay us sub-lease
payments essentially equal to the payments under the lease. The terms of the
sublease agreement required us to make certain leasehold improvements. The third
party commenced paying sub-lease payments to us in September 2008; however, the third
party failed to pay its December 2008 and January and February 2009 rent when due.
We are a beneficiary to a letter of credit in the amount of $151,503, which is
available for us to draw against in the event of the third partys failure to pay its
rent when due. Effective December 31, 2008, we have accrued $629,396 related to the
non-terminable lease for the abandoned facilities, which is net present value of our
future lease payments due under the remaining sublease agreement term, plus
managements estimate of utility payments, which are estimated to be $773,311, less
managements estimate of future sub-lease revenue secured by the letter of credit,
which is estimated to be $120,023.
|
|
|
|
|
In 2008, we incurred telephone and communications expense of $709,415 as compared
to $809,839 in 2007. The decrease was primarily attributable the closure of
Telesales New York sales office reduced sales and sales support staff in our
Florida office.
|
|
|
|
In 2008, we incurred professional fees of $1,672,450 as compared to $1,915,223 in 2007
for a decrease of $242,774 or 13%. The decrease was primarily attributable to lower
recruiting and technology outsourcing fees.
|
32
|
|
|
During the first quarter of 2008, Telesales closed its sales office located in New York.
As of March 31, 2008, we determined that all furniture and lease-hold improvements located
at the New York sales office were impaired as a result of the office closure. During the
first quarter of 2008, we recorded an $88,922 expense to write-down the value of these
assets to their net realizable value in loss on impairment of property and equipment.
|
|
|
|
|
Loss on impairment of intangible assets pertains to the following:
|
|
|
|
During the first quarter of 2008, we determined that the portion of the license
fee paid by Telesales for a commission system, together with capitalized costs
incurred to implement the commission system, was impaired as a result of the absence
of definitive plans to implement this system for internal use in Telesales. We
recorded a $295,633 expense in the first quarter of 2008 to write-off the value of
this asset.
|
|
|
|
|
As a result of Ivan Spinners termination of employment, we have determined the
value of an employment and non-compete agreement acquired pertaining to Mr. Spinner
impaired as of December 31, 2008 and recorded an impairment charge of $85,078 in
loss on impairment of intangible asset.
|
|
|
|
Other general and administrative expenses consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
Licensing and appointment fees
|
|
$
|
295,549
|
|
|
$
|
440,240
|
|
Travel and entertainment
|
|
|
112,977
|
|
|
|
301,206
|
|
Office expense
|
|
|
353,519
|
|
|
|
824,181
|
|
Other
|
|
|
594,621
|
|
|
|
244,272
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,356,666
|
|
|
$
|
1,809,899
|
|
|
|
|
|
|
|
|
|
|
|
We incur licensing and appointment costs associated with the licensing of our employee
insurance agents. The reduction in licensing cost is primarily the result of the reduction
in licensed employees.
|
|
|
|
In March 2008, we closed our New York sales office and also reduced sales and
sales support staff in our Florida office. As a result, we terminated 34 licensed
sales agents and eliminated eight open licensed sales positions, which were vacated
subsequent to December 31, 2007. In October 2008, we further reduced our Telesales
sales and sales support staff in our Florida office and terminated 51 employees,
including 22 agents.
|
33
|
|
|
Subsequent to December 31, 2008, we ceased the direct marketing and sale of
health and life insurance and related products to individuals and families in our
Telesales call center. We continue to sell health and life insurance and related
products to individuals and families through our non-employee ISG agents. Our
Telesales business segment eliminated all of its licensed employee sales agents. We
do not incur licensing and appointment fees for our non-employee ISG agents.
|
|
|
|
In 2008, we had a decrease of $658,891, or 36%, in travel, entertainment and office
expense as compared to 2007, due to the closing of the New York sales office and an overall
reduction in travel.
|
|
|
|
|
In 2008, we had an increase of $350,349 in other expense as compared to 2007, primarily
due to estimated cost of settling certain litigation.
|
Loss from operations
As result of these factors described above, we reported a loss from operations of $8,231,905 in
2008 as compared to a loss from operations of $14,650,531 in 2007 in our Telesales business
segment.
34
Results of Operations for the Atiam Business Segment
We acquired Atiam on October 1, 2007. The results of Atiams operations prior to our October 1,
2007 acquisition have been excluded from our financial statements. The results of our Atiam
business segment have been included in the Companys statement of operations as of October 1, 2007.
Thus Atiam segments results from operations for years ended December 31, 2008 and 2007 are not
comparable.
Revenues
For 2008, we earned revenues of $5,578,512, which consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months
|
|
|
|
Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
Consulting and implementation services
|
|
$
|
3,889,069
|
|
|
$
|
668,674
|
|
ASP revenue
|
|
|
1,123,943
|
|
|
|
244,854
|
|
Sales of software licenses
|
|
|
115,000
|
|
|
|
137,500
|
|
Maintenance revenue
|
|
|
450,500
|
|
|
|
90,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
5,578,512
|
|
|
$
|
1,141,028
|
|
|
|
|
|
|
|
|
In 2008, we earned revenues from seven clients as follows:
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months
|
|
|
|
Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
Client 1
|
|
$
|
2,885,388
|
|
|
$
|
474,626
|
|
Client 2
|
|
|
786,740
|
|
|
|
344,863
|
|
Client 3
|
|
|
576,399
|
|
|
|
225,089
|
|
Client 4
|
|
|
552,138
|
|
|
|
96,450
|
|
Clients 5, 6, 7
|
|
|
777,847
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
5,578,512
|
|
|
$
|
1,141,028
|
|
|
|
|
|
|
|
|
|
|
|
Consulting and implementation services revenues are from seven InsPro clients.
Implementation services provided to these clients included assisting clients in setting up
their insurance products in InsPro, providing modifications to InsPros functionality to
support the clients business, interfacing InsPro with the clients other systems,
automation of client correspondence to their customers and data conversion from the
clients existing systems to InsPro.
|
|
|
|
|
In 2008, we earned ASP revenue from five InsPro clients. ASP hosting service enables a
client to lease the InsPro software, paying only for the capacity required to support its
business. ASP clients access InsPro installed on Atiam owned servers located at Atiams
offices or at a third partys site.
|
35
|
|
|
In 2008, we earned software license revenue from a single InsPro client.
|
|
|
|
|
In 2008, we earned maintenance revenues from four clients.
|
Total Operating Expenses
Our Atiam business segments total operating expenses in 2008 were $6,310,318 and consisted of the
following:
|
|
|
Salaries, commission and related taxes consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months
|
|
|
|
Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
Salaries, wages and bonuses
|
|
$
|
3,073,867
|
|
|
$
|
410,962
|
|
Employee benefits
|
|
|
192,053
|
|
|
|
29,405
|
|
Payroll taxes
|
|
|
201,231
|
|
|
|
26,699
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
3,467,151
|
|
|
$
|
467,066
|
|
|
|
|
|
|
|
|
|
|
|
The Atiam business segment had 31 employees at December 31, 2008.
|
|
|
|
Lead, advertising and other marketing was $15,017 in 2008 as compared to $11,052 in
2007 and consisted primarily of marketing and conference fees.
|
|
|
|
|
Depreciation and amortization expense consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months
|
|
|
|
Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
Amortization of intangibles acquired as a
result of the Atiam acquisition
|
|
$
|
468,081
|
|
|
$
|
117,020
|
|
Software development costs for external
marketing
|
|
|
43,574
|
|
|
|
|
|
Depreciation expense
|
|
|
134,052
|
|
|
|
14,831
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
645,707
|
|
|
$
|
131,851
|
|
|
|
|
|
|
|
|
|
|
|
In 2008, we incurred amortization expense of $468,081 for the intangible assets
acquired from Atiam. The Atiam acquisition was effective October 1, 2007.
Intangible assets acquired from Atiam were assigned the following values:
|
|
|
|
value of client contracts and relationships (other than licenses) with an
assigned value of $1,089,223, amortized straight line over five years
|
36
|
|
|
value of purchased software for sale and licensing value with an assigned
value of $644,449, amortized on a straight line basis over five years
|
|
|
|
|
employment and non-compete agreements acquired with an assigned value of
$364,000, amortized on a straight line basis over three years.
|
|
|
|
In 2008, we incurred amortization expense of $43,574 for software development
cost for external marketing.
|
|
|
|
In 2008, we incurred rent, utilities, telephone and communications expense, which
consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months
|
|
|
|
Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
Rent, utilities and other occupancy
|
|
$
|
126,844
|
|
|
$
|
46,248
|
|
Telephone and communications
|
|
|
63,781
|
|
|
|
16,016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
190,625
|
|
|
$
|
62,264
|
|
|
|
|
|
|
|
|
|
|
|
In 2008, we incurred professional fees of $1,276,053, which pertain primarily to
outsourced system development costs and to a lesser extent employee recruiting services.
|
|
|
|
|
In 2008, we incurred other general and administrative expenses, which consisted of the
following:
|
|
|
|
|
|
|
|
|
|
|
|
For
the Twelve Months
Ended December 31,
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
Office expenses
|
|
$
|
23,367
|
|
|
$
|
114,652
|
|
Travel and entertainment
|
|
|
113,217
|
|
|
|
21,894
|
|
Computer processing, hardware, software and
other
|
|
|
579,181
|
|
|
|
(12,125
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
715,765
|
|
|
$
|
124,421
|
|
|
|
|
|
|
|
|
|
|
|
We incur travel and entertainment expenses in connection with marketing, sales
and implementation of InsPro at client locations.
|
|
|
|
|
We incur computer processing fees associated with ASP hosting services. Atiam
has a hosting services contract with a third party, which can be terminated with
notice and payment of a termination fee. This third party provides Atiam with
hosting services for our clients ASP production and test environments.
|
37
Loss From Operations
As a result of these factors described above, we reported a loss from operations of $731,806 in
2008 in our Atiam business segment.
LIQUIDITY AND CAPITAL RESOURCES
At December 31, 2008, we had a cash balance of $1,842,419 and working capital deficit of
$(3,540,008).
On March 31, 2008, we entered into securities purchase agreements with certain institutional
investors and completed a private placement of an aggregate of 6,250,000 shares of our common stock
and warrants to purchase 6,250,000 shares of our common stock. Pursuant to the agreements we sold
investment units at a per unit purchase price of $0.80. Each unit sold in the private placement
consisted of one share of common stock and a warrant to purchase one share of common stock at an
initial exercise price of $0.80 per share, subject to adjustment as provided therein. The gross
proceeds from the private placement were $5,000,000 and we incurred $70,238 of legal and other
expenses in connection with the private placement. We have and are using the net proceeds of the
private placement for working capital purposes.
At December 31, 2008, we had a restricted cash balance of $1,150,000, which represents money market
account balances pertaining to two letters of credit for the benefit of the landlords of our
Florida and New York offices. The money market accounts are on deposit with the issuer of the
letters of credit. We receive interest on the money market accounts.
Net cash used by operations was $8,354,232 in 2008 as compared to cash used by operations of
$5,500,884 in 2007. In 2008, we used cash to fund:
|
|
|
Our net loss of $8,976,084.
|
|
|
|
|
Decreases in unearned commission advances of $5,428,424 relating to decreased commission
payments from certain of our insurance carriers that advance our future commission revenue.
|
|
|
|
We have agreements with certain of our insurance carriers whereby our
insurance carriers advance our first year premium commissions before the commissions
are earned. The unearned portion of premium commissions has been included in the
consolidated balance sheet as a liability for unearned commission advances. These
advance agreements represent a material source of cash to fund our operations.
Unearned commission advances are recognized as commission revenue after we receive
notice that the insurance company has received payment of the related premium. In
the event that the insurance company does not receive payment of the related premium
pertaining to a commission advance, the insurance company generally deducts the
unearned commission advance from its commission payments to us.
|
38
|
|
|
We have an advance agreement with Golden Rule that is contractually limited
to a maximum of $9,000,000, can be terminated by either party at any time, and in the
event of termination, our outstanding advance balance (including interest, if any)
can be called by Golden Rule with seven days written notice. This advance agreement
expired on December 31, 2008 and, as a result, Golden Rule will no longer advance
first year premium commissions to us going forward. As of December 31, 2008, our
outstanding advance balance with Golden Rule was $2,317,003. Subsequent to December
31, 2008 in connection with the eHealth transactions, eHealth paid Golden Rule a
total of $966,097, which represented a partial repayment of our outstanding advance
balance owed to Golden Rule. eHealth advanced these funds from amounts that
otherwise would have been due to us from eHealth under the terms of the eHealth
transaction. In addition, eHealth assumed approximately $794,000 of our outstanding
advance balance with Golden Rule as of the date of the eHealth transaction.
|
|
|
|
|
We have an advance agreement with Humana that allows the insurance carrier
to terminate future advances and convert the outstanding advance balance into a
promissory note, which, if not repaid within 30 days, would incur interest expense.
As of December 31, 2008, our outstanding advance balance with Humana was $353,808.
Subsequent to December 31, 2008 in connection with the eHealth transaction eHealth
assumed $370,794 of the Companys outstanding advance balance with Humana as of the
date of the eHealth transaction. Effective January 31, 2009 Humana notified the
Company that it will no longer advance first year premium commissions and charged
back to the Company the remaining unearned commission advance as of January 31, 2009.
|
|
|
|
|
As of December 31, 2008, our outstanding advance balance with Assurant was
$236,064. Subsequent to December 31, 2008, in connection with the eHealth
transaction, eHealth assumed approximately $220,000 of our outstanding advance
balance with Assurant as of the date of the eHealth transaction.
|
|
|
|
The payment of $157,288 of income tax liabilities assumed as a result of our acquisition
of Atiam in 2007.
|
|
|
|
|
Decreases in accounts payable of $570,313 in 2008, which is primarily the result of the
payment of lead and marketing costs.
|
|
|
|
|
Increases in accrued expense of $599,307 in 2008, which is primarily the result of
increased professional services in the fourth quarter of 2008.
|
|
|
|
|
Decreases in accounts receivable of $753,398 in 2008, which is the result of decreased
commission payments from certain of our insurance carriers that advance us future
commission revenue.
|
39
In addition to cash used in operating activities, we incurred $4,623,332 of non cash expenses and
impairments in 2008, which were included in our net loss, including:
|
|
Stock-based compensation and consulting expense of $1,516,686 and $1,772,031 in 2008 and
2007, respectively.
|
|
|
|
Depreciation and amortization expense of $2,568,145 and $2,286,767 in 2008 and 2007,
respectively.
|
|
|
|
$135,401 loss on impairment of property and equipment pertaining to furniture and
lease-hold improvements located at our former New York sales office.
|
|
|
|
$380,711 loss on impairment of intangible assets, which included $295,633 of expense in
2008 to write-off the value of license fee and capitalized costs incurred to implement a
commission system; and $85,078 as a result of Ivan Spinners termination of employment and
impairment of acquired ISG employee contracts.
|
Net cash used by investing activities in 2008 was $760,558 as compared to $1,887,020 in 2007.
Investing activities pertain to internal development of software for internal and external use and
the purchase of property and equipment supporting current and future operations. Investing
activities in 2007 included $1.35 million for the purchase of Atiam on October 1, 2007.
Net cash provided by financing activities in 2008 was $5,169,624 as compared to $10,863,708 in
2007.
|
|
|
In the first quarter of 2008, we completed a private placement with certain
institutional accredited investors and issued 6,250,000 shares of our common stock and
warrants to purchase 6,250,000 shares of our common stock. Our gross proceeds were
$5,000,000 and we incurred $70,238 of legal and other expenses in connection with the
private placement.
|
|
|
|
|
In the first quarter of 2007, we completed a private placement with certain
institutional and individual accredited investors and issued 5,000,000 shares of our common
stock and warrants to purchase 2,500,000 shares of our common stock. Gross proceeds were
$11,250,000 and placement and other fees paid in connection with the private placement were
$895,240.
|
|
|
|
|
In 2008, our Atiam business segment has entered into several capital lease obligations
to purchase equipment used for operations.
|
40
During the year ended December 31, 2008 we used $8,354,232 of cash to fund operations and $760,558
of cash to fund investing activities. As of December 31, 2008, we have funded our operating
activities from the proceeds of the sale of our common stock; however, based on our most recent
financial projections, we believe that our current level of liquid assets and our expected cash
flows from operations may not be sufficient to finance our operations and financial commitments in
the future. As a result, we have begun to reduce and expect to further reduce our cost structure.
For example, during the first quarter of 2008, we closed our former New York sales office and
reduced staffing at our Florida office in order to reduce expenses and our negative cash flow.
During the third quarter of 2008, we sub-leased our former New York office and began receiving
sub-lease rental revenue, which will offset the lease occupancy costs of the New York office.
Subsequent to September 30, 2008, we further reduced our staffing and subleased a portion of its
Florida office to further reduce our expenses and negative cash flow; however we anticipate that we
will continue to use cash to fund operations for the foreseeable future. Management believes that
our cash on hand together with the net proceeds of the January 2009 private placement and the
recent sale of the Telesales agency business to eHealth will be sufficient to meet our cash
requirements through at least the next 12 months.
Off-Balance Sheet Arrangements
We do not currently have any relationships with unconsolidated entities or financial partnerships,
such as entities referred to as structured finance or special purpose entities, which would have
been established for the purpose of facilitating off-balance sheet or other contractually narrow or
limited purposes.
The letters of credit pertaining to the lease for our Florida office and our New York office were
collateralized in the form of a money market account, which as of December 31, 2008, had a balance
of $1,150,000. This money market account is on deposit with the issuer of the letters of credit
and is classified as restricted cash on our balance sheet. The terms of the money market account
allow us to receive interest on the principal but prohibits us from withdrawing the principal for
the life of the letters of credit.
41
Guarantee of Indebtedness by the Company to Third Parties Pertaining to Unearned Commission
Advances Paid to Non-employee ISG Agents
The Company is a party to sales and marketing agreements whereby the Company has guaranteed the
repayment of unearned commission advances paid directly from third parties including certain of the
Companys insurance carriers to the Companys non-employee ISG agents. Under these agreements
certain third parties pay commissions directly to the Companys non-employee ISG agents and such
payments include advances of first year premium commissions before the commissions are earned.
Unearned commission advances from the Companys insurance carriers to the Companys non-employee
ISG agents are earned after the insurance company has received payment of the related premium. In
the event that the insurance company does not receive payment of the related premium pertaining to
an unearned commission advance the third parties generally deduct the unearned commission advance
from its commission payments to the Companys non-employee ISG agents in the form of charge-backs.
In the event that commission payments from these third parties to the Companys non-employee ISG
agents do not exceed the charge-backs these third parties may deduct the unearned commission
advance to non-employee ISG agents from their payments to the Company or demand repayment of the
non-employee ISG agents unearned commission balance from the Company. The current amount of the
unearned commission advances these third parties to the Companys non-employee ISG agents, which is
the maximum potential amount of future payments the Company could be required to make to these
third parties, is estimated to be approximately $643,000 as of December 31, 2008. As of December
31, 2008 the Company has recorded a liability of $76,651 in accrued expenses for the estimated
amount the Company anticipates it will pay pertaining to these guarantees. Unearned commission
advances from these third parties are collateralized by the future commission payments to the
non-employee ISG agents and to the Company. The Company has recourse against certain non-employee
ISG agents in the event the Company must pay the unearned commission advances.
License Agreement With Realtime Solutions Group
On May 31, 2006, we entered into a Software and Services Agreement (the License Agreement) with
Realtime Solutions Group, L.L.C. (Realtime), under which Realtime granted us a worldwide,
transferable, non-exclusive, perpetual and irrevocable license to use, display, copy, modify,
enhance, create derivate works within, and access Realtime Solutions Groups Straight Through
Processing software (STP) and all associated documentation, source code and object code, for use
in the marketing, promotion and sale of health benefits or insurance products.
As consideration for the grant of the rights and licenses under the License Agreement, we paid to
Realtime a $10,000 nonrefundable cash deposit and upon delivery of the STP software and other
materials we will pay a license fee in the form of 216,612 unregistered shares of our common stock.
Concurrent with entering into the License Agreement, HBDC and Realtime entered into a Registration
Rights Agreement that provides for piggyback registration rights for the to be issued shares.
The Company may unilaterally terminate the License Agreement, with or without cause, at any time on
30 calendar day prior written notice to Realtime. The license rights in the software granted under
the License Agreement survive any termination of the License Agreement in perpetuity.
As of December 31, 2008 the Company has not taken delivery of the STP software or issued Common
Stock in connection with the License Agreement.
42
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
FINANCIAL STATEMENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
Page
|
|
|
|
Number
|
|
|
|
|
|
|
HEALTH BENEFITS DIRECT CORPORATION
|
|
|
|
|
|
|
|
|
|
|
|
|
F-2
|
|
|
|
|
F-3
|
|
|
|
|
F-4
|
|
|
|
|
F-5
|
|
|
|
|
F-6
|
|
|
|
|
F-7
|
|
|
|
|
F-8
|
|
F-1
MANAGEMENTS REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Our management is responsible for establishing and maintaining adequate internal control over
financial reporting, as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934. Our
internal control over financial reporting is designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with accounting principles generally accepted in the United States and
include those policies and procedures that:
|
|
|
Pertain to the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of our assets;
|
|
|
|
|
Provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with accounting principles generally
accepted in the United States;
|
|
|
|
|
Provide reasonable assurance that our receipts and expenditures are being made only in
accordance with authorization of our management and directors; and
|
|
|
|
|
Provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use, or disposition of our assets that could have a material effect on the
financial statements.
|
Because of its inherent limitations, such as resource constraints, human error, lack of knowledge
or awareness and the possibility of intentional circumvention of these controls, internal control
over financial reporting may not prevent or detect misstatements. Furthermore, the design of any
control system is based, in part, upon assumptions about the likelihood of future events, which
assumptions may ultimately prove to be incorrect. Therefore, even those systems determined to be
effective can provide only reasonable assurance with respect to financial statement preparation and
presentation.
Our management assessed the effectiveness of its internal control over financial reporting as of
December 31, 2008. In making this assessment, management used the criteria established in
Internal
Control-Integrated Framework
issued by the Committee of Sponsoring Organizations of the Treadway
Commission (COSO). Based on its assessment, management has concluded that the Companys internal
control over financial reporting was effective as of December 31, 2008.
This Annual Report on Form 10-K does not include an attestation report of the Companys registered
public accounting firm regarding internal control over financial reporting. Managements report
was not subject to attestation by the Companys registered public accounting firm pursuant to
temporary rules of the Securities and Exchange Commission that permit the Company to provide only
managements report in this Annual Report on Form 10-K.
|
|
|
|
|
|
|
|
|
/s/ Anthony R. Verdi
|
|
|
Anthony R. Verdi
|
|
|
Chief Financial Officer and Chief Operating Officer
(Principal Executive Officer and Principal Financial Officer)
March 31, 2009
|
|
F-2
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors
Health Benefits Direct Corporation and Subsidiaries
Radnor, Pennsylvania
We have audited the accompanying consolidated balance sheets of Health Benefits Direct Corporation
and Subsidiaries as of December 31, 2008 and December 31, 2007, the related consolidated statements
of operations, changes in shareholders equity and cash flows for the years ended December 31, 2008
and December 31, 2007. These consolidated financial statements are the responsibility of the
Companys management. Our responsibility is to express an opinion on these consolidated financial
statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement. The
Company is not required to have, nor were we engaged to perform, an audit of its internal control
over financial reporting. Our audit included consideration of internal control over financial
reporting as a basis for designing audit procedures that are appropriate in the circumstances, but
not for the purposes of expressing an opinion on the effectiveness of the Companys internal
control over financial reporting. Accordingly, we express no such opinion. An audit includes
examining on a test basis, evidence supporting the amounts and disclosures in the consolidated
financial statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall consolidated financial
statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all
material respects, the financial position of Health Benefits Direct Corporation and Subsidiaries as
of December 31, 2008 and December 31, 2007, and the results of their operations and their cash
flows for the years ended December 31, 2008 and December 31, 2007, in conformity with accounting
principles generally accepted in the United States of America.
|
|
|
|
|
|
|
|
|
/s/ Sherb & Co., LLP
|
|
|
Certified Public Accountants
|
|
Boca Raton, Florida
March 26, 2009
F-3
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT ASSETS:
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
1,842,419
|
|
|
$
|
5,787,585
|
|
Accounts receivable, less allowance for doubtful
accounts $2,173 and $59,106
|
|
|
919,868
|
|
|
|
1,720,014
|
|
State tax receivable
|
|
|
31,290
|
|
|
|
|
|
Deferred compensation
advances
|
|
|
36,186
|
|
|
|
578,372
|
|
Prepaid expenses
|
|
|
177,833
|
|
|
|
182,087
|
|
Other current assets
|
|
|
8,461
|
|
|
|
22,285
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
current
assets
|
|
|
3,016,057
|
|
|
|
8,290,343
|
|
|
|
|
|
|
|
|
|
|
Restricted cash
|
|
|
1,150,000
|
|
|
|
1,150,000
|
|
Property and equipment, net of accumulated
depreciation $1,545,150 and $1,115,562
|
|
|
1,163,948
|
|
|
|
1,592,480
|
|
Intangibles, net of accumulated
amortization $4,859,779 and $3,108,771
|
|
|
3,198,407
|
|
|
|
5,095,960
|
|
Other assets
|
|
|
180,641
|
|
|
|
165,871
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
8,709,053
|
|
|
$
|
16,294,654
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
912,751
|
|
|
$
|
1,483,064
|
|
Accrued expenses
|
|
|
2,030,948
|
|
|
|
1,406,641
|
|
Current portion of capital lease
obligations
|
|
|
89,297
|
|
|
|
14,707
|
|
Sub-tenant
security deposit
|
|
|
39,093
|
|
|
|
|
|
Due to related
parties
|
|
|
4,315
|
|
|
|
28,500
|
|
Unearned
commission
advances
|
|
|
3,022,161
|
|
|
|
8,450,585
|
|
Deferred revenue
|
|
|
457,500
|
|
|
|
209,125
|
|
Income tax payable
|
|
|
|
|
|
|
157,288
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
current
liabilities
|
|
|
6,556,065
|
|
|
|
11,749,910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LONG TERM LIABILITIES:
|
|
|
|
|
|
|
|
|
Capital
lease
obligations
|
|
|
209,511
|
|
|
|
44,241
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total long
term
liabilities
|
|
|
209,511
|
|
|
|
44,241
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS EQUITY:
|
|
|
|
|
|
|
|
|
Preferred stock ($.001 par value;
10,000,000 shares authorized;
no shares
issued and
outstanding)
|
|
|
|
|
|
|
|
|
Common stock ($.001 par value;
90,000,000 shares authorized;
41,279,645 and 34,951,384
shares issued and outstanding
|
|
|
41,279
|
|
|
|
34,951
|
|
Additional paid-in
capital
|
|
|
43,281,139
|
|
|
|
36,868,409
|
|
Accumulated deficit
|
|
|
(41,378,941
|
)
|
|
|
(32,402,857
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
shareholders equity
|
|
|
1,943,477
|
|
|
|
4,500,503
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
shareholders equity
|
|
$
|
8,709,053
|
|
|
$
|
16,294,654
|
|
|
|
|
|
|
|
|
See accompanying notes to audited consolidated financial statements.
F-4
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
24,128,027
|
|
|
$
|
20,709,750
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
Salaries, commission and related taxes
|
|
|
17,132,830
|
|
|
|
17,544,167
|
|
Lead, advertising and other marketing
|
|
|
4,390,483
|
|
|
|
8,489,695
|
|
Depreciation and amortization
|
|
|
2,568,145
|
|
|
|
2,286,767
|
|
Rent, utilities, telephone and communications
|
|
|
3,509,713
|
|
|
|
2,720,735
|
|
Professional fees
|
|
|
2,948,503
|
|
|
|
2,062,107
|
|
Loss on impairment of property and equipment
|
|
|
88,922
|
|
|
|
|
|
Loss on impairment of intangible asset
|
|
|
380,711
|
|
|
|
125,000
|
|
Other general and administrative
|
|
|
2,072,431
|
|
|
|
1,934,320
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,091,738
|
|
|
|
35,162,791
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(8,963,711
|
)
|
|
|
(14,453,041
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense):
|
|
|
|
|
|
|
|
|
Loss on disposal of property and equipment
|
|
|
(46,479
|
)
|
|
|
(2,592
|
)
|
Interest income
|
|
|
73,913
|
|
|
|
350,707
|
|
Interest expense
|
|
|
(39,807
|
)
|
|
|
(31,673
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other income (expense)
|
|
|
(12,373
|
)
|
|
|
316,442
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(8,976,084
|
)
|
|
$
|
(14,136,599
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share:
|
|
|
|
|
|
|
|
|
Net loss per common share basic and diluted
|
|
$
|
(0.23
|
)
|
|
$
|
(0.43
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding basic and diluted
|
|
|
39,734,505
|
|
|
|
33,006,127
|
|
|
|
|
|
|
|
|
See accompanying notes to audited consolidated financial statements.
F-5
HEALTH
BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY
FOR THE YEARS ENDED DECEMBER 31, 2008 AND 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, $.001
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
Number of
|
|
|
|
|
|
Additional
|
|
Accumulated
|
|
Shareholders
|
|
|
Shares
|
|
Amount
|
|
Paid-in Capital
|
|
Deficit
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance December 31, 2006
|
|
|
28,586,471
|
|
|
$
|
28,586
|
|
|
$
|
22,668,453
|
|
|
$
|
(18,266,258
|
)
|
|
$
|
4,430,781
|
|
Common stock issued in private placement
|
|
|
5,000,000
|
|
|
|
5,000
|
|
|
|
10,349,760
|
|
|
|
|
|
|
|
10,354,760
|
|
Common stock issued in SCA purchase
|
|
|
739,913
|
|
|
|
740
|
|
|
|
1,649,266
|
|
|
|
|
|
|
|
1,650,006
|
|
Common stock issued to directors as compensation
|
|
|
75,000
|
|
|
|
75
|
|
|
|
161,175
|
|
|
|
|
|
|
|
161,250
|
|
Modification of employee stock options
|
|
|
|
|
|
|
|
|
|
|
212,426
|
|
|
|
|
|
|
|
212,426
|
|
Issuance of restricted stock to employees
|
|
|
250,000
|
|
|
|
250
|
|
|
|
(250
|
)
|
|
|
|
|
|
|
|
|
Common stock issued upon exercise of warrants
|
|
|
300,000
|
|
|
|
300
|
|
|
|
449,700
|
|
|
|
|
|
|
|
450,000
|
|
Issuance of stock options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of deferred compensation
|
|
|
|
|
|
|
|
|
|
|
1,377,879
|
|
|
|
|
|
|
|
1,377,879
|
|
Net loss for the period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(14,136,599
|
)
|
|
|
(14,136,599
|
)
|
|
|
|
Balance December 31, 2007
|
|
|
34,951,384
|
|
|
|
34,951
|
|
|
|
36,868,409
|
|
|
|
(32,402,857
|
)
|
|
|
4,500,503
|
|
Common stock issued in private placement
|
|
|
6,250,000
|
|
|
|
6,250
|
|
|
|
4,923,512
|
|
|
|
|
|
|
|
4,929,762
|
|
Common stock issued to directors as compensation
|
|
|
174,010
|
|
|
|
174
|
|
|
|
167,814
|
|
|
|
|
|
|
|
167,988
|
|
Return of restricted stock from employees in payment of withholding tax
|
|
|
(20,749
|
)
|
|
|
(21
|
)
|
|
|
(27,368
|
)
|
|
|
|
|
|
|
(27,389
|
)
|
Forfeiture of restricted stock
|
|
|
(75,000
|
)
|
|
|
(75
|
)
|
|
|
75
|
|
|
|
|
|
|
|
|
|
Amortization of deferred compensation
|
|
|
|
|
|
|
|
|
|
|
1,348,697
|
|
|
|
|
|
|
|
1,348,697
|
|
Net loss for the period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8,976,084
|
)
|
|
|
(8,976,084
|
)
|
|
|
|
Balance December 31, 2008
|
|
|
41,279,645
|
|
|
$
|
41,279
|
|
|
$
|
43,281,139
|
|
|
$
|
(41,378,941
|
)
|
|
$
|
1,943,477
|
|
|
|
|
See
accompanying notes to audited consolidated financial statements
F-6
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
Cash Flows From Operating Activities:
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(8,976,084
|
)
|
|
$
|
(14,136,599
|
)
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
2,568,145
|
|
|
|
2,286,767
|
|
Stock-based compensation and consulting
|
|
|
1,516,686
|
|
|
|
1,772,031
|
|
Loss on impairment of property and equipment
|
|
|
88,922
|
|
|
|
|
|
Loss on impairment of intangible assets
|
|
|
380,711
|
|
|
|
|
|
Loss on the disposal of property and equipment
|
|
|
46,479
|
|
|
|
|
|
Provision for bad debt
|
|
|
46,748
|
|
|
|
(20,317
|
)
|
Changes in assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
753,398
|
|
|
|
1,140,843
|
|
State tax receivable
|
|
|
(31,290
|
)
|
|
|
|
|
Deferred compensation advances
|
|
|
542,186
|
|
|
|
106,626
|
|
Prepaid expenses
|
|
|
4,254
|
|
|
|
(71,944
|
)
|
Other current assets
|
|
|
13,824
|
|
|
|
(11,274
|
)
|
Other assets
|
|
|
(14,770
|
)
|
|
|
(61,308
|
)
|
Accounts payable
|
|
|
(570,313
|
)
|
|
|
288,532
|
|
Accrued expenses
|
|
|
599,301
|
|
|
|
(143,662
|
)
|
Sub-tenant security deposit
|
|
|
39,093
|
|
|
|
|
|
Due to related parties
|
|
|
(24,185
|
)
|
|
|
(35,172
|
)
|
Unearned commission advances
|
|
|
(5,428,424
|
)
|
|
|
3,295,468
|
|
Deferred revenue
|
|
|
248,375
|
|
|
|
51,837
|
|
Income tax payable
|
|
|
(157,288
|
)
|
|
|
37,288
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in operating activities
|
|
|
(8,354,232
|
)
|
|
|
(5,500,884
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows From Investing Activities:
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
(533,661
|
)
|
|
|
(555,787
|
)
|
Proceeds from the sale of property and equipment
|
|
|
64,950
|
|
|
|
|
|
Purchase of intangible assets and capitalization of software development
|
|
|
(291,847
|
)
|
|
|
(1,331,233
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(760,558
|
)
|
|
|
(1,887,020
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows From Financing Activities:
|
|
|
|
|
|
|
|
|
Capital leases obligations assumed
|
|
|
|
|
|
|
19,081
|
|
Gross proceeds from capital leases
|
|
|
282,271
|
|
|
|
41,875
|
|
Payments on capital leases
|
|
|
(42,409
|
)
|
|
|
(2,008
|
)
|
Gross proceeds from sales of common stock
|
|
|
5,000,000
|
|
|
|
11,250,000
|
|
Gross proceeds from exercise of warrants
|
|
|
|
|
|
|
450,000
|
|
Placement and other fees paid in connection with offering
|
|
|
(70,238
|
)
|
|
|
(895,240
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
5,169,624
|
|
|
|
10,863,708
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash
|
|
|
(3,945,166
|
)
|
|
|
3,475,804
|
|
|
|
|
|
|
|
|
|
|
Cash beginning of the year
|
|
|
5,787,585
|
|
|
|
2,311,781
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash end of the year
|
|
$
|
1,842,419
|
|
|
$
|
5,787,585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental Disclosures of Cash Flow Information
Cash payments for income taxes
|
|
$
|
188,578
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non cash investing and financing activities:
|
|
|
|
|
|
|
|
|
Common stock issued for the purchase of SCA
|
|
$
|
|
|
|
$
|
1,650,006
|
|
|
|
|
|
|
|
|
See accompanying notes to audited consolidated financial statements.
F-7
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Organization
Health Benefits Direct Corporation (the Company, we, us or our) was incorporated under the
laws of the state of Nevada on October 21, 2004 as Darwin Resources Corp., (Darwin-NV). On
November 22, 2005, Darwin-NV merged with and into its newly-formed wholly-owned subsidiary, Darwin
Resources Corp., a Delaware corporation (Darwin-DE), solely for the purpose of changing the
Companys state of incorporation from Nevada to Delaware. On November 23, 2005, HBDC II, Inc., a
newly-formed wholly-owned subsidiary of Darwin-DE, was merged with and into Health Benefits Direct
Corporation, a privately-held Delaware corporation (HBDC), and the name of the resulting entity
was changed from Health Benefits Direct Corporation to HBDC II, Inc. Following the merger,
Darwin-DE changed its name to Health Benefits Direct Corporation.
HBDC was formed in January 2004 for the purpose of acquiring, owning and operating businesses
engaged in direct marketing and distribution of health and life insurance products, primarily
utilizing the Internet. On September 9, 2005, HBDC acquired three affiliated Internet health
insurance marketing companies, namely Platinum Partners, LLC, a Florida limited liability company,
Health Benefits Direct II, LLC, a Florida limited liability company, and Health Benefits Direct
III, LLC, a Florida limited liability company. HBDC issued 7,500,000 shares of its common stock and
a warrant to purchase 50,000 shares of its common stock, in the aggregate, in exchange for 100% of
the limited liability company interests of these companies.
The acquisition of HBDC by the Company was accounted for as a reverse merger because, on a
post-merger basis, the former HBDC shareholders held a majority of the outstanding common stock of
the Company on a voting and fully diluted basis. As a result, HBDC was deemed to be the acquirer
for accounting purposes. Accordingly, the consolidated financial statements presented for the
period ended December 31, 2005, are those of HBDC for all periods prior to the acquisition, and the
financial statements of the consolidated companies from the acquisition date forward. The
historical shareholders deficit of HBDC prior to the acquisition has been retroactively restated
(a recapitalization) for the equivalent number of shares received in the acquisition after giving
effect to any differences in the par value of the Company and HBDCs common stock, with an offset
to additional paid-in capital. The restated consolidated retained earnings of the accounting
acquirer, HBDC, are carried forward after the acquisition.
The Company operates though two business segments, which are the Telesales Business Segment
(Telesales) and the Atiam Business Segment (Atiam).
F-8
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Telesales specializes in the direct marketing of health and life insurance and related products to
individuals and families. Telesales has developed proprietary technologies and processes to connect
prospective insurance customers with Telesales agents and service personnel using an integrated
on-line platform with call center follow up. Telesales employs licensed agents supported by
tele-application, customer service and technology employees for the purpose of providing immediate
information to prospective customers and selling insurance products. Telesales receives commission
and other fees from the insurance companies on behalf of which it sells insurance products for the
sale of such products. See Note 14 Subsequent Events
Cessation of Direct Marketing and
Sales in the Telesales Call Center, Transactions with eHealth and Reduction in Staffing.
Atiam is a provider of comprehensive, web-based insurance administration software applications.
Atiams flagship software product is InsPro, which was introduced in 2004. InsPro incorporates a
modular design, which enables the customer to purchase only the functionality needed. Atiams
clients include insurance carriers and third party administrators. Atiam realizes revenue from the
sale of software licenses, application service provider fees, software maintenance fees and
consulting and implementation services. See Note 5 Atiam Acquisition and Note 16 Segment
Information.
Basis of presentation
The consolidated financial statements are prepared in accordance with generally accepted accounting
principles in the United States of America (US GAAP). The consolidated financial statements of
the Company include the Company and its subsidiaries. All material inter-company balances and
transactions have been eliminated.
For purposes of comparability, certain prior period amounts have been reclassified to conform to
the 2008 presentation.
Use of estimates
The preparation of financial statements in conformity with US GAAP requires management to make
estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual
results could differ from those estimates. Significant estimates in 2008 and 2007 include the
allowance for doubtful accounts, stock-based compensation, the useful lives of property and
equipment and intangible assets, revenue recognition and deferred compensation advances to
employees.
Cash and cash equivalents
The Company considers all liquid debt instruments with original matuirities of 3 months or less to
be cash equivalents.
F-9
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Restricted cash
The Company considers all cash and cash equivalents held in restricted accounts pertaining to the
Companys letters of credit as restricted cash.
Accounts receivable
The Company has a policy of establishing an allowance for uncollectible accounts based on its best
estimate of the amount of probable credit losses in its existing accounts receivable. The Company
periodically reviews its accounts receivable to determine whether an allowance is necessary based
on an analysis of past due accounts and other factors that may indicate that the realization of an
account may be in doubt. Account balances deemed to be uncollectible are charged to the allowance
after all means of collection have been exhausted and the potential for recovery is considered
remote. At December 31, 2008, the Company has established, based on a review of its outstanding
balances, an allowance for doubtful accounts in the amount of $2,173.
Accounts receivable from the Companys largest Atiam client as measured by receivable balance
accounted for 30% and 13% of the Companys total accounts receivable balance at December 31, 2008
and 2007, respectively. Accounts receivable from the Companys largest insurance carrier accounted
for 20% and 53% of the Companys total accounts receivable balance at December 31, 2008 and 2007,
respectively.
Fair value of financial instruments
The carrying amounts of financial instruments, including cash and cash equivalents, restricted
cash, accounts receivable, accounts payable, accrued expenses and capital leases approximated fair
value as of December 31, 2008 and December 31, 2007, because of the relatively short-term maturity
of these instruments and their market interest rates.
Property and equipment
Property and equipment are carried at cost. The cost of repairs and maintenance is expensed as
incurred; major replacements and improvements are capitalized. When assets are retired or disposed
of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or
losses are included in income in the year of disposition. In accordance with Statement of
Financial Accounting Standards (SFAS) No. 144, Accounting for the Impairment or Disposal of
Long-Lived Assets the Company examines the possibility of decreases in the value of fixed assets
when events or changes in circumstances reflect the fact that their recorded value may not be
recoverable.
F-10
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Intangible assets
Intangible assets consist of assets acquired in connection with the acquisitions of Insurance
Specialist Group, Inc. (ISG) and Atiam, costs incurred in connection with the development of the
Companys software and website and the purchase of internet domain names. See Note 3 ISG
Acquisition, Note 3 Atiam Acquisition and Note 5 Intangible Assets.
The Companys Telesales segment capitalized certain costs valued in connection with developing or
obtaining internal use software in accordance with American Institute of Certified Public
Accountants Statement of Position 98-1, Accounting for the Costs of Computer Software Developed or
Obtained for Internal Use. These costs, which consist of direct technology labor costs, are
capitalized and amortized using the straight-line method over expected useful lives. Costs that the
Company has incurred in connection with developing the Companys websites and purchasing domain
names are capitalized and amortized using the straight-line method over an expected useful life.
Under the criteria set forth in SOP 98-1, Accounting for the Costs of Computer Software Developed
or Obtained for Internal Use capitalization of software development costs begins upon the
establishment of technological feasibility of the software. The establishment of technological
feasibility and the ongoing assessment of the recoverability of these costs require considerable
judgment by management with respect to certain external factors, including, but not limited to,
anticipated future gross product revenues, estimated economic life, and changes in software and
hardware technology. Capitalized software development costs are amortized utilizing the
straight-line method over the estimated economic life of the software not to exceed three years. We
regularly review the carrying value of software development assets and a loss is recognized when
the unamortized costs are deemed unrecoverable based on the estimated cash flows to be generated
from the applicable software.
F-11
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
The Companys Atiam segment capitalized certain costs valued in connection with developing or
obtaining software for external use in accordance with Statement of Financial Accounting Standards
(SFAS) No. 86,
Accounting for the Costs of Computer Software to be Sold, Leased, or Otherwise
Marketed.
These costs, which consist of direct technology labor costs, are capitalized subsequent
to the establishment of technological feasibility and until the product is available for general
release. Both prior and subsequent costs relating to the establishment of technological
feasibility are expensed as incurred. Development costs associated with product enhancements that
extend the original products life or significantly improve the original products marketability
are also capitalized once technological feasibility has been established. Software development
costs are amortized on a straight-line basis over the estimated useful lives of the products not to
exceed two years, beginning with the initial release to customers. The Company continually
evaluates whether events or circumstances have occurred that indicate the remaining useful life of
the capitalized software development costs should be revised or the remaining balance of such
assets may not be recoverable. The Company evaluates the recoverability of capitalized software
based on the net realizable value of its software products, as defined by the estimated future
revenue from the products less the estimated future costs of completing and disposing of the
products, compared to the unamortized capitalized costs of the products. As of December 31, 2008,
management believes no revisions to the remaining useful life or additional write-downs of
capitalized software development costs are required because the net realizable value of its
software products exceeds the unamortized capitalized costs. Managements estimates about future
revenue and costs associated with its software products are subject to risks and uncertainties
related to, among other things, market and industry conditions, technological changes, and
regulatory factors. A change in estimates could result in an impairment charge related to
capitalized software costs.
Impairment of long-lived assets
In accordance with Statement of Financial Accounting Standards (SFAS) No. 144, Accounting for the
Impairment or Disposal of Long-Lived Assets, the Company periodically reviews its long-lived
assets for impairment whenever events or changes in circumstances indicate that the carrying amount
of the assets may not be fully recoverable. The Company recognizes an impairment loss when the sum
of expected undiscounted future cash flows is less than the carrying amount of the asset. The
amount of impairment is measured as the difference between the assets estimated fair value and its
book value.
Effective June 30, 2007, the Company executed a software license agreement with Atiam Technologies
L.P., which granted the Company a non-exclusive perpetual and irrevocable license to use certain
modules of Atiams policy insurance software, InsPro, for internal use in Telesales. As of March
31, 2008, we determined that the portion of license fee paid for the commission module, together
with capitalized costs incurred to implement the commission module, was impaired as a result of the
absence of definitive plans to implement this module for internal use in Telesales. The Company
recorded a $295,633 expense in the 2008 to write-off the value of this asset.
During the first quarter of 2008, the Company closed its sales office located in New York. As of
March 31, 2008, the Company determined that all furniture and lease-hold improvements located at
the New York sales office were impaired as a result of the office closure. The Company recorded
$88,922 expense to write-down the value of these assets to their net realizable value. During the
third quarter of 2008 the Company sold all furniture and equipment located at the New York office
and realized a loss of $92,374.
F-12
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
As a result of termination of Ivan Spinners employment the Company has determined the value of an
employment and non-compete agreement acquired pertaining to Mr. Spinner impaired as of December 31,
2008 and recorded an impairment charge of $85,078.
Income taxes
The Company accounts for income taxes under the liability method in accordance with Statement of
Financial Accounting Standards No. 109, Accounting for Income Taxes under this method, deferred
income tax assets and liabilities are determined based on differences between the financial
reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and
laws that will be in effect when the differences are expected to reverse.
Loss per common share
In accordance with SFAS No. 128 Earnings Per Share, basic earnings per share is computed by
dividing net income by the weighted average number of shares of common stock outstanding during the
period. Diluted earnings per share is computed by dividing net income by the weighted average
number of shares of common stock, common stock equivalents and potentially dilutive securities
outstanding during each period. Diluted loss per common share is not presented because it is
anti-dilutive. The Companys common stock equivalents at December 31, 2008 include the following:
|
|
|
|
|
Options
|
|
|
4,291,200
|
|
Warrants
|
|
|
13,636,686
|
|
|
|
|
|
|
|
|
|
17,927,886
|
|
|
|
|
|
|
Revenue recognition
We follow the guidance of the Commissions Staff Accounting Bulletin 104 for revenue recognition.
In general, the Company records revenue when persuasive evidence of an arrangement exists, services
have been rendered or product delivery has occurred, the sales price to the customer is fixed or
determinable, and collectibility is reasonably assured.
F-13
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Telesales segment revenue recognition
Our Telesales business segment generates revenue primarily from the receipt of commissions paid to
the Company by insurance companies based upon the insurance policies sold to consumers by the
Company. These revenues are in the form of first year, bonus and renewal commissions that vary by
company and product. We recognize commission revenue primarily from the sale of health insurance,
after we receive notice that the insurance company has received payment of the related premium.
First year commission revenues per policy can fluctuate due to changing premiums, commission rates,
and types or amount of insurance sold. Insurance premium commission revenues are recognized
pro-rata over the terms of the policies. Revenues for renewal commissions are recognized after we
receive notice that the insurance company has received payment for a renewal premium. Renewal
commission rates are significantly less than first year commission rates and may not be offered by
every insurance company or with respect to certain types of products. The unearned portion of
premium commissions has been included in the consolidated balance sheet as a liability for unearned
commission advances.
The length of time between when we submit a consumers application for insurance to an insurance
company and when we recognize revenue varies. The type of insurance product, the insurance
companys premium billing and collection process, and the insurance companys underwriting backlog
are the primary factors that impact the length of time between submitted applications and revenue
recognition. Any changes in the amount of time between submitted application and revenue
recognition, which are influenced by many factors not under our control, create fluctuations in our
operating results and could affect our business, operating results and financial condition.
The Company receives bonuses based upon individual criteria set by insurance companies, which vary
over time and generally do not extend beyond the current calendar year. We recognize bonus revenues
when we receive notification from the insurance company of the bonus due to us.
The Company receives fees for the placement and issuance of insurance policies that are in addition
to, and separate from, any sales commissions paid by insurance companies. As these policy fees are
not refundable and the Company has no continuing obligation, all such revenues are recognized on
the effective date of the policies or, in certain cases, the billing date, whichever is later.
F-14
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
The Company also generates revenue from the sale of leads to third parties. Such revenues are
recognized when the Company delivers the leads and bills the purchaser of the leads.
The Company also generates revenue from the sub-lease of our leased New York City office and a
portion of our leased Deerfield Beach Florida office, which are both leased under operating leases.
The terms of the Companys sub-lease of our New York City office is under similar terms as our
lease. The Company sub-leases portions of our Deerfield Beach office to two unaffiliated parties
through January 31, 2010. Sub-lease revenue includes base rent, additional rent representing a
portion of occupancy expenses under the terms of the sub-leases and certain technology and facility
services provided. We recognize sub-lease revenue when lease rent payments are due in accordance
with the sub-lease agreements in accordance with SFAS No. 13 Accounting for Leases. Recognition
of sub-lease revenue commences when control of the facility has been given to the tenant. We record
a provision for losses on accounts receivable equal to the estimated uncollectible amounts. This
estimate is based on our historical experience and a review of the current status of the Companys
receivables.
See Note 14 Subsequent Events.
Atiam segment revenue recognition
The Companys Atiam business segment offers InsPro on a licensed and an application service
provider (ASP) basis. An InsPro software license entitles the purchaser a perpetual license to a
copy of the InsPro software installed at a single client location. Alternatively, ASP hosting
service enables a client to lease the InsPro software, paying only for that capacity required to
support their business. ASP clients access InsPro installed on Atiam owned servers located at
Atiams offices or at a third partys site.
Software maintenance fees apply to both licensed and ASP clients. Maintenance fees cover periodic
updates to the application and the InsPro help desk.
Consulting and implementation services are generally associated with the implementation of an
InsPro instance for either an ASP or licensed client, and cover such activity as InsPro
installation, configuration, modification of InsPro functionality, client insurance plan set-up,
client insurance document design and system documentation.
The Company recognizes revenues in accordance with AICPA Statement of Position (SOP) 97-2,
Software
Revenue Recognition
, as amended by SOP 98-9 (Modification of SOP 97-2, Software Revenue
Recognition, With Respect to Certain Transactions). Revenue from software license agreements is
recognized when persuasive evidence of an agreement exists, delivery of the software has occurred,
the fee is fixed or determinable, and collectibility is probable. The Company considers fees
relating to arrangements with payment terms extending beyond one year to not be fixed or
determinable and revenue for these arrangements is recognized as payments become due from the
customer. In software arrangements that include more than one InsPro module, the Company allocates
the total arrangement fee among the modules based on the relative fair value of each of the
modules.
F-15
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
License revenue allocated to software products generally is recognized upon delivery of the
products or deferred and recognized in future periods to the extent that an arrangement includes
one or more elements to be delivered at a future date and for which fair values have not been
established. Revenue allocated to maintenance agreements is recognized ratably over the
maintenance term and revenue allocated to training and other service elements is recognized as the
services are performed.
The unearned portion of Atiams revenue, which is revenue collected or billed but not yet
recognized as earned, has been included in the consolidated balance sheet as a liability for
deferred revenue.
Deferred compensation advances
The Company regularly advanced commissions to independent sales agents and sales employees, which
are accounted for as deferred compensation advances. If the Company does not ultimately receive
its revenue pertaining to the underlying product sales for which the Company has advanced
commissions, the Company deducts such advanced commissions from the sales agents or sales
employees current or future commissions. Deferred compensation advances are charged to expense
when earned by the sales agent or sales employee, which approximates the Companys recognition of
earned revenue for the underlying product sales. The recoverability of deferred compensation
advances is periodically reviewed by management and is net of managements estimate for
uncollectability. Management believes deferred compensation advances as reported are fully
realizable.
Lead, advertising and other marketing expense
Lead expenses, which are costs incurred in Telesales, are paid referrals from third-party lead
aggregators of individuals who have expressed an interest in purchasing insurance products.
Advertising expense pertains to direct response advertising. Other marketing consists of
professional marketing services. Lead, advertising and other marketing are expensed as incurred.
See Note 14 Subsequent Events.
Concentrations of credit risk
The Company maintains its cash and restricted cash in bank deposit accounts, which exceed the
federally insured limits of $250,000 per account as of December 31, 2008. At December 31, 2008,
the Company had approximately $1,209,000 in United States bank deposits, which exceeded federally
insured limits. Effective October 3, 2008 through December 31, 2009, federally insured limits have
been increased from $100,000 to $250,000 per account. The Company has not experienced any losses
in such accounts through December 31, 2008.
During the year ended December 31, 2008, approximately 36% and 16% of the Companys revenue was
earned from each of the Companys two largest insurance carriers. During the years ended December
31, 2007, approximately 50% and 16% of the Companys revenue was earned from each of the Companys
two largest insurance carriers. See Note 14 Subsequent Events.
F-16
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Stock-based compensation
The Company follows the provisions of SFAS No. 123(R), Share-Based Payment, under the modified
prospective method. SFAS No. 123(R) requires stock based compensation transactions be accounted for
using a fair-value-based method. Under the modified prospective method, the Company is required to
recognize compensation cost for share-based payments to employees based on their grant-date fair
value from the beginning of the fiscal period in which the recognition provisions are first
applied.
Non-employee stock based compensation
The cost of stock based compensation awards issued to non-employees for services are recorded at
either the fair value of the services rendered or the instruments issued in exchange for such
services, whichever is more readily determinable, using the measurement date guidelines enumerated
in Emerging Issues Task Force Issue (EITF) Issue No. 96-18, Accounting for Equity Instruments
That Are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or
Services (EITF 96-18).
Registration rights agreements
The Company has adopted View C of EITF 05-4 The Effect of a Liquidated Damages Clause on a
Freestanding Financial Instrument Subject to EITF Issue No. 00-19 Accounting for Derivative
Financial Instruments Indexed to, and Potentially Settled In, a Companys Own Stock (EITF 05-4).
Accordingly, the Company classifies as liability instruments the fair value of registration rights
agreements when such agreements (i) require it to file, and cause to be declared effective under
the Securities Act, a registration statement with the Commission within contractually fixed time
periods, and (ii) provide for the payment of liquidating damages in the event of its failure to
comply with such agreements. Under View C of EITF 05-4, (i) registration rights with these
characteristics are accounted for as derivative financial instruments at fair value and (ii)
contracts that are (a) indexed to and potentially settled in an issuers own stock and (b) permit
gross physical or net share settlement with no net cash settlement alternative are classified as
equity instruments.
At December 31, 2008, the Company does not believe that it is probable that the Company will incur
a penalty in connection with the registration rights agreement, which we entered into on March 31,
2008 in connection with the 2008 private placement. Accordingly, no liability was recorded as of
December 31, 2008.
F-17
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Recent accounting pronouncements
The Company adopted the provisions of FASB Interpretation No. 48 Accounting for Uncertainty in
Income Taxes on January 1, 2007. The adoption did not result in the recording of a liability for
unrecognized tax benefits. The Company or one or more of its subsidiaries files income tax returns
in the U.S. federal jurisdiction and various states and local jurisdictions. While the Companys
past tax returns are not currently under examination, generally all past returns are subject to
examination by the relevant taxing authorities. The Company has not recorded any liability for
uncertain tax positions since management believes the tax return position taken reflects the most
likely outcome upon audit and that any audit adjustment would not result in any additional tax
liability as a result of the Companys material tax losses.
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and
Financial Liabilities (SFAS No. 159), which provides companies with an option to report selected
financial assets and liabilities at fair value. SFAS No. 159 also establishes presentation and
disclosure requirements designed to facilitate comparisons between companies that choose different
measurement attributes for similar types of assets and liabilities. SFAS No. 159 is effective as of
the beginning of an entitys first fiscal year beginning after November 15, 2007. The Company
believes that the adoption of SFAS No. 159 will not have a material effect on the Companys
financial statements.
In December 2007 FASB issued FAS 141(R) Business Combinations (FAS 141 (R)) and FAS 160
Noncontrolling Interests in Consolidated Financial Statements (FAS 160). These statements are
effective for fiscal years, and interim periods within those fiscal years in case of FAS 160,
beginning on or after December 15, 2008. Earlier adoption is prohibited. Together these
statements revise the accounting rules with respect to accounting for business combinations.
Specifically, the objective of FAS 141(R) is to improve the relevance, representational
faithfulness and comparability of the information that the reporting entity provides in its
financial reports about a business combination and its effects. This statement thus establishes
principles and requirements for how the acquirer:
|
|
|
Recognizes and measures in its financial statements the identifiable assets acquired,
the liabilities assumed, and any noncontrolling interest in the acquiree;
|
|
|
|
|
Recognizes and measures the goodwill acquired in the business combination or a gain from
a bargain purchase; and
|
|
|
|
|
Determines what information to disclose to enable users of the financial statements to
evaluate the nature and financial effects of the business combination.
|
The objective of FAS 160 is to improve the relevance, comparability, and transparency of the
financial information that a reporting entity provides in its consolidated financial statements by
establishing accounting and reporting standards that require:
F-18
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
|
|
|
The ownership interests in subsidiaries held by parties other than the parent be clearly
identified, labeled, and presented in the consolidated statement of financial position
within equity, but separate from the parents equity.
|
|
|
|
|
The amount of consolidated net income attributable to the parent and to the
noncontrolling interest be clearly identified and presented on the face of the consolidated
statement of income.
|
|
|
|
|
Changes in a parents ownership interest while the parent retains its controlling
financial interest in its subsidiary be accounted for consistently. A parents ownership
interest in a subsidiary changes if the parent purchases additional ownership interests in
its subsidiary or if the parent sells some of its ownership interests in its subsidiary. It
also changes if the subsidiary reacquires some of its ownership interests or the subsidiary
issues additional ownership interests. All of those transactions are economically similar,
and this statement requires that they be accounted for similarly, as equity transactions.
|
|
|
|
|
When a subsidiary is deconsolidated, any retained noncontrolling equity investment in
the former subsidiary be initially measured at fair value. The gain or loss on the
deconsolidation of the subsidiary is measured using the fair value of any noncontrolling
equity investment rather than the carrying amount of that retained investment.
|
|
|
|
|
Entities provide sufficient disclosures that clearly identify and distinguish between
the interests of the parent and the interests of the noncontrolling owners.
|
Together these statements are not currently expected to have a significant impact on the Companys
consolidated financial statements. A significant impact may however be realized on any future
acquisition(s) by the Company. The amounts of such impact cannot be currently determined and will
depend on the nature and terms of such future acquisition(s), if any.
In March 2008, the FASB issued FASB No. 161, Disclosures about Derivative Instruments and Hedging
Activities, which amends and expands the disclosure requirements of FASB No. 133, Accounting for
Derivative Instruments and Hedging Activities, with the intent to provide users of financial
statements with an enhanced understanding of; how and why an entity sues derivative instruments,
how the derivative instruments and the related hedged items are accounted for and how the related
hedged items affect an entitys financial position, performance and cash flows. This statement is
effective for financial statements for fiscal years and interim periods beginning after November
15, 2008. Management believes this statement has no impact on the consolidated financial
statements of the Company.
F-19
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
In May 2008, the FASB issued SFAS 162,
The Hierarchy of Generally Accepted Accounting Principles
(SFAS 162)
. SFAS 162 identifies the sources of accounting principles and the framework for
selecting the principles used in the preparation of financial statements of nongovernmental
entities that are presented in conformity with GAAP in the United States. Any effect of applying
the provisions of SFAS 162 shall be reported as a change in accounting principle in accordance with
SFAS 154,
Accounting Changes and Error Corrections
. SFAS 162 is effective 60 days following
approval by the Securities and Exchange Commission of the Public Company Accounting Oversight Board
amendments to AU Section 411,
The Meaning of Present Fairly in Conformity with Generally Accepted
Accounting Principles.
Management does not anticipate that the adoption of SFAS 162 will have a
material impact on the Companys consolidated financial statements.
In June 2008, the FASB issued FASB Staff Position EITF 03-6-1, Determining Whether Instruments
Granted in Share-Based Payment Transactions Are Participating Securities (FSP 03-6-1), which
addresses whether instruments granted in share-based payment transactions are participating
securities prior to vesting and, therefore, need to be included in earnings allocation in computing
earnings per share under the two-class method. The statement is effective for financial statements
issued for fiscal years beginning after December 15, 2008 and retrospective application is required
for all periods presented. Management believes FSP 03-6-1 has no impact on the consolidated
financial statements of the Company.
On September 12, 2008, the FASB issued FSP FAS 133-1 and FIN 45-4,
Disclosures about Credit
Derivatives and Certain Guarantees: An Amendment of FASB Statement No. 133 and FASB Interpretation
No. 45; and Clarification of the Effective Date of FASB Statement No. 161
(FSP FAS 133-1 and FIN
45-4). FSP FAS 133-1 and FIN 45-4 (1) amends Statement of Financial Accounting Standards (SFAS)
No. 133,
Accounting for Derivative Instruments and Hedging Activities
(SFAS 133), to require
disclosures by sellers of credit derivatives, including credit derivatives embedded in a hybrid
instrument; (2) amends FASB Interpretation No. 45,
Guarantors Accounting and Disclosure
Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others
, to require an
additional disclosure about the current status of the payment/performance risk of a guarantee and
(3) clarifies the FASBs intent about the effective date of SFAS No. 161,
Disclosures about
Derivative Instruments and Hedging Activities an amendment of FASB Statement No. 133
(SFAS
161). FSP FAS 133-1 and FIN 45-4 is effective for reporting periods ending after November 15,
2008. Management believes FSP FAS 133-1 and FIN 45-4 have no impact on the consolidated financial
statements of the Company.
In October 2008 the FASB issued FASB Staff Position SFAS No. 157-3, Determining the Fair Value of
a Financial Asset When the Market for That Asset Is Not Active (FSP). This FSP clarifies the
application of SFAS No. 157 in an inactive market and provides an example to illustrate key
considerations in determining the fair value of a financial asset when the market for that
financial asset is not active. This FSP was effective October 10, 2008 and must be applied to prior
periods for which financial statements have not been issued. The application of this FSP did not
have a material impact to our consolidated financial statements.
F-20
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 1
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
On December 11, 2008, the FASB issued FSP FAS 140-4 and FASB Interpretation (FIN) 46(R)-8,
Disclosures about Transfers of Financial Assets and Interests in Variable Interest Entities
(FSP
FAS 140-4 and FIN 46(R)-8). This FSP requires additional disclosures by public entities with
continuing involvement in transfers of financial assets to special purpose entities and with
variable interests in VIEs. FSP FAS 140-4 and FIN 46(R)-8 was effective for reporting periods
ending after December 15, 2008. Management believes FSP FAS 140-4 and FIN 46(R)-8 have no material
impact on the consolidated financial statements of the Company.
On January 12, 2009, the Financial Accounting Standards Board (FASB) issued FASB Staff Position
(FSP) Emerging Issues Task Force (EITF) 99-20-1
, Amendments to the Impairment Guidance of EITF
Issue No. 99-20
(FSP EITF 99-20-1). This FSP amends EITF Issue No. 99-20,
Recognition of Interest
Income and Impairment on Purchased Beneficial Interests and Beneficial Interests That Continue to
Be Held by a Transferor in Securitized Financial Assets,
by eliminating the requirement that a
holders best estimate of cash flows be based upon those that a market participant would use.
Instead, FSP EITF 99-20-1 eliminates the use of market participant assumptions and requires the use
of managements judgment in the determination of whether it is probable there has been an adverse
change in estimated cash flow. This FSP was effective for reporting periods ending after December
15, 2008. Management believes FSP EITF 99-20-1 has no material impact on the consolidated financial
statements of the Company.
Other accounting standards that have been issued or proposed by the FASB or other standards-setting
bodies that do not require adoption until a future date are not expected to have a material impact
on the consolidated financial statements upon adoption.
NOTE 2
ISG ACQUISITION
On April 3, 2006, the Company entered into a merger agreement (the ISG Merger Agreement) with ISG
Merger Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of the Company
(Merger Sub), ISG, and Ivan M. Spinner pursuant to which, among other things, Merger Sub merged
with and into ISG (the ISG Merger). As consideration for the ISG Merger, the Company made a cash
payment of $920,000 and issued 1,000,000 shares of its common stock to Mr. Spinner, the sole
stockholder of ISG, in exchange for all of the outstanding stock of ISG. The ISG merger was
completed on April 4, 2006.
F-21
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 2
ISG ACQUISITION (continued)
The Company accounted for the acquisition of ISG using the purchase method of accounting in
accordance with Statement of Financial Accounting Standards No. 141 Business Combinations. The
Companys purchase price for ISG in the aggregate was $5,154,329 and consisted of the following:
|
|
|
|
|
Cash payment to seller
|
|
$
|
1,135,000
|
|
Fair value of common stock issued to seller
|
|
|
3,310,806
|
|
Discounted value of future fixed payments of employment agreement
|
|
|
225,212
|
|
Fair value of stock option issued to seller
|
|
|
425,381
|
|
Estimated direct transaction fees and expenses
|
|
|
57,930
|
|
|
|
|
|
|
|
|
|
|
Estimated purchase price
|
|
$
|
5,154,329
|
|
|
|
|
|
The following table summarizes the estimated fair values of ISGs assets acquired and liabilities
assumed at the date of acquisition.
|
|
|
|
|
Cash
|
|
$
|
111,024
|
|
Accounts receivable
|
|
|
210,889
|
|
Deferred compensation advances
|
|
|
256,775
|
|
Prepaid expenses and other assets
|
|
|
957
|
|
Property and equipment, net
|
|
|
600
|
|
Intangible assets
|
|
|
4,964,330
|
|
Accrued expenses
|
|
|
(164,549
|
)
|
Unearned commission advances
|
|
|
(225,697
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
5,154,329
|
|
|
|
|
|
Intangible assets acquired from ISG were assigned the following values: value of purchased
commission override revenue with an assigned value of $1,411,594 amortized over five years in
proportion to expected future value; value of acquired carrier contracts and agent relationships
with an assigned value of $2,752,143 amortized over five years in proportion to expected future
value; and value of an employment and non-compete agreement acquired with an assigned value of
$800,593 amortized straight line over the contractual period, which is a weighted average expected
useful life of 3.1 years. Intangible assets acquired from ISG had the following unamortized values
as of December 31, 2008: value of purchased commission override revenue of $227,779 and value of
acquired carrier contracts and agent relationships of $1,032,294. As a result of Ivan Spinners
termination of employment the Company has determined the value of an employment and non-compete
agreement acquired pertaining to Mr. Spinner impaired as of December 31, 2008 and recorded an
impairment charge of $85,078 in depreciation and amortization expense.
See Note 14 Subsequent Events.
F-22
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
Note 3
ACQUISITION OF ATIAM
On October 1, 2007, HBDC Acquisition, LLC (HBDC Sub), a Delaware limited liability company and
wholly-owned subsidiary of the Company, entered into an Agreement to Transfer Partnership Interests
(the Bilenia Agreement) with the former partners (the Bilenia Partners) of BileniaTech, L.P., a
Delaware limited partnership (Bilenia), whereby HBDC Sub purchased all of the outstanding general
and limited partnership interests of Atiam Technologies, L.P., a Delaware limited partnership,
owned by the Bilenia Partners. Bilenia owned approximately 40% of Atiam Technologies, L.P. The
execution of the Bilenia Agreement and the transfer of the Atiam partnership interests to HBDC Sub
there under were conditions precedent to the closing of the Merger Agreement (as defined below) on
October 1, 2007 (the Closing Date).
The aggregate amount paid by HBDC Sub to the Bilenia Partners for the Atiam partnership interests
under the Bilenia Agreement was $1,000,000, consisting of $500,000 in cash and 224,216 shares of
the Companys common stock, which shares had an aggregate value of $500,000 based on the average
closing price per share ($2.23) of Company Common Stock on The Over the Counter Bulletin Board
(OTCBB) on the five consecutive trading days preceding the Closing Date.
On September 21, 2007, the Company entered into an Agreement and Plan of Merger (the Atiam Merger
Agreement) by and among the Company, HBDC, System Consulting Associates, Inc., a Pennsylvania
corporation (SCA), and the shareholders of SCA party thereto (the Shareholders). SCA owned
approximately 60% of Atiam Technologies, L.P. The Company and SCA closed on the Merger on October
1, 2007.
The Atiam Merger Agreement provided for a business combination whereby SCA would be merged with and
into HBDC Sub, with HBDC Sub continuing as the surviving corporation and as a wholly-owned
subsidiary of the Company (the Atiam Merger). The aggregate amount paid by the Company with
respect to all outstanding shares of capital stock of SCA (such amount, the Atiam Merger
Consideration) was $2,000,000, consisting of (a) $850,000 in cash and (b) 515,697 unregistered
shares of the Companys common stock, which number of shares had a value of $1,150,000 based on the
average closing price per share ($2.23) of Common Stock on OTCBB on the five consecutive trading
days preceding the closing date. Upon the effectiveness of the Atiam Merger, each share of SCA
Common Stock issued and outstanding immediately prior to the closing date was converted into the
right to receive a pro rata portion of the Atiam Merger Consideration. The Company placed
certificates representing 134,529 shares, or an amount equal to $300,000, of the Companys common
stock that otherwise would be payable to the Shareholders as Atiam Merger Consideration into an
escrow account, which shares will be held in escrow for a period of one year to satisfy any
indemnification claims by the Company or HBDC Sub under the Atiam Merger Agreement.
Through October 1, 2007, SCA operated through Atiam Technologies, L.P. Subsequent to October 1,
2007, SCA was merged into HBDC Sub, which was subsequently renamed Atiam Technologies LLC and
operates as the Companys Atiam business. The results of our Atiam business segment have been
included in the Companys statement of operations as of October 1, 2007. The Companys Atiam
business segment is a provider of comprehensive, web-based insurance administration software
applications that support individual insurance products.
F-23
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
Note 3
ACQUISITION OF ATIAM (continued)
The Company accounted for the acquisition of Atiam using the purchase method of accounting in
accordance with Statement of Financial Accounting Standards No. 141 Business Combinations. Our
calculation for the consideration paid for Atiam in connection with the Bilenia Agreement and the
Atiam Merger Agreement in the aggregate was $3,080,744 and consisted of the following:
|
|
|
|
|
Cash payments to sellers
|
|
$
|
1,350,000
|
|
Fair value of common stock issued to sellers
|
|
|
1,650,006
|
|
Estimated direct transaction fees and expenses
|
|
|
80,738
|
|
|
|
|
|
Estimated purchase price
|
|
$
|
3,080,744
|
|
|
|
|
|
We estimated the fair values of Atiams assets acquired and liabilities assumed at the date of
acquisition as follows:
|
|
|
|
|
Cash
|
|
$
|
608,534
|
|
Accounts receivable
|
|
|
643,017
|
|
Prepaid expenses & other assets
|
|
|
22,623
|
|
Property and equipment, net
|
|
|
158,819
|
|
Other assets
|
|
|
3,401
|
|
Intangible assets
|
|
|
2,097,672
|
|
Accounts payable
|
|
|
(34,278
|
)
|
Accrued expenses
|
|
|
(122,675
|
)
|
Income taxes payable
|
|
|
(157,288
|
)
|
Deferred revenue
|
|
|
(120,000
|
)
|
Long and short term capital lease obligations
|
|
|
(19,081
|
)
|
|
|
|
|
|
|
$
|
3,080,744
|
|
|
|
|
|
Intangible assets acquired from Atiam were assigned the following values: value of client contracts
and relationships other than license with an assigned value of $1,089,223 amortized straight line
over five years; value of purchased software for sale and licensing value with an assigned value of
$644,449 amortized straight line over five years; and employment and non-compete agreements
acquired with an assigned value of $364,000 amortized straight line over three years. Intangible
assets acquired from Atiam had the following unamortized values as of December 31, 2008: value of
client contracts and relationships other than licensing of $816,916; value of purchased software
for sale and licensing value of $483,337; and employment and non-compete agreements acquired of
$212,319.
F-24
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
Note 3
ACQUISITION OF ATIAM (continued)
The following table summarizes the required disclosures of the pro forma combined entity, as if the
acquisition of Atiam occurred at January 1, 2007.
|
|
|
|
|
|
|
For the Year
|
|
|
Ended
|
|
|
December 31,
|
|
|
2007
|
|
|
|
|
|
Revenues, net
|
|
$
|
23,710,061
|
|
Net loss
|
|
|
(14,042,239
|
)
|
Net loss per common share basic and diluted
|
|
$
|
(0.42
|
)
|
In connection with the Atiam acquisition, Atiam entered into three-year employment agreements with
four key employees of Atiam effective October 1, 2007. These employment agreements provide that
these four key employees will be compensated at an aggregate annual base salary of $700,000 with
bonus compensation at the discretion of the Companys board. These agreements may be terminated by
the Company for cause (as such term is defined in the agreements) and without cause upon 30
days notice. These agreements may be terminated by the Company without cause, in which case the
terminated employee will be entitled to their base salary for a period ranging from six to twelve
months. These agreements also contain non-competition and non-solicitation provisions for the
duration of the agreements plus a period ranging from six to twelve months after termination of
employment.
NOTE 4
PROPERTY AND EQUIPMENT
Property and equipment consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Useful Life
|
|
|
At December 31,
|
|
|
At December 31,
|
|
|
|
(Years)
|
|
|
2008
|
|
|
2007
|
|
Computer equipment and software
|
|
|
3
|
|
|
$
|
1,326,541
|
|
|
$
|
967,347
|
|
Phone equipment and software
|
|
|
3
|
|
|
|
726,535
|
|
|
|
726,535
|
|
Office equipment
|
|
|
4.6
|
|
|
|
57,066
|
|
|
|
89,485
|
|
Office furniture and fixtures
|
|
|
6.7
|
|
|
|
388,934
|
|
|
|
575,450
|
|
Leasehold improvements
|
|
|
9.8
|
|
|
|
232,411
|
|
|
|
349,225
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,731,487
|
|
|
|
2,708,042
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less accumulated depreciation
|
|
|
|
|
|
|
(1,567,539
|
)
|
|
|
(1,115,562
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,163,947
|
|
|
$
|
1,592,480
|
|
|
|
|
|
|
|
|
|
|
|
|
For the years ended December 31, 2008 and 2007, depreciation expense was $759,457 and $605,536,
respectively.
F-25
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 5
INTANGIBLE ASSETS
Intangible assets consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Useful Life (Years)
|
|
At December 31,
|
|
At December 31,
|
|
|
Weighted average
|
|
2008
|
|
2007
|
|
|
|
ISG intangible assets acquired
|
|
|
4.7
|
|
|
$
|
4,964,338
|
|
|
$
|
4,964,338
|
|
Atiam intangible assets acquired
|
|
|
4.7
|
|
|
|
2,097,672
|
|
|
|
2,097,672
|
|
Software development costs for internal use
|
|
|
2.6
|
|
|
|
660,680
|
|
|
|
981,521
|
|
Software development costs for external
marketing
|
|
|
2.0
|
|
|
|
174,296
|
|
|
|
|
|
Internet domain
|
|
|
3.0
|
|
|
|
161,200
|
|
|
|
161,200
|
|
(www.healthbenefitsdirect.com)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,058,186
|
|
|
|
8,204,731
|
|
Less: accumulated amortization
|
|
|
|
|
|
|
(4,859,779
|
)
|
|
|
(3,108,771
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,198,407
|
|
|
$
|
5,095,960
|
|
|
|
|
|
|
|
|
For the years ended December 31, 2008 and 2007, amortization expense was $1,808,688 and $1,681,231
respectively.
Amortization expense subsequent to the period ended December 31, 2008 is as follows:
|
|
|
|
|
2009
|
|
$
|
1,456,453
|
|
2010
|
|
|
1,028,646
|
|
2011
|
|
|
453,258
|
|
2012
|
|
|
260,050
|
|
|
|
|
|
|
|
|
$
|
3,198,407
|
|
|
|
|
|
F-26
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 6
UNEARNED COMMISSION ADVANCES
The Company has agreements with certain of its insurance carriers whereby the Companys insurance
carriers advance the Company first year premium commissions before the commissions are earned. The
unearned portion of premium commissions has been included in the consolidated balance sheet as a
liability for unearned commission advances. These advance agreements represent a material source
of cash to fund the Companys operations. Unearned commission advances are recognized as
commission revenue after we receive notice that the insurance company has received payment of the
related premium. In the event that the insurance company does not receive payment of the related
premium pertaining to a commission advance the insurance company generally deducts the unearned
commission advance from its commission payments to the Company.
The Companys advance agreement with Golden Rule Insurance Company (Golden Rule) is contractually
limited to a maximum of $9,000,000, can be terminated by either party at any time, and in the event
of termination the Companys outstanding advance balance (including interest, if any) can be called
by Golden Rule with seven days written notice. The Companys advance agreement with Golden Rule
expired on December 31, 2008 and thereafter Golden Rule will no longer advance first year premium
commissions to the Company. As of December 31, 2008 the Companys outstanding advance balance with
Golden Rule was $2,317,003. Subsequent to December 31, 2008 in connection with the Companys
execution of a client transition agreement with eHealthInsurance Services, Inc. (eHealth),
eHealth paid Golden Rule $966,097, which represented a partial repayment of the Companys
outstanding advance balance owed to Golden Rule, from amounts that otherwise would have been due
the Company from eHealth. In addition eHealth assumed approximately $794,000 of the Companys
outstanding advance balance with Golden Rule as of the date of the eHealth transaction.
The Companys advance agreement with Humana, Inc. (Humana) allows the insurance carrier to
terminate future advances and convert the outstanding advance balance into a promissory note, which
if not repaid within 30 days, would incur interest expense. As of December 31, 2008 the Companys
outstanding advance balance with Humana was $353,808. Subsequent to December 31, 2008 in
connection with the eHealth transaction eHealth assumed $370,794 of the Companys outstanding
advance balance with Humana as of the date of the eHealth transaction. Effective January 31, 2009
Humana notified the Company that it will no longer advance first year premium commissions and
charged back to the Company the remaining unearned commission advance as of January 31, 2009.
As of December 31, 2008 the Companys outstanding advance balance with Time Insurance Company
(marketed under the name Assurant Health) (Assurant) was $236,064. Subsequent to December 31,
2008 in connection with the eHealth transactions eHealth assumed approximately $220,000 of the
Companys outstanding advance balance with Assurant as of the date of the eHealth transactions.
See Note 14 Subsequent Events.
NOTE 7
RELATED PARTY TRANSACTIONS
On March 30, 2007, the Companys Co-Chairman and former CEO, Alvin H. Clemens, participated in a
private placement along with other accredited and institutional investors wherein he purchased
1,000,000 shares of the Companys Common Stock and a warrant to purchase 500,000 shares of the
Companys Common Stock for a total purchase price of $2,225,000.
F-27
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 7
RELATED PARTY TRANSACTIONS (continued)
On March 30, 2007, Co-Investment Trust II, L.P., designee of Cross Atlantic Capital Partners, Inc.;
participated in a private placement along with other accredited and institutional investors wherein
it purchased 5.0 million investment units for a purchase price of $5,000,000. Mr. Tecce, who is
one of our directors effective August 2, 2007, is a managing director and counsel to Cross Atlantic
Capital Partners, Inc. Mr. Caldwell, who is also one of our directors effective April 1, 2008, is
a shareholder, director and officer of Co-Invest II Capital Partners, Inc., which is the general
partner of Co-Invest Management II, L.P., which is the general partner of The Co-Investment Fund
II, L.P and is the Chairman and Chief Executive Officer of Cross Atlantic Capital Partners, Inc.
On March 31, 2008, Co-Investment Trust II, L.P., designee of Cross Atlantic Capital Partners, Inc.
participated in a private placement along with other accredited and institutional investors wherein
it purchased 5.0 million investment units for a purchase price of $4,000,000.
See Note 8 Shareholders Equity.
As of December 31, 2007, the Company recorded $28,500 due to related parties, which consisted of
the following:
|
|
|
Keystone Equities Group, L.P provided the Company investment advisory services in 2007
at a cost of $53,572. John Harrison, a director of the Company, is associated with
Keystone Equities Group, L.P. The Company paid Keystone Equities Group, L.P $28,572 in
2007, recorded a related party liability of $25,000 as of December 31, 2007, which was
subsequently paid in 2008.
|
|
|
|
|
SendTec, Inc. (SendTec) provided certain marketing and advertising services in 2007 at
a cost of $14,950. Paul Soltoff, a director of the Company, is the Chief Executive Officer
of SendTec. The Company paid SendTec $32,741 in 2007 and recorded a related party
liability of $3,500 as of December 31, 2007, which was subsequently paid in 2008.
|
As of December 31, 2008, the Company recorded $4,315 due to related parties, which consisted of
director travel expense reimbursement to Cross Atlantic Capital Partners for Messrs. Caldwell and
Tecces travel expense to board of director meetings.
F-28
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 8
SHAREHOLDERS EQUITY
Common Stock
2007
On February 15, 2007, the Company granted 125,000 restricted shares of Common Stock to each of
Charles A. Eissa, the Companys President, and Ivan M. Spinner, the Companys former Senior Vice
President, in accordance with the terms of the Plan. The shares granted to Messrs. Eissa and
Spinner were valued at $3.00 per share and vest as follows: 50,000 shares on February 15, 2008;
50,000 additional shares on February 15, 2009; 2,083 shares per month on the 15th day of each month
thereafter beginning on March 15, 2009 through January 15, 2010; and 2,087 shares on February 15,
2010.
On March 30, 2007, the Company entered into Securities Purchase Agreements (Purchase Agreements)
and completed a private placement with certain institutional and individual accredited investors
and issued 5,000,000 shares of its Common Stock and warrants to purchase 2,500,000 shares of its
Common Stock. Pursuant to the Purchase Agreements, the Company sold investment units (each, a
2007 Unit) in the 2007 Private Placement at a per unit purchase price equal to $2.25. Each 2007
Unit sold in the 2007 Private Placement consisted of one share of Common Stock and a Warrant to
purchase one-half (1/2) of one share of Common Stock at an initial exercise price of $3.00 per
share, subject to adjustment. The gross proceeds from the 2007 Private Placement were $11,250,000.
Alvin H. Clemens purchased 1,000,000 2007 Units in the 2007 Private Placement.
In connection with the 2007 Private Placement, the Company paid the placement agents an aggregate
placement fee equal of $787,500 plus the reimbursement of certain expenses in the amount of
$42,500. The Company also issued to the placement agents warrants (the Placement Agent Warrants)
to purchase in the aggregate 350,000 shares of the Companys Common Stock with an exercise price of
$2.80 and exercisable from September 30, 2007 through March 30, 2010. The Company also incurred
legal and other expenses in the amount of $65,240 in connection with the 2007 Private Placement.
The Purchase Agreements also provide a customary participation right, subject to exceptions and
limitations, which provides for a designated investor to be able to participate in future
financings for capital raising purposes occurring within two years of March 30, 2007 at a level
based on such investors ownership percentage of the Company on a fully-diluted basis prior to such
financing.
On October 1, 2007 the Company issued 739,913 shares of its Common Stock in connection with the
Companys acquisition of Atiam. See Note 3 Acquisition of Atiam.
F-29
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 8
SHAREHOLDERS EQUITY (continued)
On December 15, 2007 the Company issued 75,000 unrestricted shares of its Common Stock to certain
directors of the Company in accordance with the Companys Non Employee Director Compensation Plan,
which were valued at $161,250 based on the $2.15 closing price of our Common Stock on the OTCBB on
December 14, 2007.
2008
On January 3, 2008, the Company issued 75,000 shares of unrestricted Common Stock to certain
directors in accordance with the Companys Non Employee Director Compensation Plan, which was
valued in aggregate at $129,000 based on the closing price per share ($1.72) of Common Stock on the
OTCBB on January 3, 2008.
On February 15, 2008, Mr. Eissa and Mr. Spinner returned to the Company in aggregate 20,749 shares
of the 100,000 shares of the Companys Common Stock that vested to them on this date as
consideration for the Company paying their estimated tax liabilities pursuant to the terms of their
February 15, 2007 restricted stock grants. The shares were valued at $1.32 per share based on
closing price of our Common Stock on the OTCBB on February 15, 2008.
On March 31, 2008, the Company entered into Securities Purchase Agreements (the 2008 Purchase
Agreements) with certain institutional and individual accredited investors (collectively, the
2008 Investors) and completed a private placement (the 2008 Private Placement) of an aggregate
of 6,250,000 shares of our Common Stock and warrants to purchase 6,250,000 shares of our Common
Stock. Pursuant to the 2008 Purchase Agreement, the Company sold investment units (each, a 2008
Unit) at a per unit purchase price equal to $0.80. Each 2008 Unit sold in the 2008 Private
Placement consisted of one share of Common Stock and a Warrant to purchase one share of Common
Stock at an initial exercise price of $0.80 per share, subject to adjustment (the 2008 Warrant).
The gross proceeds from the 2008 Private Placement were $5,000,000 and we incurred $70,238 of legal
and other expenses in connection with the 2008 Private Placement.
On March 31, 2008, 75,000 restricted shares of Common Stock issued to Ivan M. Spinner, the
Companys former Senior Vice President, were forfeited in accordance with the terms restricted
stock grant. The forfeiture was accounted for as retirement of 75,000 shares valued at $225,000
based on the fair market value on the date of grant and recorded as a reduction to salaries,
commission and related taxes, net effects are included in amortization of deferred compensation.
On April 1, 2008, the Company issued 99,010 restricted shares of its Common Stock to Mr. Edmond
Walters upon the effective date of his becoming a director of the Company in accordance with the
Companys Non Employee Director Compensation Plan and the Companys 2006 Omnibus Equity
Compensation Plan. Mr. Walters was granted shares valued at $100,000 in aggregate based on the
$1.01 closing price of our Common Stock on the OTCBB on April 1, 2008, and will vest as follows:
33,003 shares on April 1, 2008; 33,003 additional shares on April 1, 2009; 33,004 shares on April
1, 2010. Pursuant to the Companys 2006 Omnibus Equity Compensation Plan, Mr. Walters has voting,
dividend and distribution rights pertaining to his unvested shares, but he is restricted from
selling or otherwise disposing of his restricted shares until vesting occurs.
F-30
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 8
SHAREHOLDERS EQUITY (continued)
Stock Options
2007
On February 15, 2007, the Company and Daniel Brauser, the Companys former Senior Vice President,
entered into Amendment No. 1 (the Amendment) to Mr. Brausers option, dated November 10, 2005
(the Brauser Option). The Brauser Amendment was approved by the Companys board of directors on
February 15, 2007. Under the terms of the Brauser Option, Mr. Brauser has the right to purchase,
at an exercise price of $2.50 per share, 500,000 fully-paid and non-assessable shares (the Option
Shares) of the Companys Common Stock.
Under the terms of the Brauser Option, the vesting schedule of the Option Shares was as follows:
(a) 25% of the Option Shares on or after the first anniversary of the Brauser Options grant date;
(b) 10,416 Option Shares on or after the last day of each month thereafter; and (c) 10,440 Option
Shares on or after November 30, 2009. As of February 15, 2007, the Brauser Option was vested with
respect to 145,832 Option Shares and remained unvested with respect to the remaining 354,168 Option
Shares. The Amendment accelerates the vesting schedule of the Option Shares as follows: 25% of the
Option Shares subject to the Brauser Option on the first anniversary of the Brauser Options date
of grant; an additional 10,416 Option Shares on December 31, 2006; an additional 10,416 Option
Shares on January 31, 2007; an additional 19,966 Option Shares on February 15, 2007; and an
additional 30,382 Option Shares on the last day of each month thereafter beginning on February 28,
2007 through December 31, 2007.
The Amendment also provided that, in the event Mr. Brauser was removed as an officer or employee of
the Company at any time on or before December 31, 2007, 100% of the Option Shares that are
unexercisable as of the removal date will become fully vested upon such removal. Alternatively, in
the event Mr. Brauser resigned as an employee of the Company at any time after June 30, 2007 but
before December 31, 2007, 50% of the Option Shares that are unexercisable as of the resignation
date would become exercisable upon such resignation.
Finally, the Amendment provides that, upon the termination of Mr. Brausers employment with the
Company for any reason, the vested portion of the Option Shares as of the date of such termination
will remain exercisable by Mr. Brauser for one year following such termination.
On September 10, 2007, the Company and Mr. Brauser entered into a Separation and Transitional
Services Agreement, which, among other things, extended the exercisable period of Mr. Brausers
exercisable options for an additional year. The Company recorded $106,925 of compensation expense
as a result of the modification of the Brauser Option, which was valued as of September 10, 2007
using the Black-Scholes option-pricing model based on the following assumptions: expected
volatility of 50%, risk free interest rate of 4.77%, expected life of 2 years and 0% assumed
dividend yield.
F-31
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 8
SHAREHOLDERS EQUITY (continued)
On December 7, 2007, the Company and Mr. Frohman entered into an Amendment to the Separation
Agreement, which, among other things, extended the exercisable period of Mr. Frohmans exercisable
options for an additional year and terminated all future severance payments from the Company to Mr.
Frohman. The Company recorded $105,501 of compensation expense as a result of the modification of
Mr. Frohmans options, which was valued as of December 7, 2007 using the Black-Scholes
option-pricing model based on the following assumptions: expected volatility of 48%, risk free
interest rate of 3.32%, expected life of 1 year and 0% assumed dividend yield.
During 2007, the Company issued options to purchase 190,550 shares of Common Stock to various
employees at prices ranging from $2.13 to $3.00. These options vest one third on the first
anniversary and an additional one third on each anniversary thereafter.
During 2007, 239,918 options were forfeited as a result of the termination of the employment of
various employees in accordance with the terms of the stock options.
2008
On March 31, 2008, the board of directors of the Company adopted the Companys 2008 Equity
Compensation Plan (the 2008 Plan), which plan was not subject to shareholder approval. An
aggregate of 1,000,000 shares of the Companys common stock was reserved for issuance under the
2008 Plan in addition to any authorized and unissued shares of common stock available for issuance
under the Companys 2006 Omnibus Equity Compensation Plan. The purpose of the 2008 Plan is to
provide a comprehensive compensation program to attract and retain qualified individuals to serve
as directors. The Company is authorized to award cash fees and issue non-qualified stock options
under the 2008 Plan. The 2008 Plan is administered by the Companys board of directors or the
compensation committee established by the board.
Effective October 2, 2008, our shareholders approved an amendment and restatement of the 2008 Plan
to (i) permit the grant of incentive stock options, (ii) provide our compensation committee with
the flexibility to make grants that qualify as qualified performance-based compensation within
the meaning of section 162(m) of the Internal Revenue Code of 1986, as amended (the Code), (iii)
reflect the merger of the Health Benefits Direct Corporation 2006 Omnibus Equity Compensation Plan
(the 2006 Plan) with and into the 2008 Plan, (iv) amend the adjustment provision to make
clarifying changes and (v) specify the maximum number of shares authorized for issuance under the
2008 Plan.
The 2008 Plan provides that the maximum aggregate number of shares of common stock that may be made
with respect to grants, other than dividend equivalents, to any individual during any calendar year
is 1,000,000 shares, subject to adjustment as described below. Grantees may not accrue dividend
equivalents during any calendar year in excess of $1,000,000.
F-32
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 8
SHAREHOLDERS EQUITY (continued)
On March 31, 2008, the Board approved the grant of 550,000 incentive stock options to Alvin H.
Clemens, the Companys former Chief Executive Officer and current Co-Chairman, under the Health
Benefits Direct Corporation 2006 Plan, in consideration of Mr. Clemens resignation as Chief
Executive Officer and the termination of his existing Amended and Restated Employment Agreement,
effective on April 1, 2008. This option has a term of ten years, an exercise per share of $1.01
and will vest as follows: 300,000 shares on April 1, 2008; 20,833 on the first calendar day of each
month from May 1, 2008 through March 1, 2009 and 20,837 shares on April 1, 2009. The Company
recorded the entire fair value of this option as compensation expense as of June 30, 2008.
Also during 2008, the Company issued options under the 2006 Plan and 2008 Plan in aggregate to
purchase 35,000 shares of Common Stock to employees at a weighted average option exercise price of
$0.72. These options will vest one third on the first anniversary and an additional one third on
each anniversary thereafter.
During 2008, a total of 1,125,700 options granted under the 2006 Plan and 2008 Plan were forfeited
as a result of the resignation of a director and the termination of the employment of various
employees in accordance with the terms of the stock options.
The Company recorded $1,387,686 and $1,377,880 in salaries, commission and related taxes pertaining
to director and employee stock options and restricted and unrestricted stock grants in the year
ended December 31, 2008 and 2007, respectively.
F-33
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 8
SHAREHOLDERS EQUITY (continued)
A summary of the Companys outstanding stock options as of and for the years ended December 31,
2008 and 2007 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number
|
|
|
Weighted
|
|
|
|
|
|
|
Of Shares
|
|
|
Average
|
|
|
Weighted
|
|
|
|
Underlying
|
|
|
Exercise
|
|
|
Average
|
|
|
|
Options
|
|
|
Price
|
|
|
Fair Value
|
|
|
Outstanding at December 31, 2006
|
|
|
4,881,268
|
|
|
$
|
2.22
|
|
|
$
|
0.83
|
|
For the year ended December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
190,550
|
|
|
|
2.83
|
|
|
|
1.41
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
239,918
|
|
|
|
2.50
|
|
|
|
0.03
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2007
|
|
|
4,831,900
|
|
|
|
2.23
|
|
|
|
0.89
|
|
For the year ended December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
585,000
|
|
|
|
0.99
|
|
|
|
0.56
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
1,125,700
|
|
|
|
2.49
|
|
|
|
0.84
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2008
|
|
|
4,291,200
|
|
|
|
1.99
|
|
|
|
0.86
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding and exercisable at December 31, 2008
|
|
|
3,867,245
|
|
|
$
|
1.98
|
|
|
$
|
0.80
|
|
|
|
|
|
|
|
|
|
|
|
The weighted average fair value of option grants are estimated as of the date of grant using the
Black-Scholes option-pricing model based on the following assumptions for options granted during
the years ended December 31, 2008 and 2007:
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended
|
|
For the Year Ended
|
|
|
December 31, 2008
|
|
December 31, 2007
|
|
|
|
|
|
|
|
|
|
Expected volatility
|
|
|
68
|
%
|
|
|
60
|
%
|
Risk-free interest rate
|
|
|
1.41
|
%
|
|
|
4.67
|
%
|
Expected life in years
|
|
|
5
|
|
|
|
5.0
|
|
Assumed dividend yield
|
|
|
0
|
%
|
|
|
0
|
%
|
F-34
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 8
SHAREHOLDERS EQUITY (continued)
The following information applies to options outstanding at December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding
|
|
Options Exercisable
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
Weighted
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
Remaining
|
|
Average
|
|
|
|
|
|
Average
|
Exercise
|
|
Number of Shares
|
|
Contractual
|
|
Exercise
|
|
|
|
|
|
Exercise
|
Price
|
|
Underlying Options
|
|
Life
|
|
Price
|
|
Number Exercisable
|
|
Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.24
|
|
|
|
15,000
|
|
|
|
4.9
|
|
|
$
|
0.24
|
|
|
|
|
|
|
$
|
|
|
|
0.78
|
|
|
|
10,000
|
|
|
|
4.3
|
|
|
|
0.78
|
|
|
|
|
|
|
|
|
|
|
1.00
|
|
|
|
1,300,000
|
|
|
|
6.9
|
|
|
|
1.00
|
|
|
|
1,300,000
|
|
|
|
1.00
|
|
|
1.01
|
|
|
|
550,000
|
|
|
|
9.3
|
|
|
|
1.01
|
|
|
|
466,664
|
|
|
|
1.01
|
|
|
1.05
|
|
|
|
10,000
|
|
|
|
3.2
|
|
|
|
1.05
|
|
|
|
|
|
|
|
|
|
|
2.13
|
|
|
|
15,000
|
|
|
|
3.9
|
|
|
|
2.13
|
|
|
|
4,950
|
|
|
|
2.13
|
|
|
2.30
|
|
|
|
5,000
|
|
|
|
3.6
|
|
|
|
2.30
|
|
|
|
1,650
|
|
|
|
2.30
|
|
|
2.50
|
|
|
|
1,268,500
|
|
|
|
4.5
|
|
|
|
2.50
|
|
|
|
1,092,440
|
|
|
|
2.50
|
|
|
2.55
|
|
|
|
25,000
|
|
|
|
2.5
|
|
|
|
2.55
|
|
|
|
16,500
|
|
|
|
2.55
|
|
|
2.62
|
|
|
|
20,000
|
|
|
|
3.0
|
|
|
|
2.62
|
|
|
|
13,200
|
|
|
|
2.62
|
|
|
2.70
|
|
|
|
475,000
|
|
|
|
2.3
|
|
|
|
2.70
|
|
|
|
441,500
|
|
|
|
2.70
|
|
|
2.95
|
|
|
|
45,000
|
|
|
|
2.3
|
|
|
|
2.95
|
|
|
|
29,700
|
|
|
|
2.95
|
|
|
3.00
|
|
|
|
77,700
|
|
|
|
3.4
|
|
|
|
3.00
|
|
|
|
25,641
|
|
|
|
3.00
|
|
|
3.50
|
|
|
|
75,000
|
|
|
|
7.3
|
|
|
|
3.50
|
|
|
|
75,000
|
|
|
|
3.50
|
|
|
3.60
|
|
|
|
400,000
|
|
|
|
2.3
|
|
|
|
3.60
|
|
|
|
400,000
|
|
|
|
3.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,291,200
|
|
|
|
|
|
|
|
|
|
|
|
3,867,245
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2008, there were 7,000,000 shares of our common stock authorized to be issued
under the 2008 Plan, of which 1,969,790 shares of our common stock remain available for future
stock option grants.
The total intrinsic value of stock options granted during 2008 and 2007 was $0 and $0,
respectively. The total intrinsic value of stock options outstanding and exercisable as of
December 31, 2008 and December 31, 2007 was $0 and $0, respectively.
The value of equity compensation expense not yet expensed pertaining to unvested equity
compensation was $412,478 as of December 31, 2008, which will be recognized over a weighted average
0.6 years in the future.
F-35
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 8
SHAREHOLDERS EQUITY (continued)
Common Stock warrants
2007
In March 2007, in connection with the 2007 Private Placement, the Company issued warrants to
purchase an aggregate of 2,500,000 shares of common stock at an exercise price of $3.00 per share
to the participating investors in the 2007 Private Placement, which provides that the holder
thereof shall have the right, at any time after March 30, 2007, but prior to the earlier of (i) ten
business days after the Company has properly provided written notice to all such holders of a Call
Event (as defined below) or (ii) the fifth anniversary of the date of issuance of the warrant, to
acquire shares of Common Stock upon the payment of the exercise price. The Company also has the
right, at any point after which the volume weighted average trading price per share of the Common
Stock for a minimum of 20 consecutive trading days is equal to at least two times the Exercise
Price per share, provided that certain other conditions have been satisfied to call the outstanding
Warrants (a Call Event), in which case such Warrants will expire if not exercised within ten
business days thereafter. The Warrants also include a cashless exercise and weighted average
anti-dilution adjustment provisions for issuances of securities below the exercise price during the
first two years following the date of issuance of the warrants, subject to customary exceptions.
Also in March 2007, in connection with the 2007 Private Placement, the Company issued to the
placement agents warrants to purchase in the aggregate 350,000 shares of the Companys Common
Stock, which have an exercise price of $2.80 and are exercisable from September 30, 2007 through
March 30, 2010.
During 2007, certain holders of the Companys outstanding warrants exercised their warrants to
purchase an aggregate of 300,000 shares of the Companys common stock at an exercise price of $1.50
per share for an aggregate exercise price of $450,000.
2008
On March 31, 2008, in connection with the 2008 Private Placement the Company issued warrants to
purchase 6,250,000 shares of its Common Stock at an exercise price of $0.80 per share to the
participating investors in the 2008 Private Placement. The 2008 Warrants provide that the holder
thereof shall have the right, at any time after March 31, 2008 but prior to the earlier of (i) ten
business days after the Company has properly provided written notice to all such holders of a 2008
Call Event (as defined below) or (ii) the fifth anniversary of the date of issuance of the 2008
Warrant, to acquire shares of Common Stock upon the payment of $0.80 per Warrant Share (the 2008
Exercise Price). The Company also has the right, at any point after which the volume weighted
average trading price per share of the Common Stock for a minimum of 20 consecutive trading days is
equal to at least two times the 2008 Exercise Price per share, provided that certain other
conditions have been satisfied to call the outstanding 2008 Warrants (a 2008 Call Event), in
which case such 2008 Warrants will expire if not exercised within ten business days thereafter.
The 2008 Warrants also include full ratchet anti-dilution adjustment provisions for issuances of
Common Stock or Common Stock equivalents below $0.80 during the first two years following the date
of issuance of the Warrants.
F-36
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 8
SHAREHOLDERS EQUITY (continued)
Effective March 31, 2008, in connection with the 2008 Private Placement, the Company adjusted the
2007 Warrants pursuant to the weighted average anti-dilution adjustment provisions of the 2007
Warrants. The exercise price of the 2007 Warrants was adjusted from $3.00 to $2.48 and the number
of issued, exercisable and outstanding 2007 Warrants was adjusted from 2,500,000 to 3,024,186.
During 2008, warrants to purchase 3,887,500 shares of its Common Stock at an exercise price of
$1.50 per share expired in accordance with the terms of the Warrants.
A summary of the status of the Companys outstanding stock warrants granted as of December 31, 2008
and changes during the period is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
Common
|
|
|
Average
|
|
|
|
Stock
|
|
|
Exercise
|
|
|
|
Warrants
|
|
|
Price
|
|
Outstanding at December 31, 2006
|
|
|
8,200,000
|
|
|
$
|
1.50
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2007
|
|
|
|
|
|
|
|
|
Granted
|
|
|
2,850,000
|
|
|
|
2.98
|
|
Exercised
|
|
|
(300,000
|
)
|
|
|
1.50
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2007
|
|
|
10,750,000
|
|
|
|
1.89
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2008
|
|
|
|
|
|
|
|
|
Granted
|
|
|
6,250,000
|
|
|
|
0.80
|
|
Adjustment to warrants issued in 2007
for the issuance of warrants in 2008
|
|
|
524,186
|
|
|
|
2.48
|
|
Exercised
|
|
|
|
|
|
|
|
|
Expired
|
|
|
(3,887,500
|
)
|
|
|
1.50
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2008
|
|
|
13,636,686
|
|
|
$
|
1.43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2008
|
|
|
13,636,686
|
|
|
$
|
1.43
|
|
|
|
|
|
|
|
|
F-37
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 8
SHAREHOLDERS EQUITY (continued)
The following information applies to warrants outstanding at December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
Common
|
|
|
|
|
Stock
|
|
Exercise
|
Year of Expiration
|
|
Warrants
|
|
Price
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
2,762,500
|
|
|
$
|
1.50
|
|
2010
|
|
|
75,000
|
|
|
|
1.50
|
|
2010
|
|
|
350,000
|
|
|
|
2.80
|
|
2011
|
|
|
1,175,000
|
|
|
|
1.50
|
|
2012
|
|
|
3,024,186
|
|
|
|
2.48
|
|
2013
|
|
|
6,250,000
|
|
|
$
|
0.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,636,686
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding warrants at December 31, 2008 have a weighted average remaining contractual life of 2.9
years.
Registration Rights
On March 30, 2007 and in connection with 2007 Private Placement, the Company and the participating
investors entered into a Registration Rights Agreement (the Registration Rights Agreement).
Under the terms of the Registration Rights Agreement, the Company agreed to prepare and file with
the Commission, as soon as possible but in any event within 30 days following the later of (i) the
date the Company is required to file with the Commission its Annual Report on Form 10-KSB for the
fiscal year ended December 31, 2006, or (ii) the date of the Registration Rights Agreement, a
registration statement on Form SB-2 covering the resale of the shares and the warrant shares
collectively, the Registrable Securities). Subject to limited exceptions, the Company also
agreed to use its reasonable best efforts to cause the registration statement to be declared
effective under the Securities Act of 1933 as amended (the Securities Act) as soon as practicable
and agreed to use its reasonable best efforts to keep the registration statement effective under
the Securities Act until the date that is two years after the date that the registration statement
is declared effective by the Commission or such earlier date when all of the Registrable Securities
covered by the Registration Statement have been sold or may be sold without volume restrictions
pursuant to Rule 144(k) promulgated under the Securities Act. The Registration Rights Agreement
also provides for payment of partial damages to the 2007 Private Placement investors under certain
circumstances relating to failure to file or obtain or maintain effectiveness of the registration
statement, subject to adjustment.
In connection with the 2007 Private Placement, the Company issued to the placement agents the
Placement Agent Warrants. Under the terms of the Registration Rights Agreement, the holders of the
Placement Agent Warrants have certain piggyback registration rights for the shares of Common
Stock underlying the Placement Agent Warrants (the Placement Agent Warrant Shares).
F-38
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 8
SHAREHOLDERS EQUITY (continued)
On May 2, 2007, the Company and Alvin H. Clemens entered into a Waiver of Registration Rights
Agreement whereby Mr. Clemens agreed to waive his registration rights for the 500,000 warrants that
he purchased in the 2007 Private Placement until the later of 60 days following the sale of
substantially all of the shares he purchased in the 2007 Private Placement or six months following
the effectiveness of the registration statement filed in connection with the 2007 Private
Placement. On May 10, 2007, the Company and Mr. Clemens entered into a Consent and Waiver of
Registration Rights Agreement whereby Mr. Clemens and the Company consented to the filing of an
amendment to the registration statement filed in connection with the 2007 Private Placement to
remove the 1,000,000 shares of Common Stock that Mr. Clemens purchased in the 2007 private
placement from the registration statement until the six months following the effectiveness of such
registration statement.
On June 1, 2007, the Commission declared effective the Companys Registration Statement on Form
SB-2 filed with the Commission on May 2, 2007 as amended.
In connection with the Bilenia Agreement, the Company and CCCC entered into the Bilenia
Registration Rights Agreement. In connection with the Atiam Merger Agreement, the Company and
Shareholders also entered into a Registration Rights Agreement (the Shareholder Registration
Rights Agreement). See Note 3 Atiam Acquisition.
On April 22, 2008, the Commission declared effective the Companys Registration Statement on Form
SB-2 filed with the Commission on February 1, 2008 as amended.
In connection with the signing of the 2008 Purchase Agreement, the Company and the 2008 Investors
also entered into a Registration Rights Agreement (the 2008 Registration Rights Agreement).
Under the terms of the 2008 Registration Rights Agreement, the Company agreed to prepare and file
with the Commission, as soon as possible but in any event within 30 days following the later of (i)
the date the Company is required to file with the Commission its Annual Report on Form 10-KSB for
the fiscal year ended December 31, 2007, or (ii) the date of the Registration Rights Agreement, a
registration statement on Form S-1 (the 2008 Registration Statement) covering the resale of the
Shares and the Warrant Shares collectively, the 2008 Registrable Securities). Subject to limited
exceptions, the Company also agreed to use its reasonable best efforts to cause the 2008
Registration Statement to be declared effective under the Securities Act of 1933 as amended (the
Securities Act) as soon as practicable but, in any event, no later than 90 days following the
date of the 2008 Registration Rights Agreement (or 150 days following the date of the 2008
Registration Rights Agreement in the event the 2008 Registration Statement is subject to review by
the Commission), and agreed to use its reasonable best efforts to keep the 2008 Registration
Statement effective under the Securities Act until the date that all of the 2008 Registrable
Securities covered by the 2008 Registration Statement have been sold or may be sold without volume
restrictions pursuant to Rule 144(b)(i)) promulgated under the Securities Act. The 2008
Registration Rights Agreement also provides for payment of partial damages to the Investors under
certain circumstances relating to failure to file or obtain or maintain effectiveness of the 2008
Registration Statement, subject to adjustment.
F-39
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
Note 9
CAPITAL LEASE OBLIGATIONS
The Companys Atiam Business Segment has entered into several capital lease obligations to purchase
equipment used for operations. The Company has the option to purchase the equipment at the end of
the lease agreement for one dollar. The underlying assets and related depreciation were included in
the appropriate fixed asset category, and related depreciation account.
Property and equipment includes the following amounts for leases that have been capitalized as of
December 31, 2008 and 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Useful Life (Years)
|
|
|
December 31, 2008
|
|
|
December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Computer equipment and software
|
|
|
3
|
|
|
$
|
328,074
|
|
|
$
|
60,815
|
|
Phone System
|
|
|
3
|
|
|
|
15,011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
343,085
|
|
|
|
60,815
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less accumulated depreciation
|
|
|
|
|
|
|
(68,090
|
)
|
|
|
(4,125
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
274,995
|
|
|
$
|
56,690
|
|
|
|
|
|
|
|
|
|
|
|
|
Future minimum payments required under capital leases at December 31, 2008 are as follows:
|
|
|
|
|
2009
|
|
$
|
115,973
|
|
2010
|
|
|
119,325
|
|
2011
|
|
|
99,705
|
|
2012
|
|
|
23,078
|
|
|
|
|
|
|
|
|
|
|
Total future payments
|
|
|
358,081
|
|
Less amount representing interest
|
|
|
59,272
|
|
|
|
|
|
|
|
|
|
|
Present value of future minimum payments
|
|
|
298,808
|
|
Less current portion
|
|
|
89,297
|
|
|
|
|
|
|
|
|
|
|
Long-term portion
|
|
$
|
209,511
|
|
|
|
|
|
F-40
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 10
DEFINED CONTRIBUTION 401(k) PLAN
The Company implemented a 401(k) plan on January 1, 2007. Eligible employees contribute to the
401(k) plan. Employees become eligible after attaining age 19 and after 6 months of employment with
the Company. The employee may become a participant of the 401(k) plan on the first day of the
month following the completion of the eligibility requirements. Effective January 1, 2007 the
Company implemented an elective contribution to the plan of 25% of the employees contribution up
to 4% of the employees contribution (the Contribution). The Contributions are subject to a
vesting schedule and become fully vested after one year of service, retirement, death or
disability, whichever occurs first. The Company made contributions of $57,556 and $73,236 for the
years ended December 31, 2008 and 2007.
NOTE 11
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES
Employment and Separation Agreements
On March 31, 2008, in connection with our 2008 Private Placement and Mr. Clemens resignation as
our Chief Executive Officer and appointment as Co-Chairman of our board of directors, Mr. Clemens
amended and restated employment agreement was terminated effective upon his resignation on April 1,
2008. Also in connection with our 2008 Private Placement, the Company and Mr. Clemens agreed to
enter into a new employment agreement within 15 days of the effective date of Mr. Clemens
resignation as Chief Executive Officer, which agreement will provide for a one year term and a
salary of $300,000, which salary shall be effective as of the date of Mr. Clemens resignation.
On March 31, 2008, following Mr. Clemens resignation as our Chief Executive Officer, Anthony R.
Verdi, our Chief Financial Officer, was also appointed to the position of Chief Operating Officer,
effective April 8, 2008. Mr. Verdi shall have the authority, as our Chief Operating Officer, to
lead the Company as the principal executive officer in the absence of a Chief Executive Officer and
Mr. Verdi shall have such authority until we appoint a new Chief Executive Officer or until such
time as our board of directors determines otherwise.
Mr. Verdis amended and restated employment agreement, as amended on March 31, 2008, provides for
an initial term of one year with automatic successive one-year renewals unless we or Mr. Verdi
gives the other party 60 days written notice prior to the end of the then current term. Mr.
Verdis base salary is $225,000 per year.
F-41
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 11
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES (continued)
If we terminate Mr. Verdis employment for cause or Mr. Verdi terminates his employment agreement
without good reason, Mr. Verdi will be entitled to receive (i) all accrued and unpaid salary and
vacation pay through the date of termination and (ii) continued participation for one month in our
benefit plans. Otherwise if we terminate Mr. Verdis employment or Mr. Verdi terminates his
employment agreement for good reason including his permanent disability he will be entitled to
receive 18 months base salary at the then current rate, payable in accordance with our usual
practices, continued participation for 18 months in our benefit plans and payment, within a
commercially reasonable time and on a prorated basis, of any bonus or other payments earned in
connection with our bonus plan existing at the time of termination. In addition, if Mr. Verdis
employment is terminated in accordance with the foregoing sentence within two months prior to, or
24 months following, a change in control (as described in the employment agreement), Mr. Verdi will
be entitled to receive 18 months base salary at the then current rate upon the date of
termination, regardless of our usual practices, and all stock options held by Mr. Verdi at the date
of termination will immediately become 100% vested and all restrictions on such options will lapse.
If Mr. Verdis employment is terminated due to a permanent disability we may credit any such
amounts against any proceeds paid to Mr. Verdi with respect to any disability policy maintained and
paid for by us for Mr. Verdis benefit.
If Mr. Verdi dies during the term of his employment agreement, the employment agreement will
automatically terminate and Mr. Verdis estate or beneficiaries will be entitled to receive (i)
three months base salary at the then current rate, payable in a lump sum and (ii) continued
participation for one year in our benefit plans.
Mr. Verdi was appointed to the Board on June 20, 2008.
Pursuant to a written employment agreement, which we amended on March 31, 2008, Mr. Charles Eissa
serves as our President. Pursuant to his amended employment agreement, his annual base salary is
$250,000 per year. He is entitled to receive such bonus compensation as a majority of the members
of our board of directors may determine from time to time. Mr. Eissa s amended employment
agreement is effective beginning on March 31, 2008 and expires on March 31, 2009, subject to
automatic annual renewals.
In the event of Mr. Eissa s termination without cause or for good reason, he or his estate would
receive his then current base annual salary, plus unpaid accrued employee benefits, which is
primarily accrued vacation, plus the continuation of his employee benefits for a period of one
year, less all applicable taxes. In the event of his voluntary termination, death or disability, he
or his estate would receive unpaid accrued employee benefits, plus the continuation of his employee
benefits for a period of 1 month, less all applicable taxes.
F-42
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 11
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES (continued)
Restricted Cash and Operating Leases
On February 17, 2006, the Company entered into a lease agreement with FG2200, LLC, a Florida
limited liability company, for approximately 50,000 square feet of office space at 2200 S.W. 10th
Street, Deerfield Beach, Florida (the Lease). The initial term of the Lease commences on March
15, 2006 and terminates on March 31, 2016. The Company has the option to extend the term for two
additional 36-month periods, as well as the right to terminate the Lease within the first five
years. The monthly rent increases every 12 months, starting at $62,500 plus certain building
expenses incurred by the landlord and ending at approximately $81,550 plus certain building
expenses incurred by the landlord. In connection with the Lease, the Company provided a $1 million
letter of credit to the landlord as a security deposit for the Companys obligations under the
Lease.
On February 21, 2008 the Company entered into a sub-lease agreement with a third party whereby the
third party sub-leased approximately 5,200 square feet of our Deerfield Beach office space
beginning March 1, 2008 through February 28, 2009. This sub-lease agreement was amended and
restated on October 3, 2008 to increase the sub-leased square footage to 13,900 and extend the
lease term through January 31, 2010.
On October 1, 2008 the Company entered into a sub-lease agreement with a third party whereby the
third party sub-leased approximately 8,000 square feet of our Deerfield Beach office space
beginning October 15, 2008 through January 31, 2010. In accordance with this sub-lease agreement
the Company recognizes base rent, additional rent representing a portion of certain actual
occupancy expenses for our Deerfield Beach office and certain telephony, technology and facility
services provided to our sub-tenant.
On July 7, 2006, the Company entered into a lease agreement with Radnor Properties-SDC, L.P. (the
Landlord) for the lease of 7,414 square feet of office space located in Radnor Financial Center,
Building B, 150 Radnor-Chester Road, Radnor, Pennsylvania. The term of the lease commenced on
November 1, 2006, which was the date the Company, with the Landlords prior consent, assumed
possession of the premises and the date the Landlord tendered possession of the premises to the
Company following the substantial completion of the improvements required to be made by the
Landlord under the lease agreement, and will expire on the last day of the 125
th
month
following the commencement of the lease term. The annual rent increases every 12 months, starting
at approximately $161,592 plus a proportionate share of landlords building expenses after the
second month and ending at approximately $258,378 plus a proportionate share of landlords building
expenses. Under the terms of the lease agreement, rent is waived for the first five months of the
lease term with respect to 5,238 square feet and for the first twelve months for the remaining
2,176 square feet. The Company recorded an expense charge and liability for deferred rent in the
amount of $38,578 as of December 31, 2006.
F-43
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 11
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES (continued)
The Company paid to the Landlord a security deposit of $100,000 under the lease (the Security
Deposit) during the third quarter of 2006, which is accounted for as a deposit in other assets.
The Company will not earn interest on the Security Deposit. The Security Deposit will decrease and
the Landlord will return to the Company $10,000 on the third anniversary of the commencement date
of the lease and on each anniversary thereafter until the required Security Deposit has been
reduced to $20,000. The Security Deposit will be returned to the Company 30 days after the end of
the lease provided the Company has complied with all provisions of the lease.
Effective during the first quarter of 2007, the letters of credit pertaining to the lease for our
Florida office and our New York office were collateralized in the form of a money market account,
which as of December 31, 2008 and December 31, 2007 had a balance of $1,150,000. This money market
account is on deposit with the issuer of the letters of credit and is classified as restricted cash
on the Companys balance sheet. The terms of the money market account allow the Company to receive
interest on the principal but prohibits the Company from withdrawing the principal for the life of
the letters of credit.
On March 7, 2006, the Company entered into a sublease for approximately 13,773 square feet of
office space located on the 7th floor at 1120 Avenue of the Americas, New York, New York (Sublease
Agreement). The initial term of the Sublease Agreement commences in March 2006, and terminates on
December 31, 2010. The monthly rent increases every 12 months, starting at approximately $303,000
per annum plus a proportionate share of landlords building expenses and ending at approximately
$341,000 per annum plus a proportionate share of landlords building expenses. In connection with
the Sublease Agreement, the Company provided a $151,503 letter of credit to the landlord as a
security deposit for the Companys obligations under the sublease. On May 15, 2006 the Company
received the landlords consent, dated April 18, 2006, to the Sublease Agreement. In March 2008,
the Company closed its sales office located in New York. On April 17, 2008 the Company entered
into a sub-lease agreement with a third party (2008 Sublease Agreement) whereby the third party
will sub-lease the Companys New York office space for the balance of the Companys Sublease
Agreement and pay the Company sub-lease payments essentially equal to the Companys costs under the
Sublease Agreement. The terms of the 2008 Sublease Agreement required the Company to make certain
leasehold improvements. The third party commenced paying sub-sublease payments to the Company in
September 2008 however the third party failed to pay their December 2008, January and February 2009
rent when due. The Company is a beneficiary to a letter of credit in the amount of $151,503, which
is available for the Company to draw against in the event of the third partys failure to pay their
rent when due. Effective December 31, 2008, the Company has accrued $629,396 related to the
non-cancelable lease for the abandoned facilities, which is net present value of the Companys
future lease payments due under the remaining Sublease Agreement term plus managements estimate of
utility payments, which is estimated to be $773,311, less managements estimate of future sub-lease
revenue under the 2008 Sublease Agreement secured by the letter of credit, which is estimated to be
$120,023.
The Company leases certain real and personal property under non-cancelable operating leases. Rent
expense was $2,482,008 and $1,710,010 for the years ended December 31, 2008 and 2007, respectively.
F-44
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 11
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES (continued)
Future minimum payments required under operating leases, severance and employment agreements and
service agreements at December 31, 2008 are as follows:
|
|
|
|
|
2009
|
|
$
|
2,114,929
|
|
2010
|
|
|
1,934,411
|
|
2011
|
|
|
1,602,323
|
|
2012
|
|
|
1,418,744
|
|
2013
|
|
|
1,191,826
|
|
thereafter
|
|
|
2,920,264
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
11,182,497
|
|
|
|
|
|
Litigation
On August 7, 2008, a former employee of the Company (the Plaintiff) filed a putative collective
action in the United States District Court for the Southern District of Florida, case no.
08-CV-61254-Ungaro-Simonton, alleging that the Company and a co-defendant, who is an officer of the
Company, unlawfully failed to pay overtime to its insurance sales agents in violation of the Fair
Labor Standards Act (FLSA). Plaintiff purported to bring claims on behalf of a class of current
and former insurance sales agents who were classified as non-exempt by the Company and compensated
at an hourly rate, plus commissions (Agents). On October 16, 2008, the Court conditionally
certified a collective action under the FLSA covering all Agents who worked for the Company within
the last three years. Plaintiff and all Agents who opt to participate in the collective action
seek payment from the Company of compensation for all overtime hours worked at the rate of one and
one-half times their regular rate of pay, liquidated damages, attorneys fees, costs, and interest.
On March 2, 2009, the parties reached an agreement to settle this case. That settlement will be
submitted to the court for necessary approval. As of December 31, 2008 the Company recorded
$200,000 of expense in other general and administrative expense, which represents the estimated
cost of the settlement.
On August 28, 2008, a former employee of the Company (the Plaintiff) filed a national class
action complaint in the Seventeenth Judicial Circuit of Florida, Broward County, case no. 062008 CA
042798 XXX CE, alleging that the Company breached a contract with employees by failing to provide
certain commissions and/or bonuses. The complaint also contains claims for an accounting and for
declaratory relief relating to the alleged compensation agreement. Plaintiff purports to bring
these claims on behalf of a class of current and former insurance sales agents. Plaintiff seeks
payment from the Company of all commissions allegedly owed to him and the putative class, triple
damages, attorneys fees, costs, and interest. The Company filed a motion to dismiss the
complaint, which is set for hearing on November 13, 2008. The Company filed a motion to dismiss the
complaint, which has not yet been heard by the court. The Company believes that these claims are
without merit and intends to vigorously defend the litigation.
F-45
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 11
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES (continued)
Guarantee of Indebtedness by the Company to Third Parties Pertaining to Unearned Commission
Advances Paid to Non-employee ISG Agents
The Company is a party to sales and marketing agreements whereby the Company has guaranteed the
repayment of unearned commission advances paid directly from third parties including certain of the
Companys insurance carriers to the Companys non-employee ISG agents. Under these agreements
certain third parties pay commissions directly to the Companys non-employee ISG agents and such
payments include advances of first year premium commissions before the commissions are earned.
Unearned commission advances from the Companys insurance carriers to the Companys non-employee
ISG agents are earned after the insurance company has received payment of the related premium. In
the event that the insurance company does not receive payment of the related premium pertaining to
an unearned commission advance the third parties generally deduct the unearned commission advance
from its commission payments to the Companys non-employee ISG agents in the form of charge-backs.
In the event that commission payments from these third parties to the Companys non-employee ISG
agents do not exceed the charge-backs these third parties may deduct the unearned commission
advance to non-employee ISG agents from their payments to the Company or demand repayment of the
non-employee ISG agents unearned commission balance from the Company. The current amount of the
unearned commission advances these third parties to the Companys non-employee ISG agents, which is
the maximum potential amount of future payments the Company could be required to make to these
third parties, is estimated to be approximately $643,000 as of December 31, 2008. As of December
31, 2008 the Company has recorded a liability of $76,651 in accrued expenses for the estimated
amount the Company anticipates it will pay pertaining to these guarantees. Unearned commission
advances from these third parties are collateralized by the future commission payments to the
non-employee ISG agents and to the Company. The Company has recourse against certain non-employee
ISG agents in the event the Company must pay the unearned commission advances.
License Agreement with Realtime Solutions Group
On May 31, 2006, the Company entered into a Software and Services Agreement (the License
Agreement) with Realtime Solutions Group, L.L.C. (Realtime), under which Realtime granted the
Company a worldwide, transferable, non-exclusive, perpetual and irrevocable license to use,
display, copy, modify, enhance, create derivate works within, and access Realtime Solutions Groups
Straight Through Processing software (STP) and all associated documentation, source code and
object code, for use in the marketing, promotion and sale of health benefits or insurance products.
As consideration for the grant of the rights and licenses under the License Agreement, the Company
paid to Realtime a $10,000 nonrefundable cash deposit and upon delivery of the STP software and
other materials the Company will pay a license fee in the form of 216,612 unregistered shares of
our common stock. Concurrent with entering into the License Agreement, HBDC and Realtime entered
into a Registration Rights Agreement that provides for piggyback registration rights for the to be
issued shares.
The Company may unilaterally terminate the License Agreement, with or without cause, at any time on
30 calendar day prior written notice to Realtime. The license rights in the software granted under
the License Agreement survive any termination of the License Agreement in perpetuity.
F-46
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 11
RESTRICTED CASH, COMMITMENTS AND CONTINGENCIES (continued)
As of December 31, 2008 the Company has not taken delivery of the STP software or issued Common
Stock in connection with the License Agreement.
NOTE 12
SEGMENT INFORMATION
The Company derives the results of the business segments directly from its internal management
reporting system. The accounting policies the Company uses to derive business segment results are
substantially the same as those the consolidated company uses. Business segment results are
presented net of inter-segment amounts. Management measures the performance of each business
segment based on several metrics, including earnings from operations. Management uses these
results, in part, to evaluate the performance of, and to assign resources to, each of the business
segments.
We acquired Atiam on October 1, 2007. The results of Atiams operations prior to our October 1,
2007 acquisition have been excluded from our financial statements. The results of our Atiam
business segment have been included in the Companys statement of operations as of October 1, 2007.
Thus Atiam segments results from operations for years ended December 31, 2008 and 2007 are not
comparable.
Selected operating results and total asset information for each business segment was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months
|
|
For the Twelve Months
|
|
|
Ended December 31, 2008
|
|
Ended December 31, 2007
|
|
|
Telesales
|
|
Atiam
|
|
Total
|
|
Telesales
|
|
Atiam
|
|
Total
|
Revenue
|
|
$
|
18,549,515
|
|
|
$
|
5,578,512
|
|
|
$
|
24,128,027
|
|
|
$
|
19,568,722
|
|
|
|
1,141,028
|
|
|
$
|
20,709,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) from operations
|
|
$
|
(8,231,905
|
)
|
|
$
|
(731,806
|
)
|
|
$
|
(8,963,711
|
)
|
|
$
|
(14,650,531
|
)
|
|
|
197,490
|
|
|
$
|
(14,453,041
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008
|
December 31, 2007
|
Total assets
|
|
$
|
4,817,971
|
|
|
$
|
3,891,082
|
|
|
$
|
8,709,053
|
|
|
$
|
12,492,533
|
|
|
|
3,802,121
|
|
|
$
|
16,294,654
|
|
F-47
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 13
INCOME TAXES
The Company has net operating losses carry-forwards for federal income tax purposes of
approximately $25,000,000 at December 31, 2008, the unused portion of which, if any, expires in
years 2025 through 2028. The Company accounts for income taxes under Statement of Financial
Accounting Standards No. 109, Accounting for Income Taxes SFAS 109. SFAS 109 requires the
recognition of deferred tax assets and liabilities for both the expected impact of differences
between the financial statements and the tax basis of assets and liabilities, and for the expected
future tax benefit to be derived from tax losses and tax credit carry forwards. SFAS 109
additionally requires the establishment of a valuation allowance to reflect the likelihood of
realization of deferred tax assets. Internal Revenue Code Section 382 places a limitation on the
amount of taxable income that can be offset by carry forwards after a change in control (generally
greater than a 50% change in ownership).
The table below summarizes the differences between the Companys effective tax rate and the
statutory federal rate as follows for the periods ended December 31, 2008 and 2007:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
Computed expected benefit
|
|
$
|
(3,141,629
|
)
|
|
$
|
(4,953,699
|
)
|
State tax benefit, net of federal effect
|
|
|
(269,283
|
)
|
|
|
(424,603
|
)
|
Amortization of acquisition related assets
|
|
|
724,266
|
|
|
|
489,211
|
|
Other permanent differences
|
|
|
57,489
|
|
|
|
13,737
|
|
Increase in valuation allowance
|
|
|
2,629,157
|
|
|
|
4,875,354
|
|
|
|
|
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
Deferred tax assets and liabilities are provided for significant income and expense items
recognized in different years for tax and financial reporting purposes. The components of the net
deferred tax assets for the years ended December 31, 2008 and 2007 were as follows:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
Deferred tax assets:
|
|
|
|
|
|
|
|
|
Net operating loss carry forward
|
|
$
|
9,589,320
|
|
|
$
|
5,668,883
|
|
Unearned commission advances
|
|
|
1,148,421
|
|
|
|
3,211,222
|
|
Stock option and other compensation expense
|
|
|
2,036,038
|
|
|
|
1,431,623
|
|
Depreciation
|
|
|
41,011
|
|
|
|
|
|
All Other
|
|
|
444,645
|
|
|
|
411,434
|
|
|
|
|
|
|
|
|
Total deferred tax asset
|
|
|
13,259,435
|
|
|
|
10,723,162
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
Depreciation
|
|
|
0
|
|
|
|
(37,196
|
)
|
Software development costs
|
|
|
(317,291
|
)
|
|
|
(372,979
|
)
|
|
|
|
|
|
|
|
Net deferred tax asset
|
|
|
12,942,144
|
|
|
|
10,312,987
|
|
|
|
|
|
|
|
|
Less: Valuation allowance
|
|
|
(12,942,144
|
)
|
|
|
(10,312,987
|
)
|
|
|
|
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
The Company fully reserved the net deferred tax asset due to the substantial uncertainty of the
realization of any tax assets in future periods. The valuation allowance was increased by
$2,629,157 from the prior year.
F-48
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 14
SUBSEQUENT EVENTS
Expiration of Warrants
On January 10, 2009, warrants to purchase 2,762,500 shares of the Companys Common Stock at an
exercise price of $1.50 per share expired in accordance with the terms of the warrants.
Issuance of Stock, Amendments to Articles of Incorporation or Bylaws
On January 14, 2009, the Company entered into and, on January 15, 2009 completed, a private
placement (the 2009 Private Placement) with Co-Investment Fund II, L.P., a Delaware limited
partnership (Co-Investment or the Investor), for an aggregate of 1,000,000 shares (each, a
Preferred Share) of its Series A Convertible Preferred Stock, par value $0.001 per share
(Preferred Stock), and warrants (2009 Warrants) to purchase 1,000,000 shares of its Preferred
Stock (each, a Preferred Warrant Share), pursuant to the terms of the Securities Purchase
Agreement (the 2009 Purchase Agreement). The gross proceeds from the closing were $4 million and
the Company intends to use the net proceeds of the Private Placement for working capital purposes.
Pursuant to the Purchase Agreement, the Company agreed to sell to Co-Investment 1,000,000
investment units (each, a 2009 Unit) in the 2009 Private Placement at a per 2009 Unit purchase
price equal to
$4.00. Each 2009 Unit sold in the 2009 Private Placement consisted of one share of Preferred Stock
and a Warrant to purchase one share of Preferred Stock at an initial exercise price of $4.00 per
share, subject to adjustment (the 2009 Warrant).
The Preferred Stock is entitled to vote as a single class with the holders of the Companys common
stock, with each Share of Preferred Stock having the right to 20 votes. Upon the liquidation, sale
or merger of the Company, each Share of Preferred Stock is entitled to receive an amount equal to
the greater of (A) a liquidation preference equal to two and a half (2.5) times the Preferred Stock
original issue price, subject to certain customary adjustments, or (B) the amount such Share of
Preferred Stock would receive if it participated
pari passu
with the holders of Common Stock on an
as-converted basis. Each Share of Preferred Stock becomes convertible into 20 shares of Common
Stock (the Shares), subject to adjustment and at the option of the holder of the Preferred Stock,
immediately after stockholder approval of the Charter Amendment (as defined below). For so long as
any shares of Preferred Stocks are outstanding, the vote or consent of the Holders of at least
two-thirds of the Preferred Stock is required to approve (Y) any amendment to the Companys
certificate of incorporation or bylaws that would adversely alter the voting powers, preferences or
special rights of the Preferred Stock or (Z) any amendment to the Companys certificate of
incorporation to create any shares of capital stock that rank senior to the Preferred Stock. In
addition to the voting rights described above, for so long as 1,000,000 Share of Preferred Stocks
are outstanding, the vote or consent of the holders of at least two-thirds of the Share of
Preferred Stock is required to effect or validate any merger, sale of substantially all of the
assets of the Company or other fundamental transaction, unless such transaction, when consummated,
will provide the holders of Preferred Stock with an amount per share equal to two and a half (2.5)
times the Preferred Stock original issue price.
F-49
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 14
SUBSEQUENT EVENTS (continued)
The Company is also required, under the terms of the 2009 Purchase Agreement, to file a proxy
statement (the Proxy Statement) and hold a special meeting of the Companys stockholders (the
Special Meeting) within 75 days of the effective date of the Purchase Agreement for the purpose
of approving a certificate of amendment to the Companys certificate of incorporation to increase
the total number of the Companys authorized shares of Common Stock from 90,000,000 to 250,000,000
(the Charter Amendment). Under the terms of the 2009 Purchase Agreement, Co-Investment has
agreed to vote all Preferred Shares and shares of Common Stock beneficially owned by it in favor of
the Charter Amendment at the Special Meeting.
The 2009 Warrants provide that the holder thereof shall have the right (A) at any time after the
Stockholder Approval Deadline, but prior to the earlier of (i) ten business days after the Company
has properly provided written notice to all such holders of a Call Event (as defined below), (ii)
the date on which the Companys stockholders approve the Charter Amendment (the Stockholder
Approval Date) and (iii) January 14, 2014, to acquire 1,000,000 shares of Preferred Stock upon the
payment of $4.00 per Preferred Warrant Share and (B) at any time after the Stockholder Approval
Date, but prior to the earlier of (i) ten business days after the Company has properly provided
written notice to all such holders of a Call Event (as defined below) and (ii) January 14, 2014, to
acquire up to a total of 20,000,000 shares of Common Stock of the Company (each a Warrant Share)
upon the payment of $0.20 per Warrant Share (the Exercise Price). The Company also has the
right, at any point after the Stockholder Approval Date and after which the volume weighted average
trading price per share of the Preferred Stock for a minimum of 20 consecutive trading days is
equal to at least eight times the Exercise Price per share, provided that certain other conditions
have been satisfied, to call the outstanding 2009 Warrants (a Call Event), in which case such
2009 Warrants will expire if not exercised within ten business days thereafter. The 2009 Warrants
also include full ratchet anti-dilution adjustment provisions for issuances of securities below
$0.20 per share of Common Stock during the first two years following the date of issuance of the
2009 Warrants, subject to customary exceptions.
Upon shareholder approval of the Charter Amendment at the Special Meeting and the filing of the
Certificate of Amendment, all outstanding shares of Series A Preferred Stock will become
immediately convertible, at the election of each holder of Preferred Shares, into twenty shares of
the Companys common stock and the 2009 Warrants issued in the 2009 Private Placement will
automatically become exercisable for twenty shares of Common Stock.
F-50
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 14
SUBSEQUENT EVENTS (continued)
In connection with the signing of the 2009 Purchase Agreement, the Company and the Investor also
entered into a Registration Rights Agreement (the 2009 Registration Rights Agreement). Under the
terms of the 2009 Registration Rights Agreement, the Company agreed to prepare and file with the
SEC, within 30 days following the receipt of a demand notice of a holder of Registrable Securities,
a registration statement on Form S-1 (the Registration Statement) covering the resale of the
Shares and the Warrant Shares (collectively, the Registrable Securities). Subject to limited
exceptions, the Company also agreed to use its reasonable best efforts to cause the Registration
Statement to be declared effective under the Securities Act of 1933, as amended (the Securities
Act), as soon as practicable but, in any event, no later than 60 days following the date of the
2009 Registration Rights Agreement (or 120 days following the date of the 2009 Registration Rights
Agreement in the event the Registration Statement is subject to review by the SEC), and agreed to
use its reasonable best efforts to keep the Registration Statement effective under the Securities
Act until the date that all of the Registrable Securities covered by the Registration Statement
have been sold or may be sold without volume restrictions pursuant to Rule 144(b)(i) promulgated
under the Securities Act. In addition, if the Company proposes to register any of its securities
under the Securities Act in connection with the offering of such securities for cash, the Company
shall, at such time, promptly give each holder of Registrable Securities notice of such intent, and
such holders shall have the option to register their Registrable Securities on such additional
registration statement. The 2009 Registration Rights Agreement also provides for payment of
partial damages to the Investor under certain circumstances relating to failure to file or obtain
or maintain effectiveness of the Registration Statement, subject to adjustment.
The Company also agreed, pursuant to the terms of the 2009 Purchase Agreement, that, except for the
Follow-on Financing, for a period of 90 days after the effective date (the
Initial
Standstill
) of the 2009 Purchase Agreement, the Company shall not, subject to certain
exceptions, offer, sell, grant any option to purchase, or otherwise dispose of any equity
securities or equity equivalent securities, including without limitation, any debt, preferred
stock, rights, options, warrants or other instrument that is at any time convertible into or
exchangeable for, or otherwise entitles the holder thereof to receive, capital stock and other
securities of the Company (any such issuance, offer, sale, grant, disposition or announcement being
referred to as a
Subsequent Placement
). Additionally, the Company has agreed with
Co-Investment that, for an additional 90 day period following the Initial Standstill, it shall not
engage in any Subsequent Placement without the prior written consent of Co-Investment, if such
Subsequent Placement seeks to raise less than $15 million.
The 2009 Purchase Agreement also provides for a customary participation right for Co-Investment,
subject to certain exceptions and limitations, which grants Co-Investment the right to participate
in any future capital raising financings of the Company occurring prior to January 14, 2011.
Co-Investment may participate in such financings at a level based on Co-Investments ownership
percentage of the Company on a fully-diluted basis prior to such financing.
On January 14, 2009, the Company filed the Certificate of Designation with the Secretary of State
of the State of Delaware. The Certificate of Designation was approved by the Companys Board of
Directors on
January 12, 2009 and became effective upon filing. The Certificate of Designation provides for the
terms of the Preferred Stock issued pursuant to the 2009 Purchase Agreement.
F-51
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 14
SUBSEQUENT EVENTS (continued)
Cessation of Direct Marketing and Sales in the Telesales Call Center, Transactions with eHealth
and Reduction in Staffing
During the first quarter of 2009, the Company ceased the direct marketing and sale of health and
life insurance and related products to individuals and families in its Telesales call center. The
Company continues to sell health and life insurance and related products to individuals and
families through its non employee ISG agents. The Companys Telesales business segment eliminated
43 positions including all of its licensed employee sales agents along with other Telesales service
and support personnel and eliminated another 20 positions in Telesales through attrition.
On February 20, 2009 (the Closing Date), the Company entered into and completed the sale of the
Companys Telesales call center produced agency business (the Agency Business) to eHealth, an
unaffiliated third party, pursuant to the terms of a Client Transition Agreement (the Agreement).
Pursuant to the Agreement the Company transferred to eHealth broker of record status and the right
to receive commissions on certain of the in-force individual and family major medial health
insurance policies and ancillary dental, life and vision insurance policies issued by Aetna, Inc.,
Golden Rule, Humana, PacifiCare, Inc., Assurant and United Healthcare Insurance Co. (collectively,
the Specified Carriers) on which the Company was designated as broker of record as of the Closing
Date (collectively, the Transferred Policies and each, a Transferred Policy). Certain policies
and products were excluded from the transaction, including the Companys agency business generated
through its ISG agents, all short term medical products and all business produced through carriers
other than the Specified Carriers. In addition, the Agreement also provides for the transfer to
eHealth of certain lead information relating to health insurance prospects (the Lead Database).
The estimated aggregate initial amount of consideration paid by eHealth pursuant to the Agreement
is approximately $1,280,000. In addition, on the Closing Date, eHealth agreed to assume from the
Company certain liabilities relating to historical commission advances on the Transferred Policies
made by the Specified Carriers in an aggregate amount of approximately $1,385,000. In addition,
eHealth has agreed to pay to HBDC II a portion of each commission payment received by eHealth and
reported by the Specified Carrier relating to a Transferred Policy for the duration of the policy,
provided that eHealth remains broker of record on such Transferred Policy.
Simultaneous with the execution of the Agreement, the Company and eHealth also entered into a
Marketing and Referral Agreement, dated as of February 20, 2009 (the
Referral Agreement
).
Pursuant to the terms of the Referral Agreement, eHealth agreed to construct one or more websites
for the purpose of selling health insurance products (the
Referral Sites
) and to pay to
HBDC II a portion of all first year and renewal commissions received by eHealth from policies sold
through the Referral Sites that result from marketing to prospects using the Lead Database or other
leads delivered by the Company to eHealth.
The Referral Agreement is scheduled to terminate 18 months following the Closing Date and is
terminable by the Company or eHealth upon material breach by the other party.
F-52
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 14
SUBSEQUENT EVENTS (continued)
As a result of above, management anticipates a significant decline in future Telesales revenues as
a result of the cessation of direct marketing and sales in Telesales and the eHealth transaction.
Revenue from the five insurance carriers subject to the eHealth transactions accounted for 66% and
75% of the Companys total revenue for the years ended December 31, 2008 and 2007. Management
believes the reduction in future revenues will be mitigated if not more than offset by significant
reductions in future expenses. During the year ended December 31, 2008, the Company incurred
approximately $12,697,000 of expense in Telesales call center, which will be eliminated as a
result of the cessation of direct marketing and sales activities, including approximately
$7,668,000 of salaries, commissions and related taxes, approximately $4,013,000 of lead,
advertising and other marketing, approximately $848,000 rent and other occupancy costs and
approximately $168,000 of other general and administrative expense.
We have not completed a determination of the impairment of long term assets as a result of the
cessation of direct marketing and sales and the Agreement. The long term assets, which may be
impaired, and their net book value as of December 31, 2008 include property and equipment net of
depreciation of approximately $434,000, intangible assets net of accumulated amortization acquired
from ISG including value of purchased commission override revenue of $227,779 and value of acquired
carrier contracts and agent relationships of $1,032,294. We anticipate completing an impairment
determination during the first quarter of 2009.
Results of March 25, 2009 Special Shareholder Meeting
Effective March 25, 2009, our shareholders approved an amendment to our certificate of
incorporation, as amended, to increase the number of authorized Common Shares from 90,000,000
shares to 200,000,000.
Amendments
to Articles of Incorporation Pertaining to the Convertibility of
Preferred Shares into
Common Shares
As a result of shareholder approval of an amendment to our certificate of incorporation, as
amended, to increase the number of authorized shares of Common Stock from 90,000,000 shares to
200,000,000 on March 25, 2009, the Company filed a Certificate of Amendment with the Secretary of
State of the State of Delaware. The Certificate of Amendment was approved by the Companys board of
directors on January 12, 2009 and became effective upon filing
on March 25, 2009. Upon the filing of the Certificate
of Amendment, all outstanding shares of Series A Preferred Stock
became immediately convertible, at the election of each holder of Preferred Shares, into twenty shares of the
Companys common stock and the 2009 Warrants issued in the 2009 Private Placement
automatically became exercisable for twenty shares of Common Stock.
Anti-dilution Adjustment to 2007 Warrants and 2008 Warrants
Effective March 25, 2009, in connection with our shareholders approval of an amendment to our
certificate of incorporation, the Company adjusted the 2007 Warrants pursuant to the weighted
average anti-dilution adjustment provisions of the 2007 Warrants. The exercise price of the 2007
Warrants was adjusted from $2.48 to $1.51 and the number of issued, exercisable and outstanding
2007 Warrants were adjusted from 3,024,186 to 4,968,491.
F-53
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 14
SUBSEQUENT EVENTS (continued)
Also effective March 25, 2009, in connection with our shareholders approval of an amendment to our
certificate of incorporation, the Company adjusted the 2008 Warrants pursuant to the full ratchet
anti-dilution adjustment provisions of the 2008 Warrants. The exercise price of the 2008 Warrants
was adjusted from $0.80 to $0.20 and the number of issued, exercisable and outstanding 2008
Warrants were adjusted from 6,250,000 to 25,000,000.
Action of the Compensation Committee on February 5, 2009
On February 5, 2009, the Compensation Committee (the Committee) of the Companys board of
directors authorized and issued stock option grants and bonuses to each of Anthony R. Verdi, the
Companys Chief Financial Officer, Chief Operating Officer and acting principal executive officer,
and Robert Oakes, a director of the Company and President of the Companys Atiam Technologies LLC
subsidiary.
The Committee approved a $100,000 cash bonus payable to Mr. Verdi in four equal monthly
installments beginning in April 2009 and a $50,000 cash bonus payable to Mr. Oakes in February
2009. The Committee also authorized and issued to Mr. Verdi a stock option grant to purchase a
total of 650,000 shares of the Companys common stock, which vests as follows: 130,000 shares of
Common Stock on each of May 31, 2009, September 30, 2009, May 31, 2010 and September 30, 2010;
65,000 shares of Common Stock on May 31, 2011; and 32,500 shares of Common Stock on each of
September 30, 2011 and May 31, 2012.
The Committee authorized and issued to Mr. Oakes a stock option grant to purchase a total of
1,000,000 shares of the Companys common stock, which vests as follows: 200,000 shares of Common
Stock on each of May 31, 2009, September 30, 2009, May 31, 2010 and September 30, 2010; 100,000
shares of Common Stock on May 31, 2011; and 50,000 shares of Common Stock on each of September 30,
2011 and May 31, 2012.
Each of the options issued to Messrs. Verdi and Oakes have a five year term and an exercise price
of $0.101, which is equal to closing price of one share of the Companys common stock as quoted on
the OTCBB on February 5, 2009.
Separation of Employment Agreement and General Release With Charles Eissa
On March 31, 2009, Charles Eissa, the Companys President, and the Company agreed to a Separation
of Employment and General Release Agreement whereby Mr. Eissa and the Company mutually agreed that
Mr. Eissas employment terminated effective March 31, 2009 (Separation Date). Under the terms of
the agreement the Company will continue to pay Mr. Eissa his current base salary for a period of
fourteen
(14) months after the Separation Date, less applicable tax withholding, which will be paid in equal
installments in accordance with the Companys normal payroll practices. The Company will provide
Mr. Eissa with continued medical, dental and vision coverage at the level in effect as of the
Separation Date until the end of the twelve (12)-month period following the Separation Date. In
addition the Company agreed to vest effective with the Separation Date all remaining restricted
common stock granted to Mr. Eissa on February 15, 2007 subject to the payment in cash of any
withholding taxes to the Company, which would have vested between March 15, 2009 and February 15,
2010. Any stock option grants held by Mr. Eissa that are not vested as of the Separation Date
shall be forfeited as of the Separation Date.
F-54
HEALTH BENEFITS DIRECT CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
NOTE 14
SUBSEQUENT EVENTS (continued)
As of March 31, 2009 the Company and Mr. Eissa entered into a consulting agreement that outlines
certain advisory services to be provided by Mr. Eissa to the Company.
F-55
|
|
|
ITEM 9.
|
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINACIAL
DISCLOSURE
|
NONE.
|
|
|
ITEM 9A(T).
|
|
CONTROLS AND PROCEDURES.
|
Disclosure Controls and Procedures.
Our management is responsible for establishing and maintaining adequate internal control over
financial reporting for the Company. Under the supervision of our Chief Executive Officer and
Chief Financial Officer, our management conducted an assessment of the effectiveness of our
disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under
the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this
report. Based on the results of such assessment, management have concluded that our disclosure
controls and procedures as of the end of the period covered by this report have been designed and
are functioning effectively to provide reasonable assurance that the information required to be
disclosed by the Company in reports filed under the Securities Exchange Act of 1934, as amended, is
recorded, processed, summarized and reported within the time periods specified in the SECs rules
and is accumulated and communicated to management, including the Companys principal executive and
principal financial officers, or person performing similar functions, as appropriate to allow
timely decisions regarding required disclosure.
Internal Control over Financial Reporting.
There have not been any changes in the Companys internal control over financial reporting
during the Companys last fiscal year to which this report relates that have materially affected,
or are reasonably likely to materially affect, the Companys internal control over financial
reporting.
A control system, no matter how well conceived and operated, can provide only reasonable, not
absolute, assurance that the objectives of the control system are met. Because of the inherent
limitations in all control systems, no evaluation of controls can provide absolute assurance that
all control issues and instances of fraud, if any, within the Company have been detected. The
design of any system of controls also is based in part upon certain assumptions about the
likelihood of future events, and there can be no assurance that any design will succeed in
achieving its stated goals under all potential future conditions; over time, control may become
inadequate because of changes in conditions, or the degree of compliance with the policies or
procedures may deteriorate. Because of the inherent limitations in a cost-effective control system,
misstatements due to error or fraud may occur and not be detected.
Managements report on internal control over financial reporting is included in Item 8,
Financial Statements
, of this Annual Report on Form 10-K.
|
|
|
ITEM 9B.
|
|
OTHER INFORMATION.
|
On March 31, 2009, Charles Eissa, the Companys President, and the Company agreed to a Separation
of Employment and General Release Agreement whereby Mr. Eissa and the Company mutually agreed that
Mr. Eissas employment terminated effective March 31, 2009 (Separation Date). Under the terms of
the agreement the Company will continue to pay Mr. Eissa his current base salary for a period of
fourteen (14) months after the effective date, less applicable tax withholding, which will be paid
in equal installments in accordance with the Companys normal payroll practices, beginning within
thirty (30) days following the Separation Date. The Company will provide Mr. Eissa with continued
medical, dental and vision coverage at the level in effect as of the Separation Date (or generally
comparable coverage) for Employee, on the same terms as such coverage is available to employees of
the Company generally, at the same premium rates and cost sharing as may be charged from time to
time for employees of the Company generally, as if Employee had continued in employment until the
end of the
twelve (12)-month period following the Separation Date. In addition the Company agreed to vest
effective on the Separation Date all remaining restricted common stock granted to Mr. Eissa on
February 15, 2007 subject to the
98
payment in cash of any withholding taxes to the Company, which
would have vested between March 15, 2009 and February 15, 2010. Any stock option grants held by
Mr. Eissa that are not vested as of the Separation Date shall be forfeited as of the Separation
Date and Employee shall have no further rights with respect thereto.
As of March 31, 2009 the Company and Mr. Eissa entered into a consulting agreement that outlines
certain advisory services to be provided by Mr. Eissa to the Company.
As a result of shareholder approval of an amendment to our certificate of incorporation, as
amended, to increase the number of authorized shares of Common Stock from 90,000,000 shares to
200,000,000 on March 25, 2009, the Company filed a Certificate of Amendment with the Secretary of
State of the State of Delaware. The Certificate of Amendment was approved by the Companys board of
directors on January 12, 2009 and became effective upon filing
on March 25, 2009. Upon the filing of the Certificate
of Amendment, all outstanding shares of Series A Preferred Stock
became immediately convertible, at the election of each holder of Preferred Shares, into twenty shares of the
Companys common stock and the 2009 Warrants issued in the 2009 Private Placement
automatically became exercisable for twenty shares of Common Stock.
99
PART III
|
|
|
ITEM 10.
|
|
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.
|
Directors, Executive Officers and Corporate Governance
Donald R. Caldwell
, 61, has served as one of our directors and as one of the Co-Chairmen of
our board of directors since April 2008. Mr. Caldwell founded Cross Atlantic Capital Partners, Inc.
in 1999, and presently serves as its Chairman and Chief Executive Officer. He has served as a
Director at Rubicon Technology, Inc. since 2001, and at Diamond Management & Technology
Consultants, Inc. (NASDAQ) since 1994. Mr. Caldwell is a Director and a member of the Compensation
Committees of Quaker Chemical Corporation (NYSE), a provider of process chemicals and chemical
specialties, and Voxware, Inc. (NASDAQ), a supplier of voice driven solutions. From 1996 to 1999,
Mr. Caldwell was President and Chief Operating Officer and a Director of Safeguard Scientifics,
Inc. Mr. Caldwell is a Certified Public Accountant in the State of New York.
Alvin H. Clemens
, 71, has served as one of our directors since November 2005 and has served as
one of the Co-Chairmen since April 2008. Mr. Clemens has previously served as Executive Chairman of
our board of directors from January 2006 to March 2008 and as our Chief Executive Officer from
December 2006 to March 2008. Since 2001, Mr. Clemens has performed business and insurance industry
consulting services in addition to managing his private investments. In 1998, he founded HealthAxis
Inc., a publicly-traded company specializing in direct sales of insurance products utilizing the
Internet, as a subsidiary of Provident American Corporation. In 1989, Mr. Clemens acquired a
controlling interest in Provident American Corporation, an insurance holding company, and he served
as its Chairman and Chief Executive Officer until 2001. In 1970, Mr. Clemens founded Academy
Insurance Group, a company specializing in direct marketing of life and health insurance products.
He currently serves on the board of trustees and the Building, Finance, and Executive Committees of
The Pennsylvania State University.
John Harrison
, 65, has served as one of our directors since November 2005. He is a founding
Partner and Executive Director of The Keystone Equities Group, Inc., a full service investment
banking group and a registered NASD broker-dealer founded in 2003. Mr. Harrison also is a Managing
Director of Covenant Partners, a hedge fund that invests in direct marketing services companies. In
1999, Mr. Harrison became a founding Partner of Emerging Growth Equities, Ltd., a full service
investment banking and brokerage firm focused on raising capital for emerging technology companies
addressing high-growth industry sectors. From 1985 to 2000, Mr. Harrison served as President of
DiMark, a direct marketing agency that was subsequently acquired by Harte-Hanks in 1996. He also
has held senior management positions with CUNA Mutual, RLI Insurance and CNA Insurance where he
directed their direct marketing practice. Mr. Harrison was Chairman of the board of Professional
Insurance Marketing Association (PIMA) and is on the advisory board of DePaul Universitys
Interactive and Direct Marketing Institute. He serves as a director of IXI Corporation, a database
marketing company that uses proprietary wealth and asset information, and Solutionary, Inc., a
full-service provider of managed security services.
Warren V. Musser
, 81, has served as one of our directors since January 2006 and as the Vice
Chairman of our board of directors since March 2006. He also has served as President of The Musser
Group, a financial consulting company, since 2001. Mr. Musser served as Chairman and Chief
Executive Officer of Safeguard Scientifics, Inc. from 1953 until 2001. Mr. Musser is a director of
Internet Capital Group, Inc. and Chairman of the board of directors of Telkonet, Inc. Mr. Musser
serves on a variety of civic, educational and charitable boards of directors.
Robert J. Oakes
, 50, has served as one of our directors since August 2008. He has served as
the President and CEO of our Atiam Technologies LLC subsidiary since our acquisition of the
subsidiary on
100
October 1, 2007. From 1986 until 2007 Mr. Oakes was President and Chief Executive
Officer of the general partner of Atiam Technologies L.P., a software development and servicing
company that developed, expanded and serviced products to serve the insurance and financial
services markets. Mr. Oakes founded Atiam in 1986 and led the companys effort to design and
develop its flagship product,
InsPro
.
InsPro
is a state-of-the-art Insurance, Marketing,
Administration, and Claim System that provides end-to-end insurance processing, technology and
support, for a broad range of life, health, and disability products.
Sanford Rich
, 50, has served as one of our directors since April 2006. He is currently the
Managing Director, Investment Banking for Matrix USA LLC and has held this position since May 2008.
From 1995 to May 2008 Mr. Rich was Director, Senior Vice President and Portfolio Manager at GEM
Capital Management Inc. From 1993 to 1995, Mr. Rich was a Managing Director of High Yield Finance,
Capital Markets & North American Loan Syndicate, Sales and Trading at Citicorp Securities. From
1985 to 1993, he served as Managing Director of Debt Capital Markets at Merrill Lynch. From 1978 to
1985, Mr. Rich held various Analyst positions in numerous companies, including Cypress Capital
Management, Inc. (Vice President and Analyst from 1983 to 1985), FIAMCO (Distressed/High Yield Bond
Analyst from 1981 to 1983), Progressive Corporation (Financial Analyst from 1980 to 1981) and
Prescott, Ball and Turben (Distressed/High Yield Bond Analyst from 1978 to 1980).
L.J. Rowell
, 76, has served as one of our directors since April 2006. He is a past President
(1984-1996), Chief Executive Officer (1991-1996) and Chairman of the Board (1993-1996) of Provident
Mutual Life Insurance Company, where he also held various other executive and committee positions
from 1980 until his retirement in 1996. Mr. Rowell currently serves on the boards of directors of
the Southeast Pennsylvania Chapter of the American Red Cross, The PMA Group, the American College,
The Foundation at Paoli, and The Milton S. Hershey Medical Center. Mr. Rowell also has served on
the Board of Trustees of The Pennsylvania State University as a business and industry trustee since
1992. In 1991, he served as the Chairman of the Major Business Division for the United Way of
Southeastern Pennsylvania. Mr. Rowell also has served as chairman of The American Red Cross Ad
Blood Campaign and has previously served on its Major Contributions Donor Campaign.
Paul Soltoff
, 54, has served as one of our directors since November 2005. He also has served
as Chairman and Chief Executive Officer of SendTec, Inc. since its inception in February 2000.
From 1997 until February 2000, Mr. Soltoff served as Chief Executive Officer of Soltoff Direct
Corporation, a specialized direct marketing consulting company. From September 2004 until October
2005, Mr. Soltoff served as a director of theglobe.com.
Frederick C. Tecce
, 73, has served as one of our directors since August 2007. He currently
serves as of counsel with Buchanan Ingersoll & Rooney. He was an attorney with Klett Rooney Lieber
& Schorling when it joined Buchanan in 2006. Mr. Tecce also serves as counsel to Cross Atlantic
Capital Partners and has served on the investment committees of three of the funds managed by Cross
Atlantic Partners. Mr. Tecce previously served as Senior Vice President and General Counsel of
Academy Life Insurance Company. Mr. Tecce served on the transition team for Pennsylvania Governor
Tom Ridge and was appointed by Governor Ridge to serve as a member of the board of the $50 billion
Public School Employees Retirement System (PSERS), where he served as chairman of the Finance
Committee until his retirement in September of 2001. He was appointed by U.S. Senator Rick Santorum
to the Federal Judicial Nominating Committee where he served for several terms and also served on
Dr. Robert Gallos
Board of Visitors at the University of Maryland Institute for Human Virology. He has also
served on the board of directors of several listed companies.
101
Anthony R. Verdi
, 60, has served as one of our directors since June 2008, as our Chief
Financial Officer and Assistant Secretary since November 2005, as our Chief Operating Officer since
April 2008 and from June 20, 2008 as Acting Principal Executive Officer. From 2001 until November
2005, Mr. Verdi has provided consulting services to life, health and property and casualty
insurance company agency and venture capital clients. Mr. Verdi served as Chief Operating Officer
of Provident and Chief Financial Officer of HealthAxis. From January 1990 until December 1998 Mr.
Verdi served as Chief Financial Officer of Provident American Corporation. From July 1986 until
January 1990, he was the Vice President and Controller of InterCounty Hospitalization and Health
Plans, a nonprofit group medical insurer. From April 1971 until July 1986, he served in various
finance and accounting capacities for the Academy Insurance Group, ultimately serving as the
Assistant Controller.
Edmond J. Walters
, 47, has served as one of our directors since April 2008. Mr. Walters is
Founder and Chief Executive Officer of eMoney Advisor, a wealth planning and management solutions
provider for financial advisors that was founded in 2000 and is now a wholly-owned subsidiary of
Commerce Bancorp. Prior to forming eMoney Advisor in 2000, Mr. Walters spent more than 20 years in
the financial services industry, advising high net worth clients. From 1983 to 1992 he was
associated with Kistler, Tiffany & Company in Wayne, PA. In 1992, Walters helped found the Wharton
Business Group, a financial advising firm, in Malvern, PA.
Code of Business Conduct and Ethics
We adopted an amended and restated Code of Business Conduct and Ethics on January 29, 2008.
Our Code of Business Conduct and Ethics, in accordance with Section 406 of the Sarbanes-Oxley Act
of 2002 and Item 406 of Regulation S-K, applies globally to our corporate directors, executive
officers, senior financial officers, and other employees. Our Code of Business Conduct and Ethics
is intended to promote honest and ethical conduct, full and accurate reporting, and compliance with
laws as well as other matters. A printed copy of our Code of Business Conduct and Ethics may be
obtained free of charge by writing to us at Health Benefits Direct Corporation, 150 N.
Radnor-Chester Road, Suite B-101, Radnor, Pennsylvania 19087.
Corporate Governance and Committees
Our board of directors currently is composed of Messrs. Caldwell, Clemens, Harrison, Musser,
Oakes, Rich, Rowell, Soltoff, Tecce, Verdi and Waters. Mr. Clemens and Mr. Caldwell are the
Co-Chairmen of our board of directors. Directors serve until the next annual meeting of
stockholders, until their successors are elected or appointed or qualified, or until their prior
resignation or removal. Our executive officers are appointed by, and serve at the discretion of,
our board of directors. Our board of directors has established an audit committee, a compensation
committee and a nominating and governance committee. Pursuant to our bylaws, our board of directors
may from time to time establish other committees to facilitate the management of our business and
operations.
Audit Committee
The members of our audit committee are Messrs. Caldwell, Rich and Rowell. Mr. Rich chaired the
committee during 2007 through March 31, 2008. Mr. Caldwell became chairman of the committee
effective upon his appointment to the board on April 1, 2008. Our board of directors has
determined that
Mr. Caldwell is an audit committee financial expert, as such term is defined in Item
407(d)(5) of Regulation S-K promulgated by the Securities and Exchange Commission. Although our
common stock is not listed on NASDAQ and, as a result, we are not subject to NASDAQs listing
standards, we voluntarily strive to comply with such standards. Our board of directors, in
applying the above-
102
referenced standards, has affirmatively determined that each of Messrs. Rich and
Rowell are independent.
Compensation Committee
The members of our compensation committee are Messrs. Harrison and Rich. Mr. Harrison chairs
the committee.
Nominating and Governance Committee
The members of our nominating and governance committee are Messrs. Rowell, Harrison and
Soltoff. Mr. Rowell chairs the committee.
SECTION 16(A) BENEFICIAL OWNERSHIP COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934, as amended, requires our executive
officers and directors and persons who own more than 10% of our common stock to file reports of
beneficial ownership and changes in beneficial ownership of our common stock and any other equity
securities with the Securities and Exchange Commission. Executive officers, directors, and persons
who own more than 10% of our common stock are required by Securities and Exchange Commission
regulations to furnish us with copies of all Section 16(a) forms they file.
Based solely on our review of the copies of Forms 3, 4, and 5 furnished to us, or
representations from certain reporting persons that no Forms 3, 4 or 5 were required to be filed by
such persons, we believe that all of our executive officers, directors, and persons who own more
than ten percent of our common stock complied with all Section 16(a) filing requirements applicable
to them during 2008 with the exception of: Robert Oakes, who inadvertently filed a late Form 3 to
report his appointment to the board of directors on August 25, 2008; Edmond Walters, who
inadvertently filed a late Form 3 to report his appointment to the board of directors on April 1,
2008 and a late Form 4 to report the purchase of 62,623 shares on July 15, 2008; and Charles Eissa,
who inadvertently filed a late Form 4 to report the sale of 62,623 shares on July 15, 2008.
103
|
|
|
ITEM 11.
|
|
EXECUTIVE COMPENSATION
|
Summary Compensation Table
The following table summarizes the compensation paid to, awarded to or earned during the fiscal
years ended December 31, 2008 and 2007 by our Chief Executive Officer and each of our two other
most highly compensated executive officers whose total salary and bonus exceeded $100,000 for
services rendered to us in all capacities during 2008. The executive officers listed in the table
below are referred to in this report as our named executive officers. There were no non-equity
incentive plan compensation or non-qualified deferred compensation earnings for any of the named
executive officers for the fiscal years ended December 31, 2008 and December 31, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Awards
|
|
Option Awards
|
|
Compensation
|
|
|
Name and Principal Position
|
|
Fiscal Year
|
|
Salary ($)
|
|
Bonus ($)
|
|
($)
|
|
($) (8)
|
|
($) (9)
|
|
Total ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alvin H. Clemens (1)
|
|
|
2008
|
|
|
|
343,269
|
|
|
|
|
|
|
|
|
|
|
|
313,542
|
|
|
|
32,649
|
|
|
|
689,460
|
|
Co-Chairman & fomer Chief Executive
|
|
|
2007
|
|
|
|
360,577
|
|
|
|
|
|
|
|
|
|
|
|
41,250
|
|
|
|
39,301
|
|
|
|
441,127
|
|
Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charles Eissa (2)
|
|
|
2008
|
|
|
|
264,423
|
|
|
|
|
|
|
|
150,000
|
(7)
|
|
|
7,188
|
|
|
|
20,408
|
|
|
|
442,018
|
|
President
|
|
|
2007
|
|
|
|
278,846
|
|
|
|
50,000
|
(10)
|
|
|
131,250
|
(7)
|
|
|
3,750
|
|
|
|
10,189
|
|
|
|
474,035
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richard Arenschield (3)
|
|
|
2008
|
|
|
|
18,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,500
|
|
Fomer Interim Chief Executive Officer
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anthony R. Verdi (4)
|
|
|
2008
|
|
|
|
232,211
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,556
|
|
|
|
246,767
|
|
Principal Executive Officer, Chief
|
|
|
2007
|
|
|
|
235,577
|
|
|
|
25,000
|
(10)
|
|
|
|
|
|
|
35,700
|
|
|
|
13,842
|
|
|
|
310,119
|
|
Financial Officer & Chief Operating
Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert J. Oakes (5)
|
|
|
2008
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23,075
|
|
|
|
273,075
|
|
President Atiam Technologies LLC
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan M. Spinner (6)
|
|
|
2008
|
|
|
|
106,609
|
|
|
|
|
|
|
|
37,500
|
(7)
|
|
|
189,436
|
|
|
|
235,879
|
|
|
|
569,425
|
|
Senior Vice President
|
|
|
2007
|
|
|
|
356,731
|
|
|
|
|
|
|
|
131,250
|
(7)
|
|
|
156,186
|
|
|
|
13,727
|
|
|
|
657,893
|
|
|
|
|
(1)
|
|
Mr. Clemens has served as Co-Chairman of our board since April 1, 2008. Mr. Clemens served
as Executive Chairman of our board of directors from January 2006 to March 2008 and as our Chief
Executive Officer from December 2006 to March 2008
.
|
|
(2)
|
|
Mr. Eissa was appointed as our President on November 18, 2005. Mr. Eissa served as Chief
Operating Officer from November 18, 2005 to March 31, 2008.
|
|
(3)
|
|
Mr. Arenschield was appointed as our interim Chief Executive Officer on April 1, 2008 and
resigned on April 3, 2008.
|
|
(4)
|
|
Mr. Verdi was appointed as our Chief Financial Officer on November 10, 2005, Chief Operating
Officer on April 1, 2008 and Acting Principal Executive Officer on June 20, 2008.
|
|
(5)
|
|
Mr. Oakes was appointed as President of our subsidiary Atiam Technologies, LLC on October 1,
2007 concurrently with the closing of our acquisition of Atiam.
|
|
(6)
|
|
Mr. Spinner was appointed as our Senior Vice President on April 3, 2006 concurrently with the
closing of our acquisition of ISG. Mr. Spinners employment terminated on March 31, 2008.
|
104
|
|
|
(7)
|
|
Represents the dollar amount recognized for financial statement reporting purposes with
respect to the applicable fiscal year in accordance with SFAS 123(R), under the modified
prospective method. On February 15, 2007, we made restricted stock grants of 125,000 shares of our
common stock to each of Mr. Eissa and Mr. Spinner in accordance with the terms of our 2006 Omnibus
Equity Compensation Plan. These grants are subject to certain restrictions, including a
restriction on transfer prior to the shares becoming fully vested. Mr. Eissas shares will vest as
follows: 50,000 shares on the first anniversary of the grant date; 50,000 additional shares of the
second anniversary of the grant date; 2,083 shares per month on the 15th day of each month
beginning on March 15, 2009 through January 15, 2009; and 2,087 on the third anniversary of the
grant date. Mr. Spinners shares vested as follows: 50,000 shares on the first anniversary of the
grant date. Mr. Spinners remaining 75,000 unvested shares were forfeited effective with his
termination. The value of the restricted stock grants were based on the closing price per share
($3.00) of our common stock on the OTCBB on the date of the grant. Stock award expense for the
most recently completed two fiscal years pertaining to named executive officers is based on the
value of the restricted stock grants amortized straight line over their vesting period.
|
|
(8)
|
|
Represents the dollar amount recognized for financial statement reporting purposes with
respect to the applicable fiscal year in accordance with SFAS 123(R) under the modified prospective
method. Stock option expense for the two most recently completed fiscal years pertaining to the
named executive officers is based on the estimated fair value of the stock option as of the date of
grant using the Black-Scholes option-pricing model amortized over the vesting period of the option
or the duration of employment, whichever is shorter. Fair value is estimated based on an expected
life of five years, an assumed dividend yield of 0% and the assumptions below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% of Fair
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount
|
|
Expensed in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expensed in
|
|
Financial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Closing
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial
|
|
Statements
|
|
Fair Value at
|
|
Number of
|
|
Option
|
|
Stock Price
|
|
|
|
|
|
|
|
|
|
|
|
|
Statements
|
|
Based on
|
|
Date of Grant
|
|
Options
|
|
Exercise
|
|
on the Date
|
|
Date of
|
|
Expected
|
|
Risk Free
|
Name
|
|
Fiscal Year
|
|
$
|
|
Vesting
|
|
($)
|
|
Granted (#)
|
|
Price ($)
|
|
of Grant ($)
|
|
Grant
|
|
Volatility
|
|
Interest Rate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alvin H. Clemens
|
|
|
2008
|
|
|
|
313,542
|
|
|
|
100
|
%
|
|
|
313,542
|
|
|
|
550,000
|
|
|
|
1.01
|
|
|
|
1.01
|
|
|
|
4/1/2008
|
|
|
|
67.35
|
%
|
|
|
1.42
|
%
|
|
|
|
2007
|
|
|
|
41,250
|
|
|
|
27.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richard Arenschield
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charles Eissa
|
|
|
2008
|
|
|
|
7,188
|
|
|
|
47.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
|
3,750
|
|
|
|
25.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
|
3,889
|
|
|
|
25.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005
|
|
|
|
173
|
|
|
|
1.2
|
%
|
|
|
15,000
|
|
|
|
500,000
|
|
|
|
2.50
|
|
|
|
1.00
|
|
|
|
11/10/2005
|
|
|
|
25
|
%
|
|
|
3.75
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anthony R. Verdi
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
|
35,700
|
|
|
|
34.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
|
67,959
|
|
|
|
64.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005
|
|
|
|
1,341
|
|
|
|
1.3
|
%
|
|
|
105,000
|
|
|
|
350,000
|
|
|
|
1.00
|
|
|
|
1.00
|
|
|
|
11/10/2005
|
|
|
|
25
|
%
|
|
|
3.75
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan M. Spinner
|
|
|
2008
|
|
|
|
189,436
|
|
|
|
44.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
|
156,186
|
|
|
|
36.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
|
79,759
|
|
|
|
18.8
|
%
|
|
|
425,381
|
|
|
|
150,000
|
|
|
|
3.50
|
|
|
|
3.50
|
|
|
|
4/3/2006
|
|
|
|
111
|
%
|
|
|
4.55
|
%
|
Effective January 1, 2006, we adopted the provisions of SFAS No. 123(R) under the modified
prospective method. SFAS No. 123(R) eliminates accounting for share-based compensation transactions
using the intrinsic value method prescribed under APB Opinion No. 25, Accounting for Stock Issued
to Employees, and requires instead that such transactions be accounted for using a
fair-value-based method. Under the modified prospective method, we are required to recognize
compensation cost for share-based payments to employees based on their grant-date fair value from
the beginning of the fiscal period in
which the recognition provisions initially are applied. For periods prior to adoption, the
financial statements are unchanged, and the pro forma disclosures previously required by SFAS No.
123, as amended by SFAS No. 148, will continue to be required under SFAS No. 123(R) to the extent
those
105
amounts differ from those in the Statement of Operations. Expense in 2006 pertaining to
employee stock options for all named executive officers other than Mr. Spinner is recorded in
salaries, commissions and related taxes. Expense pertaining to Mr. Spinners stock option is
recorded in depreciation and amortization expense as part of the value of the employment and
non-compete agreement acquired as a result of our acquisition of ISG.
|
|
|
(9)
|
|
All other compensation paid to our named executive officers in the fiscal year ended December
31, 2008 consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments for
|
|
Company Paid
|
|
|
|
|
|
Company
|
|
Company Paid
|
|
|
|
|
Personal Use of
|
|
Health, Life and
|
|
|
|
|
|
Matching of
|
|
Entertainment
|
|
|
|
|
Auto and
|
|
Disabilitly
|
|
|
|
|
|
Employee 401(k)
|
|
and Meals ($)
|
|
|
Name
|
|
Equipment ($) (a)
|
|
Insurance ($) (b)
|
|
Severance ($) (c)
|
|
Contributions (d)
|
|
(e)
|
|
Total ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alvin H. Clemens
|
|
|
13,200
|
|
|
|
19,449
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32,649
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charles Eissa
|
|
|
9,150
|
|
|
|
7,850
|
|
|
|
|
|
|
|
2,172
|
|
|
|
1,236
|
|
|
|
20,408
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anthony R. Verdi
|
|
|
10,500
|
|
|
|
1,915
|
|
|
|
|
|
|
|
2,142
|
|
|
|
|
|
|
|
14,556
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert J. Oakes
|
|
|
|
|
|
|
20,970
|
|
|
|
|
|
|
|
2,104
|
|
|
|
|
|
|
|
23,075
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan M. Spinner
|
|
|
3,554
|
|
|
|
4,406
|
|
|
|
226,385
|
|
|
|
1,294
|
|
|
|
240
|
|
|
|
235,879
|
|
|
|
|
(a)
|
|
Payments for personal use of auto and equipment represent the taxable portion of monthly
auto allowances and company payments for cell phones and other equipment for the portion of
our named executive officers personal use of automobiles, cell phones and other equipment.
The portion of the $12,000 pertaining to business travel was considered a reimbursement for
business expenses and excluded from compensation.
|
|
(b)
|
|
Company-paid health, life and disability insurance represents the cost of company-paid
insurance premiums covering the named executive officers and, in the case of health insurance
premiums, their dependents. We pay 100% of these insurance premiums for the named executive
officers. Health insurance premiums vary based on several factors, including the age of the
named executive officer and the number of their covered dependents.
|
|
(c)
|
|
Severance represents payments to Mr. Spinner for salary, auto and equipment allowances
paid subsequent to his termination.
|
|
(d)
|
|
The Company implemented a 401(k) plan on January 1, 2007 and implemented an elective
contribution to the Plan of 25% of the employees contribution up to 4% of the employees
compensation, which were fully vested for the above named Executive Officers.
|
|
(e)
|
|
Company-paid lunches for the named executive officers.
|
|
|
|
|
(10)
|
|
Messrs. Eissa and Verdi each received a one time bonus in 2007.
|
106
Outstanding Equity Awards at Fiscal Year-End
The following table sets forth information for the outstanding equity awards held by our named
executive officers for the year ended December 31, 2008. The information below pertains to stock
options, which were granted under the 2005 Incentive Stock Plan and the 2006 Omnibus Equity
Compensation Plan, and restricted stock grants, which were granted in accordance with the terms of
our 2006 Omnibus Equity Compensation Plan. The number of shares of stock that have not vested
pertains to the February 15, 2007 restricted stock grant to the named executive officers below.
The market value of the number of shares of stock that have not vested was based on the closing
price per share ($0.08) of our common stock on the OTCBB on December 31, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan Awards:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market
|
|
|
Number of
|
|
Number of
|
|
Number of
|
|
|
|
|
|
|
|
|
|
Number of
|
|
Value of
|
|
|
Securities
|
|
Securities
|
|
Securities
|
|
|
|
|
|
|
|
|
|
Shares or
|
|
Shares or
|
|
|
Underlying
|
|
Underlying
|
|
Underlying
|
|
|
|
|
|
|
|
|
|
Units of
|
|
Units of
|
|
|
Unexercised
|
|
Unexercised
|
|
Unexercised
|
|
Option
|
|
|
|
|
|
Stock That
|
|
Stock That
|
|
|
Options
|
|
Options
|
|
Unearned
|
|
Exercise
|
|
Option
|
|
Have Not
|
|
Have Not
|
|
|
(#)
|
|
(#)
|
|
Options
|
|
Price
|
|
Expiration
|
|
Vested
|
|
Vested
|
Name
|
|
Exercisable
|
|
Unexercisable
|
|
(#)
|
|
($)
|
|
Date
|
|
(#)
|
|
($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richard Arenschield
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alvin H. Clemens
|
|
|
466,664
|
(1)
|
|
|
83,336
|
|
|
|
|
|
|
|
1.01
|
|
|
|
4/1/2018
|
|
|
|
|
|
|
|
|
|
|
|
|
300,000
|
(2)
|
|
|
|
|
|
|
|
|
|
|
1.00
|
|
|
|
11/22/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charles Eissa
|
|
|
385,400
|
(3)
|
|
|
114,600
|
|
|
|
|
|
|
|
2.50
|
|
|
|
11/9/2015
|
|
|
|
75,000
|
|
|
|
6,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anthony R. Verdi
|
|
|
350,000
|
(4)
|
|
|
|
|
|
|
|
|
|
|
1.00
|
|
|
|
11/09/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert J. Oakes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivan M. Spinner
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Vesting occurs as follows; 300,000 shares were vested on April 1, 2008, 20,833 vested on May
1, 2008 and 20,833 shares vested or will vest on the first of each month thereafter through March
1, 2009, and 20,837 shares will vest on April 1, 2009.
|
|
(2)
|
|
Vesting occurs as follows; 200,000 shares vested on May 23, 2006, 150,000 shares on November
23, 2006, 12,500 shares on December 31, 2006 and on the last day of each month thereafter until
November 30, 2007.
|
|
(3)
|
|
Vesting occurs as follows; 125,000 shares vested on November 10, 2006, 10,416 shares on
December 31, 2006 and on the last day of each month thereafter until October 31, 2007, and 10,440
shares on December 31, 2008(?).
|
|
(4)
|
|
Vesting occurs as follows; 100,000 shares vested on May 10, 2006, 125,000 shares on November
10, 2006, 10,416 shares on December 31, 2006 and on the last day of each month thereafter until
October 31, 2007, and 10,424 shares on December 31, 2008(?).
|
107
Employment, Severance and Other Agreements
Richard Arenschield
On March 31, 2008, Mr. Clemens resigned as Chief Executive Officer, effective upon the later
of April 1, 2008 and the business day immediately following the date on which we filed our Annual
Report on Form 10-KSB with the SEC for the fiscal year ended December 31, 2007. Richard Arenschield
was approved and appointed by our board of directors to serve as the interim Chief Executive
Officer, effective immediately upon the April 2, 2008 effective date of Mr. Clemens resignation.
Under the terms of a verbal agreement, Mr. Arenschield will be entitled to receive compensation for
his services as interim Chief Executive Officer in the amount of $150,000 for a term of six months,
payable in accordance with our ordinary payroll procedures, and an additional amount of $50,000 for
living expenses, payable in accordance with a schedule to be determined by the board of directors.
Mr. Arenschield resigned from the position of interim Chief Executive Officer on April 3, 2008.
Alvin H. Clemens and Ivan M. Spinner
On November 27, 2007 we entered into amended and restated employment agreements with each of
Alvin H. Clemens and Ivan M. Spinner. The employment agreements replaced and superseded the
executives existing employment agreements. On March 28, 2008, Mr. Spinners employment as our
Executive Vice President was terminated without cause. In accordance with Mr. Spinners amended
and restated employment agreement Mr. Spinner is entitled to continue to receive his salary and
benefits for a period of 18 months after his termination.
On March 31, 2008, in connection with our March 31, 2008 private placement and Mr. Clemens
resignation as our Chief Executive Officer and appointment as Co-Chairman of our Board of
Directors, Mr. Clemens amended and restated employment agreement was terminated effective upon his
resignation on April 1, 2008. In consideration of Mr. Clemens resignation as Chief Executive
Officer and the termination of his existing Amended and Restated Employment Agreement, Mr. Clemens
received incentive stock options to purchase 550,000 shares of our common stock. These options have
a term of ten years and have an exercise per share equal to $1.01. The Company and Mr. Clemens had
attempted to negotiate a new employment agreement governing the terms of Mr. Clemens position as
Co-Chairman of the Board, which would provide Mr. Clemens with a one year term and a salary of
$300,000 effective as of the date of Mr. Clemens resignation. The Company continues to pay Mr.
Clemens a salary at an annualized rate of $300,000, together with employee benefits through March
31, 2009. Mr. Clemens employment, salary and benefits cease on March 31, 2009, after which point he
will be compensated under our Non Employee Director Compensation Plan.
108
Charles A. Eissa
Pursuant to a written employment agreement, Mr. Eissa serves as our President and Chief
Operating Officer. Pursuant to his employment agreement, his annual base salary was $214,200 per
year through April, 1, 2006, was then increased to $250,000 through March 19, 2007 and then
increased to $300,000 thereafter. He is entitled to receive such bonus compensation as a majority
of our board of directors may determine from time to time. Mr. Eissas employment agreement
automatically renewed on November 18, 2007.
In connection with the March 31, 2008 private placement, Mr. Eissas employment agreement was
amended effective March 31, 2008 to revise Mr. Eissas annual base salary to $250,000 and to amend
the term of his employment agreement to a one year term commencing March 31, 2008.
On February 2, 2009, Mr. Eissas employment agreement was amended to amend the term of his
employment agreement to a term of 13 months commencing on March 31, 2008 and ending on April 30,
2009
.
In the event of Mr. Eissas termination without cause or for good reason, he or his estate
would receive his then current base annual salary, plus unpaid accrued employee benefits, which is
primarily accrued vacation, plus the continuation of his employee benefits for a period of 1 year,
less all applicable taxes. In the event of his voluntary termination, death or disability, he or
his estate would receive unpaid accrued employee benefits, plus the continuation of his employee
benefits for a period of 1 month, less all applicable taxes.
All shares of common stock held by Mr. Eissa (together with the shares held by his respective
affiliates) are subject to lock-up provisions that provide restrictions on the future sale of
common stock by the holders and their transferees. These lock-up provisions provide, in general,
that these shares may not directly or indirectly be offered, sold, offered for sale, contracted for
sale, hedged, or otherwise transferred or disposed of, for a period of twelve (12) months following
the purchase of such shares in the private placement, and for an additional twelve (12) months
thereafter each holder may only sell up to 50% of his portion of these shares. We filed a
registration statement with the SEC, which was subsequently declared effective, covering the resale
of the shares of common stock held by Mr. Eissa.
Anthony R. Verdi
Pursuant to an amended and restated employment agreement Mr. Verdi serves as our Chief
Financial Officer and Chief Operating Officer. Pursuant to his amended and restated employment
agreement, his annual base salary was $225,000 per year through April, 1, 2006, was then increased
to $250,000 through March 31, 2009 and, if not terminated, will automatically renew for one year
periods. He is entitled to receive such bonus compensation as a majority of our board of directors
may determine from time to time.
In connection with the March 31, 2008 private placement, Mr. Verdis employment agreement was
amended effective March 31, 2008 to revise Mr. Verdis annual base salary to $225,000 and to amend
the term of his employment agreement to a one year term commencing March 31, 2008.
In the event of Mr. Verdis termination without cause or for good reason, he or his estate
would receive his then current base annual salary, plus unpaid accrued employee benefits, which is
primarily accrued vacation, plus the continuation of his employee benefits for a period of 18
months, less all applicable taxes. In the event of his voluntary termination, death or disability,
he or his estate would
109
receive unpaid accrued employee benefits, plus the continuation of his employee benefits for a
period of 1 month, less all applicable taxes.
Robert J. Oakes
Pursuant to a written employment agreement with Atiam Technologies, LLC Mr. Oakes serves as
Atiam Technologies LLCs President and Chief Executive Officer. Pursuant to his employment
agreement, his annual base salary is $250,000 per year through October 1, 2010. He is entitled to
receive such bonus compensation as may be determined by the Compensation Committee of the board of
directors and such fringe benefits as are available to other executives of Health Benefits Direct
Corporation. Mr. Oakes employment agreement shall be automatically extended for an additional one
year term on October 1, 2010 and annually thereafter unless either party provides written
notification to the other party of non-renewal no later than 60 days prior to the termination date
of the agreement.
In the event of Mr. Oakess termination without cause or for good reason, he or his estate
would receive his then current base annual salary, plus unpaid accrued employee benefits, which is
primarily accrued vacation, plus the continuation of his employee benefits for a period of 12
months, less all applicable taxes. In the event of his voluntary termination, death or disability,
he or his estate would receive unpaid accrued employee benefits, plus the continuation of his
employee benefits for a period of one month, less all applicable taxes.
Pursuant to Mr. Oakes employment agreement, he is subject to a non competition and
non-solicitation provision for a period of three years after October 1, 2007 or a period of one
year following his termination, whichever is shorter.
110
Compensation of Directors
The following table sets forth information concerning the compensation of all individuals who
served on our board of directors during the fiscal year ended December 31, 2008. There were no
non-equity incentive plan compensation or nonqualified deferred compensation earnings to any of our
directors for the year ended December 31, 2008. Directors who are employees receive no additional
or special compensation for serving as directors. All director compensation for Messrs. Clemens,
Oakes and Verdi is included in the Summary Compensation Table.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned
|
|
|
|
|
|
|
|
|
|
|
|
|
or
|
|
|
|
|
|
Option
|
|
All Other
|
|
|
|
|
Paid in Cash
|
|
Stock Awards
|
|
Awards
|
|
Compensation
|
|
Total
|
Name
|
|
($)(1)
|
|
($)(2)
|
|
($)(3)
|
|
($)(4)
|
|
($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Donald Caldwell
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John Harrison
|
|
|
11,500
|
|
|
|
25,800
|
|
|
|
23,250
|
|
|
|
11,538
|
|
|
|
72,088
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C. James Jensen
|
|
|
6,000
|
|
|
|
17,200
|
|
|
|
258,423
|
|
|
|
|
|
|
|
281,623
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warren V. Musser
|
|
|
9,000
|
|
|
|
17,200
|
|
|
|
|
|
|
|
|
|
|
|
26,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sanford Rich
|
|
|
15,000
|
|
|
|
25,800
|
|
|
|
176,197
|
|
|
|
13,644
|
|
|
|
230,641
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
L.J. Rowell
|
|
|
13,500
|
|
|
|
25,800
|
|
|
|
176,197
|
|
|
|
|
|
|
|
215,497
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul Soltoff
|
|
|
10,500
|
|
|
|
17,200
|
|
|
|
23,250
|
|
|
|
|
|
|
|
50,950
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Frederick Tecce
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Edmond Walters
|
|
|
9,000
|
|
|
|
33,333
|
|
|
|
|
|
|
|
|
|
|
|
42,333
|
|
|
|
|
(1)
|
|
Represents board and committee meeting and retainer fees paid to our directors under our
Non-Employee Director Compensation Plan.
|
111
|
|
|
(2)
|
|
Represents the dollar amount recognized for financial statement reporting purposed with
respect to the applicable fiscal year n accordance with SFAS 123(R). Stock award expense paid to
our directors under our Non Employee director Compensation Plan for the most recently completed
fiscal year pertaining to directors, which is detailed by director in the following tables, was
based on the closing price per share ($1.72) of our common stock on the OTCBB on the date of the
grant.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of
|
|
Number of Shares of
|
|
|
|
|
|
Aggregate Value of
|
|
|
Stock Grant
|
|
Common Stock Granted
|
|
Value Per Share
|
|
Stock Granted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Donald Caldwell
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John Harrison
|
|
|
1/3/2008
|
|
|
|
15,000
|
|
|
$
|
1.72
|
|
|
$
|
25,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C. James Jensen (5)
|
|
|
1/3/2008
|
|
|
|
10,000
|
|
|
|
1.72
|
|
|
|
17,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warren V. Musser
|
|
|
1/3/2008
|
|
|
|
10,000
|
|
|
|
1.72
|
|
|
|
17,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sanford Rich
|
|
|
1/3/2008
|
|
|
|
15,000
|
|
|
|
1.72
|
|
|
|
25,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
L.J. Rowell
|
|
|
1/3/2008
|
|
|
|
15,000
|
|
|
|
1.72
|
|
|
|
25,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul Soltoff
|
|
|
1/3/2008
|
|
|
|
10,000
|
|
|
|
1.72
|
|
|
|
17,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Frederick C. Tecce
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Edmond Walters
|
|
|
4/1/2008
|
|
|
|
99,010
|
|
|
|
1.01
|
|
|
|
100,000
|
|
|
|
|
(3)
|
|
Represents the dollar amount recognized for financial statement reporting purposes with
respect to the applicable fiscal year in accordance with SFAS 123(R). Stock option expense for the
most recently completed fiscal year pertaining to directors is based on the estimated fair value as
of the date of grant using the Black-Scholes option-pricing model based on the terms of each option
amortized over the vesting period of the option or the duration of board membership, whichever is
shorter. Fair value was estimated based on an assumed dividend yield of 0% and the assumptions
below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount
|
|
Expensed in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expensed in
|
|
Financial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial
|
|
Statements
|
|
Fair Value
|
|
Number of
|
|
Option
|
|
Stock Price
|
|
|
|
|
|
|
|
|
|
Risk Free
|
|
Expected
|
|
Assumed
|
|
|
Statements
|
|
Based on
|
|
of Option
|
|
Options
|
|
Exercise
|
|
on the Date
|
|
Date of
|
|
Expected
|
|
Interest
|
|
Life in
|
|
Dividend
|
Name
|
|
($)
|
|
Vesting
|
|
Award ($)
|
|
Granted (#)
|
|
Price ($)
|
|
of Grant ($)
|
|
Grant
|
|
Volatility
|
|
Rate
|
|
years
|
|
Yield
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John Harrison
|
|
|
23,250
|
|
|
|
31
|
%
|
|
|
75,000
|
|
|
|
250,000
|
|
|
|
1.00
|
|
|
|
1.00
|
|
|
|
11/22/2005
|
|
|
|
25
|
%
|
|
|
3.75
|
%
|
|
|
4.5
|
|
|
|
0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
C. James Jensen
|
|
|
258,423
|
|
|
|
44
|
%
|
|
|
587,324
|
|
|
|
200,000
|
|
|
|
3.60
|
|
|
|
3.60
|
|
|
|
04/27/2006
|
|
|
|
113
|
%
|
|
|
4.66
|
%
|
|
|
5
|
|
|
|
0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Warren V. Musser
|
|
|
|
|
|
|
0
|
%
|
|
|
193,264
|
|
|
|
250,000
|
|
|
|
1.00
|
|
|
|
1.00
|
|
|
|
01/11/2006
|
|
|
|
103
|
%
|
|
|
3.75
|
%
|
|
|
5
|
|
|
|
0
|
%
|
|
|
|
|
|
|
|
0
|
%
|
|
|
896,542
|
|
|
|
425,000
|
|
|
|
2.70
|
|
|
|
2.90
|
|
|
|
03/14/2006
|
|
|
|
105
|
%
|
|
|
3.75
|
%
|
|
|
5
|
|
|
|
0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
L. J. Rowell
|
|
|
176,197
|
|
|
|
30
|
%
|
|
|
587,324
|
|
|
|
200,000
|
|
|
|
3.60
|
|
|
|
3.60
|
|
|
|
04/27/2006
|
|
|
|
113
|
%
|
|
|
4.66
|
%
|
|
|
5
|
|
|
|
0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Sanford Rich
|
|
|
176,197
|
|
|
|
30
|
%
|
|
|
587,324
|
|
|
|
200,000
|
|
|
|
3.60
|
|
|
|
3.60
|
|
|
|
04/27/2006
|
|
|
|
113
|
%
|
|
|
4.66
|
%
|
|
|
5
|
|
|
|
0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul Soltoff
|
|
|
23,250
|
|
|
|
31
|
%
|
|
|
75,000
|
|
|
|
250,000
|
|
|
|
1.00
|
|
|
|
1.00
|
|
|
|
11/23/2005
|
|
|
|
25
|
%
|
|
|
3.75
|
%
|
|
|
4.5
|
|
|
|
0
|
%
|
|
|
|
(4)
|
|
Mr. Harrison provided marketing consulting services to the Company pursuant to a verbal
agreement from January 29, 2007 through March 31, 2008. Mr. Rich provided management consulting
services from January 28, 2008 through March 6, 2008.
|
112
|
|
|
(5)
|
|
Mr. Jensen resigned from the board effective March 26, 2008.
|
The following table sets forth information concerning the aggregate number of options available for
non-employee directors as of December 31, 2008.
|
|
|
|
|
|
|
Aggregate Number of
|
|
|
Options Available as of
|
|
|
December 31, 2008
|
|
|
|
|
|
Donald Caldwell
|
|
|
|
|
|
|
|
|
|
John Harrison
|
|
|
250,000
|
|
|
|
|
|
|
C. James Jensen
|
|
|
|
|
|
|
|
|
|
Warren V. Musser
|
|
|
675,000
|
|
|
|
|
|
|
Sanford Rich
|
|
|
200,000
|
|
|
|
|
|
|
L.J. Rowell
|
|
|
200,000
|
|
|
|
|
|
|
Paul Soltoff
|
|
|
150,000
|
|
|
|
|
|
|
Frederick C. Tecce
|
|
|
|
|
|
|
|
|
|
Edmond Walters
|
|
|
|
|
Director Compensation Plan.
Directors who are employees receive no additional or special compensation for serving as
directors. Non employee directors receive the following compensation under the terms of our Non
Employee Director Compensation Plan:
|
|
|
Each non employee director will receive the following cash compensation
|
|
|
|
$5,000 annual retainer for each director
|
|
|
|
|
$2,000 annual retainer for the Audit Committee Chairperson
|
|
|
|
|
$1,000 annual retainer for the Compensation Committee Chairperson
|
|
|
|
|
$1,000 annual retainer for the Nominating and Governance Committee Chairperson
|
|
|
|
|
$1,000 meeting fee for each board meeting attending in person
|
|
|
|
|
$500 meeting fee for each committee meeting attending in person or via
teleconference.
|
113
|
|
|
Each non employee director will receive the following equity compensation:
|
|
|
|
Upon election to the Board a newly elected director will receive a
grant of restricted shares of Common stock under the 2008 Equity Compensation Plan
with an aggregate fair market value of $100,000, as determined by the closing
market price of the Companys Common Stock on the date of the directors election to
the Board., which shall vest in the following increments: (i) one-third on the date
of the directors election to the Board; (ii) one-third on the date of the first
anniversary of the directors election to the Board; (iii) one-third on the date of
the second anniversary of the directors election to the Board.
|
|
|
|
|
On a date specified by the Compensation Committee of the Board each
director who serves as a director on that specified date will receive an annual
grant of 10,000 fully vested shares of Common Stock granted under the 2008 Equity
Compensation Plan.
|
|
|
|
|
On a date specified by the Compensation Committee of the Board each
director who serves as a chairperson of a committee of the Board on that specified
date will receive an annual grant of 5,000 fully vested shares of Common Stock
granted under the 2008 Equity Compensation Plan.
|
We also purchase directors and officers liability insurance for the benefit of our directors
and officers as a group. We also reimburse our directors for their reasonable out-of-pocket
expenses incurred in attending meetings of our board of directors or its committees. No fees are
payable to directors for attendance at specially called meetings of the board.
114
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER
MATTERS.
Security Ownership of Certain Beneficial Owners and Management
The following table shows information known by us with respect to the beneficial ownership of
our Shares as of March 20, 2009, for each of the following persons:
|
|
|
each of our directors;
|
|
|
|
|
our named executive officers;
|
|
|
|
|
all of our directors, director nominees and executive officers as a group; and
|
|
|
|
|
each person or group of affiliated persons or entities known by us to
beneficially own 5% or more of our Shares.
|
The number of Shares beneficially owned, beneficial ownership and percentage ownership are
determined in accordance with the rules of the Securities and Exchange Commission (the SEC).
Under these rules, beneficial ownership includes any Shares as to which the individual or entity
has sole or shared voting power or investment power and includes any Shares that an individual or
entity has the right to acquire beneficial ownership of within 60 days of March 20, 2009 through
the exercise of any warrant, stock option or other right. In computing the number of Shares
beneficially owned by a person and the percentage ownership of that person, Shares underlying
options and warrants that are exercisable within 60 days of March 20, 2009 are considered to be
outstanding. To our knowledge, except as indicated in the footnotes to the following table and
subject to community property laws, where applicable, the persons named in this table have sole
voting and investment power with respect to all Shares shown as beneficially owned by them. The
following table is based on 41,279,645 Common Shares and 1,000,000 Preferred Shares outstanding as
of March 20, 2009. Unless otherwise indicated, the address of all individuals and entities listed
below is Health Benefits Direct Corporation, 150 N. Radnor-Chester Road, Suite B-101, Radnor,
Pennsylvania 19087.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
Percent
|
|
|
Shares
|
|
|
|
|
|
of Shares
|
|
|
Beneficially
|
|
|
|
|
|
Beneficially
|
Name of Beneficial Owner
|
|
Owned
|
|
Title of Class
|
|
Owned
|
Directors and Executive Officers:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alvin H. Clemens
|
|
|
5,083,918
|
(1)
|
|
Common Stock
|
|
|
11.5
|
%
|
Donald R. Caldwell
|
|
|
11,955,715
|
(2)
|
|
Common Stock
|
|
|
25.5
|
%
|
|
|
|
2,000,000
|
(3)
|
|
Series A Preferred Stock
|
|
|
100
|
%
|
Charles A. Eissa
|
|
|
1,633,570
|
(4)
|
|
Common Stock
|
|
|
3.9
|
%
|
Warren V. Musser
|
|
|
1,135,000
|
(5)
|
|
Common Stock
|
|
|
2.7
|
%
|
Robert J. Oakes
|
|
|
398,899
|
(6)
|
|
Common Stock
|
|
|
1.0
|
%
|
John Harrison
|
|
|
466,750
|
(7)
|
|
Common Stock
|
|
|
1.1
|
%
|
L.J. Rowell
|
|
|
400,600
|
(8)
|
|
Common Stock
|
|
|
1.0
|
%
|
Paul Soltoff
|
|
|
355,000
|
(9)
|
|
Common Stock
|
|
|
*
|
|
Sanford Rich
|
|
|
305,000
|
(8)
|
|
Common Stock
|
|
|
*
|
|
Frederick C. Tecce
|
|
|
12,105,715
|
(11)
|
|
Common Stock
|
|
|
25.8
|
%
|
|
|
|
2,000,000
|
(3)
|
|
Series A Preferred Stock
|
|
|
100
|
%
|
115
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
Percent
|
|
|
Shares
|
|
|
|
|
|
of Shares
|
|
|
Beneficially
|
|
|
|
|
|
Beneficially
|
Name of Beneficial Owner
|
|
Owned
|
|
Title of Class
|
|
Owned
|
Anthony R. Verdi
|
|
|
435,000
|
(11)
|
|
Common Stock
|
|
|
1.0
|
%
|
Edmond Walters
|
|
|
161,633
|
|
|
Common Stock
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All directors and executive officers as a group (12 persons)
|
|
|
22,471,085
|
(1)(2)(4)(5)(6)(7)(8)(9)(10)(11)(12)
|
|
Common Stock
|
|
|
43.1
|
%
|
|
|
|
2,000,000
|
(3)
|
|
Series A Preferred Stock
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Holders of More than Five
Percent of Our Common Stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Co-Investment Fund II, L. P.
|
|
|
11,955,715
|
(12)
|
|
Common Stock
|
|
|
25.5
|
%
|
|
|
|
2,000,000
|
(3)
|
|
Series A Preferred Stock
|
|
|
100
|
%
|
Cumberland Associates LLC
|
|
|
3,339,113
|
(13)
|
|
Common Stock
|
|
|
7.8
|
%
|
Gerald Unterman
|
|
|
3,104,838
|
(14)
|
|
Common Stock
|
|
|
7.3
|
%
|
|
|
|
*
|
|
Less than 1%
|
|
(1)
|
|
Includes 1,000,000 shares held by The Clemens-Beaver Creek Limited Partnership, of which
Alvin H. Clemens is the general partner. Mr. Clemens disclaims beneficial ownership of these
shares, except to the extent of his pecuniary interest therein. Also includes 100,000 shares
held by Mr. Clemenss minor children. Also includes 850,000 shares underlying options and
804,838 shares underlying warrants, all of which are exercisable within 60 days of March 20,
2009. Also includes 500,000 shares underlying warrants held by the Clemens-Beaver Creek
Limited Partnership.
|
|
(2)
|
|
Includes 6,350,877 shares and 5,604,838 shares underlying warrants that are exercisable
within 60 days of March 20, 2009 and are beneficially owned by Co-Investment Trust II, L. P.
(the Fund), designee of Cross Atlantic Capital Partners, Inc. Mr. Caldwell is a managing
partner of Cross Atlantic Capital Partners, Inc. Mr. Caldwell is also a shareholder, director
and officer of Co-Invest II Capital Partners, Inc., which is the general partner of Co-Invest
Management II, L.P., which is the general partner of the Fund. Mr. Caldwell disclaims
beneficial ownership of these securities, except to the extent of his pecuniary interest
therein.
|
|
(3)
|
|
Includes 1,000,000 Preferred Shares underlying warrants, all of which are exercisable within
60 days of March 20, 2009. Represents securities owned by the Fund, the designee of Cross
Atlantic Capital Partners, Inc., of which Frederick C. Tecce is the managing director and of
which Donald R. Caldwell is managing partner. Mr. Caldwell is also a shareholder, director
and officer of Co-Invest II Capital Partners, Inc., which is the general partner of Co-Invest
Management II, L.P., which is the general partner of the Fund. Mr. Tecce and Mr. Caldwell
disclaim beneficial ownership of these securities, except to the extent of their pecuniary
interest therein.
|
|
(4)
|
|
Includes 437,480 shares underlying options, all of which are exercisable within 60 days of
March 20, 2009. Excludes 62,250 shares underlying options that are not exercisable within 60
days of March 20, 2009.
|
116
|
|
|
(5)
|
|
Includes 440,000 shares underlying warrants and 675,000 shares underlying options, all of
which are exercisable within 60 days of March 20, 2009.
|
|
(6)
|
|
Excludes 1,000,000 shares of underlying options that are not exercisable within 60 days of
March 20, 2009.
|
|
(6)
|
|
Includes 250,000 shares underlying options and 86,750 shares underlying warrants, all of
which are exercisable within 60 days of March 20, 2009.
|
|
(7)
|
|
Includes 200,000 shares underlying options that are exercisable within 60 days of March 20,
2009.
|
|
(8)
|
|
Includes 150,000 shares underlying options and 25,000 shares underlying warrants, all of
which are exercisable within 60 days of March 20, 2009.
|
|
(9)
|
|
Includes 25,000 shares underlying warrants that are exercisable within 60 days of March 20,
2009.
|
|
(10)
|
|
Includes 50,000 shares underlying warrants that are exercisable within 60 days of March 20,
2009. Also includes 6,450,877 shares and 5,604,838 shares underlying warrants that are
exercisable within 60 days of March 20, 2009 and are beneficially owned by the Fund, designee
of Cross Atlantic Capital Partners, Inc. Mr. Tecce is a managing partner of Cross Atlantic
Capital Partners, Inc. Mr. Tecce disclaims beneficial ownership of these securities, except
to the extent of his pecuniary interest therein.
|
|
(11)
|
|
Includes 350,000 shares underlying options and 25,000 shares underlying warrants, all of
which are exercisable within 60 days of March 20, 2009.
|
|
(12)
|
|
Includes 5,604,838 shares underlying warrants that are exercisable within 60 days of March
20, 2009. Excludes 650,000 shares of underlying options that are not exercisable within 60
days of March 20, 2009.
|
|
(13
|
|
Includes 1,522,352 shares underlying warrants that are exercisable within 60 days of March
20, 2009.
|
|
(14)
|
|
According to Schedule 13G filed with the Commission by Mr. Unterman on April 18, 2007.
Includes 1,104,839 shares underlying warrants that are exercisable within 60 days of March 20,
2009.
|
117
Equity Compensation Plan Information
The following table shows certain information concerning our common stock to be issued in
connection with our equity compensation plans as of December 31, 2008:
EQUITY COMPENSATION PLAN
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Number of
|
|
|
|
|
|
Securities Remaining
|
|
|
Securities to be
|
|
Weighted-
|
|
Available for Future
|
|
|
Issued upon
|
|
Average Exercise
|
|
Issuance
|
|
|
Exercise of
|
|
Price of
|
|
Under Equity
|
|
|
Outstanding
|
|
Outstanding
|
|
Compensation Plans
|
|
|
Options,
|
|
Options,
|
|
(Excluding Securities
|
|
|
Warrants
|
|
Warrants and
|
|
Reflected in the first
|
Plan Category
|
|
and Rights
|
|
Rights
|
|
Column)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity compensation
plans approved by
security holders
|
|
|
17,927,886
|
|
|
$
|
1.42
|
|
|
|
1,969,790
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity compensation
plans not approved by
security holders
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
17,927,886
|
|
|
$
|
1.42
|
|
|
|
1,969,790
|
|
A description of the material terms of our equity compensation plans can be found in Note 8
Shareholders Equity Stock Options in the notes to the consolidated financial statements
contained in Item 8 of this Annual Report on Form 10-K.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.
Transactions With Related Persons
From the beginning of our last fiscal year until the date of this annual report on Form 10-K,
there has been no transaction, nor is there any transaction currently proposed, to which we were,
are, or would be a participant, in which the amount involved exceeded or would exceed the lesser of
$120,000 or one percent of the average of our total assets at year end for the last two completed
fiscal years and in which any of our directors or executive officers, any holder of more than 5% of
our common stock or any member of the immediate family of any of these persons or entities had or
will have a direct or indirect material interest, other than the compensation and compensation
arrangements (including with respect to equity compensation and board compensation) described
below.
118
We believe that we have executed all of the transactions described below on terms no less
favorable to us than we could have obtained from unaffiliated third parties. It is our intention to
ensure that all future transactions between us and our officers, directors and principal
stockholders and their affiliates are approved by a majority of our board of directors, including a
majority of the independent and disinterested members of our board of directors, and are on terms
no less favorable to us than those that we could obtain from unaffiliated third parties.
We have engaged in the following transactions regarding sales of our common stock with our
executive officers and directors, and with the beneficial holders of 5% or more of our common
stock:
|
|
|
On March 31, 2008, we completed a private placement of an aggregate of 6,250,000 shares
of our common stock and warrants exercisable for 5,000,000 shares of our common stock. We
sold 6,250,000 investment units in the private placement, each investment unit consisting
of one share of our common stock and a warrant to purchase one share of common stock for an
aggregate purchase price of $5,000,000. In connection with this private placement:
|
|
|
|
Co-Investment Trust II, L.P., designee of Cross Atlantic Capital
Partners, Inc., purchased 5.0 million investment units for a purchase price of
$4,000,000. Mr. Tecce, who is one of our directors, is a managing partner of Cross
Atlantic Partners, Inc. Mr. Caldwell, who is also one of our directors, is a
shareholder, director and officer of Co-Invest II Capital Partners, Inc., which is
the general partner of Co-Invest Management II, L.P., which is the general partner
of The Co-Investment Fund II, L.P.
|
|
|
|
|
Cumberland Associates LLC, a holder of more than 5% of our shares of
common stock, purchased 1.25 million investment units in the private placement for
a purchase price of $1,000,000.
|
|
|
|
On January 15, 2009, we completed a private placement with Co-Investment Fund II, L.P.,
for an aggregate of 1,000,000 shares of our Series A Convertible Preferred Stock and
warrants to purchase 1,000,000 shares of our Series A Convertible Preferred Stock.
|
|
|
|
The preferred stock is entitled to vote as a single class with the
holders of the Companys common stock with each share of preferred stock having the
right to 20 votes. Upon the liquidation, sale or merger of the Company, each share
of preferred stock is entitled to receive an amount equal to the greater of (A) a
liquidation preference equal to two and a half (2.5) times the preferred stock
original issue price, subject to certain customary adjustments, or (B) the amount
such share of preferred stock would receive if it participated
pari passu
with the
holders of Common Stock on an as-converted basis. Each Share of preferred stock
becomes convertible into 20 shares of common stock (the
Shares
), subject
to adjustment and at the option of the holder of the preferred stock, immediately
after stockholder approval of the amendment to our companys charter. For so long
as any shares of preferred stocks are outstanding, the vote or consent of the
holders of at least two-thirds of the preferred stock is required to approve (Y)
any amendment to the Companys certificate of incorporation or bylaws that would
adversely alter the voting powers, preferences or special rights of the preferred
stock or (Z) any amendment to the Companys certificate of incorporation to create
any shares of capital stock that rank senior to the preferred stock. In addition
to the voting rights described above, for so long as 1,000,000 Share of preferred
stocks are outstanding, the vote or consent of the holders of at least two-thirds
of the share of preferred stocks is required to effect or validate any merger, sale
of substantially all of the assets of the Company or
|
119
|
|
|
other fundamental transaction, unless such transaction, when consummated, will
provide the holders of preferred stock with an amount per share equal to two and a
half (2.5) times the preferred stock original issue price.
|
|
|
|
The warrants provide that the holder thereof shall have the right (A)
at any time after the Stockholder Approval Deadline, but prior to the earlier of
(i) ten business days after the Company has properly provided written notice to
all such holders of a Call Event (as defined below), (ii) the date on which the
Companys stockholders approve the Charter Amendment (the
Stockholder Approval
Date
) and (iii) January 14, 2014, to acquire 1,000,000 shares of Preferred
Stock upon the payment of $4.00 per Preferred Warrant Share and (B) at any time
after the Stockholder Approval Date, but prior to the earlier of (i) ten business
days after the Company has properly provided written notice to all such holders of
a Call Event (as defined below) and (ii) January 14, 2014, to acquire up to a total
of 20,000,000 shares of Common Stock of the Company (each a
Warrant
Share
) upon the payment of $0.20 per Warrant Share (the
Exercise
Price
). The Company also has the right, at any point after the Stockholder
Approval Date and after which the volume weighted average trading price per share
of the Preferred Stock for a minimum of 20 consecutive trading days is equal to at
least eight times the Exercise Price per share, provided that certain other
conditions have been satisfied, to call the outstanding Warrants (a
Call
Event
), in which case such Warrants will expire if not exercised within ten
business days thereafter. The Warrants also include full ratchet anti-dilution
adjustment provisions for issuances of securities below $0.20 per share of Common
Stock during the first two years following the date of issuance of the Warrants,
subject to customary exceptions.
|
Director Independence
Although our common stock is not listed on NASDAQ and, as a result, we are not subject to
NASDAQs listing standards, we voluntarily strive to comply with such standards. As required under
the NASDAQ listing standards, a majority of the members of a listed companys board of directors
must qualify as independent, as affirmatively determined by a companys board of directors. Our
board of directors, in applying the standards for independence as defined by Rule 4200(a)(15) of
the NASDAQ listing standards and Rule 10A-3(b)(1)(ii) promulgated by the Securities and Exchange
Commission, has affirmatively determined that Messrs. Harrison, Rich, Rowell, Tecce and Soltoff are
independent directors.
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
A summary of the fees of Sherb & Co., LLP for the years ended December 31, 2008 and 2007 are
set forth below:
|
|
|
|
|
|
|
|
|
|
|
2008 Fees
|
|
2007 Fees
|
Audit Fees(1)
|
|
$
|
96,285
|
|
|
$
|
79,000
|
|
Audit-Related Fees(2)
|
|
|
15,000
|
|
|
|
730
|
|
Tax Fees(3)
|
|
|
15,000
|
|
|
|
|
|
All Other Fees
|
|
|
|
|
|
|
|
|
Total Fees
|
|
$
|
126,285
|
|
|
$
|
79,730
|
|
|
|
|
(1)
|
|
Audit fees for the fiscal years ended December 31, 2008 and 2007 were for
professional services rendered for the audits and interim quarterly reviews of our
consolidated
|
120
|
|
|
|
|
financial statements and services that are normally provided in
connection with statutory and regulatory filings or engagements.
|
|
(2)
|
|
Audit-related fees for the fiscal year ended December 31, 2008 were for
professional services rendered for the audit of the Companys 401(k) plan.
Audit-related fees for the fiscal year ended December 31, 2007 were for out of pocket
expenses incurred for the audit of our consolidated financial statements.
|
|
(3)
|
|
Tax fees were for tax compliance, tax advice and tax planning.
|
Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditors
.
The audit committee pre-approves all audit and permissible non-audit services provided by the
independent registered public accounting firm. These services may include audit services,
audit-related services, tax services and other services.
121
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
The following documents are filed as part of this Form 10-K:
1.
Financial
Statements
. See Financial Statements on page 43 of this Annual Report on Form
10-K.
2.
Financial Statement Schedules
. None, as all information required in these schedules is
included in the consolidated financial statements or the notes thereto.
3.
Exhibits
. The Exhibits listed below are filed or incorporated by reference as part of this
Annual Report on Form 10-K. Where so indicated by footnote, exhibits which were previously filed
are incorporated by reference. For exhibits incorporated by reference, the location of the exhibit
in the previous filing is indicated below.
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
2.1
|
|
Agreement and Plan of Merger, dated November 23, 2005, among Darwin Resources Corp.,
Health Benefits Direct Corporation, and HBDC II, Inc. (incorporated by reference to
Exhibit 2.1 to the Registrants Current Report on Form 8-K filed with the Commission on
November 30, 2005).
|
|
|
|
2.2
|
|
Agreement and Plan of Merger, dated as of September 21, 2007, by and among the Company,
HBDC Acquisition, LLC, System Consulting Associates, Inc. and the shareholders of System
Consulting Associates, Inc. party thereto (incorporated by reference from Exhibit 2.1 to
the Companys current report on From 8-K, filed with the Commission on September 26,
2007).
|
|
|
|
3.1
|
|
Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the
Registrants Current Report on Form 8-K filed with the Commission on November 22, 2005).
|
|
|
|
3.2
|
|
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the
Registrants Current Report on Form 8-K filed with the Commission on December 3, 2007).
|
|
|
|
3.3
|
|
Certificate of Amendment to Certificate of Incorporation (incorporated by reference to
Exhibit 3.3 to the Registrants Current Report on Form 8-K filed with the Commission on
November 30, 2005).
|
|
|
|
3.4
|
|
Certificate of Merger of HBDC II, Inc. with and into Health Benefits Direct Corporation
(incorporated by reference to Exhibit 3.4 to the Registrants Current Report on Form 8-K
filed with the Commission on November 30, 2005).
|
|
|
|
3.5
|
|
Certificate of Amendment to Certificate of Incorporation (incorporated by reference to
Exhibit 3.5 to the Registrants Registration Statement on Form SB-2, filed with the
Commission on February 1, 2008).
|
|
|
|
3.6
|
|
Certificate of Designation with respect to shares of Series A Preferred Stock
(incorporated by reference to Exhibit 3.1 to the Registrants Current Report on Form 8-K
filed with the Commission on January 21, 2009).
|
|
|
|
3.7**
|
|
Certificate of Amendment to Certificate of Incorporation.
|
122
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
4.1
|
|
Form of Common Stock Purchase Warrant Certificate (incorporated by reference to Exhibit
4.1 to the Registrants Current Report on Form 8-K filed with the Commission on November
30, 2005).
|
|
|
|
4.2
|
|
Warrant to Purchase Common Stock issued to Alvin H. Clemens (incorporated by reference
to Exhibit 4.2 to the Registrants Annual Report on Form 10-KSB for the fiscal year
ended December 31, 2005, filed with the Commission on March 31, 2006).
|
|
|
|
4.3
|
|
Securities Purchase Agreement, dated March 30, 2007, by and between Health Benefits
Direct Corporation and the Investors party thereto (incorporated by reference to Exhibit
4.1 to the Registrants Current Report on Form 8-K, filed with the Commission on March
30, 2007).
|
|
|
|
4.4
|
|
Registration Rights Agreement, dated March 30, 2007, by and between Health Benefits
Direct Corporation and the Investors party thereto (incorporated by reference to Exhibit
4.2 to the Registrants Current Report on Form 8-K, filed with the Commission on March
30, 2007).
|
|
|
|
4.5
|
|
Form of Warrant (incorporated by reference to Exhibit 4.3 to the Registrants Current
Report on Form 8-K, filed with the Commission on March 30, 2007).
|
|
|
|
4.6
|
|
Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.4 to the
Registrants Current Report on Form 8-K, filed with the Commission on March 30, 2007).
|
|
|
|
4.7
|
|
Registration Rights Agreement, dated October 1, 2007, by and between Health Benefits
Direct Corporation and Computer Command and Control Company (incorporated by reference
from Exhibit 4.1 to the Companys current report on From 8-K, filed with the Commission
on October 4, 2007).
|
|
|
|
4.8
|
|
Registration Rights Agreement, dated October 1, 2007, by and among Health Benefits
Direct Corporation and Robert J. Oakes, Jeff Brocco, Tim Savery and Lisa Roetz
(incorporated by reference from Exhibit 4.2 to the Companys current report on From 8-K,
filed with the Commission on October 4, 2007).
|
|
|
|
4.9
|
|
Securities Purchase Agreement, dated March 31, 2008, by and between Health Benefits
Direct Corporation and the Investor party thereto (incorporated by reference from
Exhibit 4.1 to the Registrants Current Report on Form 8-K, filed with the Commission on
March 31, 2008).
|
|
|
|
4.10
|
|
Securities Purchase Agreement, dated March 31, 2008, by and between Health Benefits
Direct Corporation and the Investors party thereto (incorporated by reference from
Exhibit 4.2 to the Registrants Current Report on Form 8-K, filed with the Commission on
March 31, 2008).
|
|
|
|
4.11
|
|
Form of Warrant (incorporated by reference to Exhibit 4.3 to the Registrants Current
Report on Form 8-K, filed with the Commission on March 31, 2008).
|
|
|
|
4.12
|
|
Form of Registration Rights Agreement, dated March 31, 2008, by and among Health
Benefits Direct Corporation and the Investors party thereto (incorporated by reference
from Exhibit 4.4 to the Companys current report on From 8-K, filed with the Commission
on March 31, 2008).
|
123
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
4.13
|
|
Form of Registration Rights Agreement, dated March 31, 2008, by and among Health
Benefits Direct Corporation and the Investors party thereto (incorporated by reference
from Exhibit 4.3 to the Companys current report on From 8-K, filed with the Commission
on March 31, 2008).
|
|
|
|
4.14
|
|
Board Representation Agreement, date March 31, 2008, between the Company and The
Co-Investment Fund II, L.P. (incorporated by reference from Exhibit 4.5 to the
Registrants Current Report on Form 8-K, filed with the Commission on March 31, 2008).
|
|
|
|
10.1
|
|
Health Benefits Direct Corporation 2005 Incentive Stock Plan (incorporated by reference
to Exhibit 10.1 to the Registrants Current Report on Form 8-K filed with the Commission
on November 30, 2005).
|
|
|
|
10.2
|
|
Health Benefits Direct Corporation 2005 Non-Employee Directors Stock Option Plan
(incorporated by reference to Exhibit 10.1 to the Registrants Current Report on Form
8-K/A filed with the Commission on December 22, 2005).
|
|
|
|
10.3
|
|
Health Benefits Direct Corporation Compensation Plan for Directors (incorporated by
reference to Exhibit 10.1 to the Registrants Current Report on Form 8-K filed with the
Commission on March 20, 2006).
|
|
|
|
10.4
|
|
Lease Agreement, dated February 9, 2004, between Case Holding Co. and Platinum Partners,
LLC (incorporated by reference to Exhibit 10.7 to the Registrants Form 8-K filed with
the Commission on November 30, 2005).
|
|
|
|
10.5
|
|
Lease between Health Benefits Direct Corporation and FG2200, LLC, effective March 15,
2006 (incorporated by reference to Exhibit 10.1 to the Registrants Current Report on
Form 8-K filed with the Commission on March 6, 2006).
|
|
|
|
10.6
|
|
Employment Agreement, dated November 18, 2005, between Health Benefits Direct
Corporation and Charles A. Eissa (incorporated by reference to Exhibit 10.14 to the
Registrants Current Report on Form 8-K filed with the Commission on November 30, 2005).
|
|
|
|
10.7
|
|
Amendment 2008-1 to Employment Agreement, dated March 31, 2008, between Health Benefits
Direct Corporation and Charles A. Eissa (incorporated by reference to Exhibit 10.4 to
the Registrants Current Report on Form 8-K filed with the Commission on March 31,
2008).
|
|
|
|
10.8
|
|
Form of Director and Officer Indemnification Agreement (incorporated by reference to
Exhibit 10.1 to the Registrants Current Report on Form 8-K filed with the Commission on
January 17, 2006).
|
|
|
|
10.9
|
|
Securities Contribution Agreement, dated September 9, 2005, among Health Benefits Direct
Corporation, Marlin Capital Partners I, LLC, Scott Frohman, Charles A. Eissa, Platinum
Partners II LLC and Dana Boskoff (incorporated by reference to Exhibit 10.22 to the
Registrants Current Report on Form 8-K filed with the Commission on November 30, 2005).
|
124
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
10.12
|
|
Merger Agreement, dated April 3, 2006, among Health Benefits Direct Corporation, ISG
Merger Acquisition Corp., Insurance Specialist Group Inc. and Ivan M. Spinner
(incorporated by reference to the Registrants Current Report on Form 8-K filed with the
Commission on April 6, 2006).
|
|
|
|
10.13
|
|
Employment Agreement, dated April 3, 2006, between HBDC II, Inc. and Ivan M. Spinner
(incorporated by reference to the Registrants Current Report on Form 8-K filed with the
Commission on April 6, 2006).
|
|
|
|
10.14
|
|
Health Benefits Direct Corporation 2006 Omnibus Equity Compensation Plan (incorporated
by reference to the Registrants Current Report on Form 8-K filed with the Commission on
May 2, 2006).
|
|
|
|
10.15
|
|
Health Benefits Direct Corporation 2006 Omnibus Equity Compensation Plan Form of
Nonqualified Stock Option Grant (incorporated by reference to the Registrants Current
Report on Form 8-K filed with the Commission on May 2, 2006).
|
|
|
|
10.16
|
|
Health Benefits Direct Corporation 2008 Equity Compensation Plan (incorporated by
reference to the Registrants Current Report on Form 8-K filed with the Commission on
March 31, 2008).
|
|
|
|
10.17
|
|
Health Benefits Direct Corporation 2008 Equity Compensation Plan Form of Nonqualified
Stock Option Grant (incorporated by reference to the Registrants Current Report on Form
8-K filed with the Commission on March 28, 2008).
|
|
|
|
10.18
|
|
Sublease, dated March 7, 2006, between Health Benefits Direct Corporation and World
Travel Partners I, LLC Form of Nonqualified Stock Option Grant (incorporated by
reference to the Registrants Current Report on Form 8-K filed with the Commission on
May 19, 2006).
|
|
|
|
10.19
|
|
First Amendment to Sublease, dated April 18, 2006, between Health Benefits Direct
Corporation ad World Travel Partners I, LLC (incorporated by reference to the
Registrants Current Report on Form 8-K filed with the Commission on May 19, 2006).
|
|
|
|
10.20
|
|
Letter Agreement, dated April 18, 2006, among World Travel Partners I, LLC, Health
Benefits Direct Corporation, and 1120 Avenue of the Americas, LLC (incorporated by
reference to the Registrants Current Report on Form 8-K filed with the Commission on
May 19, 2006).
|
|
|
|
10.21
|
|
Software and Services Agreement, dated May 31, 2006, among Health Benefits Direct
Corporation, Insurint Corporation, and Realtime Solutions Group, L.L.C. (incorporated by
reference to the Registrants Current Report on Form 8-K filed with the Commission on
June 2, 2006).
|
|
|
|
10.22
|
|
Lease, dated July 7, 2006, between Health Benefits Direct Corporation and Radnor
Properties-SDC, L.P. (incorporated by reference to the Registrants Current Report on
Form 8-K filed with the Commission on July 10, 2006).
|
|
|
|
10.23
|
|
Separation Agreement, dated December 7, 2006, between Health Benefits Direct Corporation
and Scott Frohman (incorporated by reference to the Registrants Current Report on Form
8-K filed with the Commission on December 11, 2006).
|
125
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
10.24
|
|
Amendment No. 1 to Option, dated as of February 15, 2007, delivered by Health Benefits
Direct Corporation to Daniel Brauser (incorporated by reference to the Registrants
Current Report on Form 8-K filed with the Commission on February 16, 2007).
|
|
|
|
10.25
|
|
Consent and Lock-Up Agreement, dated April 5, 2007, between Health Benefits Direct
Corporation and Scott Frohman (incorporated by reference to the Registrants Current
Report on Form 8-K filed with the Commission on April 6, 2007).
|
|
|
|
10.26
|
|
Agreement to Transfer Partnership Interests, dated October 1, 2007, by and among HBDC
Acquisition, LLC and the former partners of BileniaTech, L.P. (incorporated by reference
from Exhibit 10.1 to the Companys current report on From 8-K, filed with the Commission
on October 4, 2007).
|
|
|
|
10.27
|
|
Amended and Restated Employment Agreement, dated November 27, 2007, between Health
Benefits Direct Corporation and Alvin H. Clemens (incorporated by reference to Exhibit
10.1 to the Registrants Current Report on Form 8-K filed with the Commission on
December 3, 2007).
|
|
|
|
10.28
|
|
Amended and Restated Employment Agreement, dated November 27, 2007, between Health
Benefits Direct Corporation and Anthony R. Verdi (incorporated by reference to Exhibit
10.2 to the Registrants Current Report on Form 8-K filed with the Commission on
December 3, 2007).
|
|
|
|
10.29
|
|
Amendment 2008-1 to Amended and Restated Employment Agreement, dated March 31, 2008,
between Health Benefits Direct Corporation and Anthony R. Verdi (incorporated by
reference to Exhibit 10.3 to the Registrants Current Report on Form 8-K filed with the
Commission on March 31, 2008).
|
|
|
|
10.30
|
|
Amended and Restated Employment Agreement, dated November 27, 2007, between Health
Benefits Direct Corporation and Ivan M. Spinner (incorporated by reference to Exhibit
10.3 to the Registrants Current Report on Form 8-K filed with the Commission on
December 3, 2007).
|
|
|
|
10.31**
|
|
Client Transition Agreement,
between Health Benefits Direct Corporation, HBDC II, Inc. and
eHealthInsurance Services, Inc.
|
|
|
|
14
|
|
Amended and Restated Code of Business Conduct and Ethics (incorporated by reference to
Exhibit 14.1 to the Registrants Current Report on Form 8-K filed with the Commission on
February 4, 2008).
|
|
|
|
21**
|
|
Subsidiaries of Health Benefits Direct Corporation.
|
|
|
|
23.1**
|
|
Consent of Sherb & Co., LLP.
|
|
|
|
31.1**
|
|
Section 302 Certification of Principal Executive Officer.
|
|
|
|
31.2**
|
|
Section 302 Certification of Principal Financial Officer.
|
126
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
32.1**
|
|
Section 906 Certification of Principal Executive Officer and Principal Financial Officer.
|
127
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
|
|
|
|
HEALTH BENEFITS DIRECT CORPORATION
|
|
|
By:
|
/s/ Anthony R. Verdi
|
|
|
|
Anthony R. Verdi
|
|
|
|
Principal Executive Officer, Chief
Financial
Officer and Chief Operating Officer
|
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been
signed below by the following persons on behalf of the registrant and in the capacities and on the
dates indicated.
|
|
|
|
|
/s/ ANTHONY R. VERDI
Anthony R. Verdi
|
|
Chief Financial Officer,
Chief Operating Officer
and Director
(Principal Executive
Officer, Principal
Financial and Accounting
Officer)
|
|
March 31, 2009
|
|
|
|
|
|
|
|
Co-Chairman
|
|
March 31, 2009
|
Alvin H. Clemens
|
|
|
|
|
|
|
|
|
|
|
|
Co-Chairman
|
|
March 31, 2009
|
Donald R. Caldwell
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
March 31, 2009
|
Warren V. Musser
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
March 31, 2009
|
John Harrison
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
March 31, 2009
|
Robert J. Oakes
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
March 31, 2009
|
Paul Soltoff
|
|
|
|
|
128
|
|
|
|
|
|
|
Director
|
|
March 31, 2009
|
Sanford Rich
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
March 31, 2009
|
L.J. Rowell
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
March 31, 2009
|
Frederick C. Tecce
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
March 31, 2009
|
Edmond Walters
|
|
|
|
|
129
EXHIBIT INDEX
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
2.1
|
|
Agreement and Plan of Merger, dated November 23, 2005, among
Darwin Resources Corp., Health Benefits Direct Corporation, and
HBDC II, Inc. (incorporated by reference to Exhibit 2.1 to the
Registrants Current Report on Form 8-K filed with the Commission
on November 30, 2005).
|
|
|
|
2.2
|
|
Agreement and Plan of Merger, dated as of September 21, 2007, by
and among the Company, HBDC Acquisition, LLC, System Consulting
Associates, Inc. and the shareholders of System Consulting
Associates, Inc. party thereto (incorporated by reference from
Exhibit 2.1 to the Companys current report on From 8-K, filed
with the Commission on September 26, 2007).
|
|
|
|
3.1
|
|
Certificate of Incorporation (incorporated by reference to Exhibit
3.1 to the Registrants Current Report on Form 8-K filed with the
Commission on November 22, 2005).
|
|
|
|
3.2
|
|
Amended and Restated Bylaws (incorporated by reference to Exhibit
3.2 to the Registrants Current Report on Form 8-K filed with the
Commission on December 3, 2007).
|
|
|
|
3.3
|
|
Certificate of Amendment to Certificate of Incorporation
(incorporated by reference to Exhibit 3.3 to the Registrants
Current Report on Form 8-K filed with the Commission on November
30, 2005).
|
|
|
|
3.4
|
|
Certificate of Merger of HBDC II, Inc. with and into Health
Benefits Direct Corporation (incorporated by reference to Exhibit
3.4 to the Registrants Current Report on Form 8-K filed with the
Commission on November 30, 2005).
|
|
|
|
3.5
|
|
Certificate of Amendment to Certificate of Incorporation
(incorporated by reference to Exhibit 3.5 to the Registrants
Registration Statement on Form SB-2, filed with the Commission on
February 1, 2008).
|
|
|
|
3.6
|
|
Certificate of Designation with respect to shares of Series A
Preferred Stock (incorporated by reference to Exhibit 3.1 to the
Registrants Current Report on Form 8-K filed with the Commission
on January 21, 2009).
|
|
|
|
3.7**
|
|
Certificate of Amendment to Certificate of Incorporation.
|
|
|
|
4.1
|
|
Form of Common Stock Purchase Warrant Certificate (incorporated by
reference to Exhibit 4.1 to the Registrants Current Report on
Form 8-K filed with the Commission on November 30, 2005).
|
|
|
|
4.2
|
|
Warrant to Purchase Common Stock issued to Alvin H. Clemens
(incorporated by reference to Exhibit 4.2 to the Registrants
Annual Report on Form 10-KSB for the fiscal year ended December
31, 2005, filed with the Commission on March 31, 2006).
|
130
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
4.3
|
|
Securities Purchase Agreement, dated March 30, 2007, by and
between Health Benefits Direct Corporation and the Investors party
thereto (incorporated by reference to Exhibit 4.1 to the
Registrants Current Report on Form 8-K, filed with the Commission
on March 30, 2007).
|
|
|
|
4.4
|
|
Registration Rights Agreement, dated March 30, 2007, by and
between Health Benefits Direct Corporation and the Investors party
thereto (incorporated by reference to Exhibit 4.2 to the
Registrants Current Report on Form 8-K, filed with the Commission
on March 30, 2007).
|
|
|
|
4.5
|
|
Form of Warrant (incorporated by reference to Exhibit 4.3 to the
Registrants Current Report on Form 8-K, filed with the Commission
on March 30, 2007).
|
|
|
|
4.6
|
|
Form of Placement Agent Warrant (incorporated by reference to
Exhibit 4.4 to the Registrants Current Report on Form 8-K, filed
with the Commission on March 30, 2007).
|
|
|
|
4.7
|
|
Registration Rights Agreement, dated October 1, 2007, by and
between Health Benefits Direct Corporation and Computer Command
and Control Company (incorporated by reference from Exhibit 4.1 to
the Companys current report on From 8-K, filed with the
Commission on October 4, 2007).
|
|
|
|
4.8
|
|
Registration Rights Agreement, dated October 1, 2007, by and among
Health Benefits Direct Corporation and Robert J. Oakes, Jeff
Brocco, Tim Savery and Lisa Roetz (incorporated by reference from
Exhibit 4.2 to the Companys current report on From 8-K, filed
with the Commission on October 4, 2007).
|
|
|
|
4.9
|
|
Securities Purchase Agreement, dated March 31, 2008, by and
between Health Benefits Direct Corporation and the Investor party
thereto (incorporated by reference from Exhibit 4.1 to the
Registrants Current Report on Form 8-K, filed with the Commission
on March 31, 2008).
|
|
|
|
4.10
|
|
Securities Purchase Agreement, dated March 31, 2008, by and
between Health Benefits Direct Corporation and the Investors party
thereto (incorporated by reference from Exhibit 4.2 to the
Registrants Current Report on Form 8-K, filed with the Commission
on March 31, 2008).
|
|
|
|
4.11
|
|
Form of Warrant (incorporated by reference to Exhibit 4.3 to the
Registrants Current Report on Form 8-K, filed with the Commission
on March 31, 2008).
|
|
|
|
4.12
|
|
Form of Registration Rights Agreement, dated March 31, 2008, by
and among Health Benefits Direct Corporation and the Investors
party thereto (incorporated by reference from Exhibit 4.4 to the
Companys current report on From 8-K, filed with the Commission on
March 31, 2008).
|
|
|
|
4.13
|
|
Form of Registration Rights Agreement, dated March 31, 2008, by
and among Health Benefits Direct Corporation and the Investors
party thereto (incorporated by reference from Exhibit 4.3 to the
Companys current report on From 8-K, filed with the Commission on
March 31, 2008).
|
131
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
4.14
|
|
Board Representation Agreement, date March 31, 2008, between the
Company and The Co-Investment Fund II, L.P. (incorporated by
reference from Exhibit 4.5 to the Registrants Current Report on
Form 8-K, filed with the Commission on March 31, 2008).
|
|
|
|
10.1
|
|
Health Benefits Direct Corporation 2005 Incentive Stock Plan
(incorporated by reference to Exhibit 10.1 to the Registrants
Current Report on Form 8-K filed with the Commission on November
30, 2005).
|
|
|
|
10.2
|
|
Health Benefits Direct Corporation 2005 Non-Employee Directors
Stock Option Plan (incorporated by reference to Exhibit 10.1 to
the Registrants Current Report on Form 8-K/A filed with the
Commission on December 22, 2005).
|
|
|
|
10.3
|
|
Health Benefits Direct Corporation Compensation Plan for Directors
(incorporated by reference to Exhibit 10.1 to the Registrants
Current Report on Form 8-K filed with the Commission on March 20,
2006).
|
|
|
|
10.4
|
|
Lease Agreement, dated February 9, 2004, between Case Holding Co.
and Platinum Partners, LLC (incorporated by reference to Exhibit
10.7 to the Registrants Form 8-K filed with the Commission on
November 30, 2005).
|
|
|
|
10.5
|
|
Lease between Health Benefits Direct Corporation and FG2200, LLC,
effective March 15, 2006 (incorporated by reference to Exhibit
10.1 to the Registrants Current Report on Form 8-K filed with the
Commission on March 6, 2006).
|
|
|
|
10.6
|
|
Employment Agreement, dated November 18, 2005, between Health
Benefits Direct Corporation and Charles A. Eissa (incorporated by
reference to Exhibit 10.14 to the Registrants Current Report on
Form 8-K filed with the Commission on November 30, 2005).
|
|
|
|
10.7
|
|
Amendment 2008-1 to Employment Agreement, dated March 31, 2008,
between Health Benefits Direct Corporation and Charles A. Eissa
(incorporated by reference to Exhibit 10.4 to the Registrants
Current Report on Form 8-K filed with the Commission on March 31,
2008).
|
|
|
|
10.8
|
|
Form of Director and Officer Indemnification Agreement
(incorporated by reference to Exhibit 10.1 to the Registrants
Current Report on Form 8-K filed with the Commission on January
17, 2006).
|
|
|
|
10.9
|
|
Securities Contribution Agreement, dated September 9, 2005, among
Health Benefits Direct Corporation, Marlin Capital Partners I,
LLC, Scott Frohman, Charles A. Eissa, Platinum Partners II LLC and
Dana Boskoff (incorporated by reference to Exhibit 10.22 to the
Registrants Current Report on Form 8-K filed with the Commission
on November 30, 2005).
|
132
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
10.12
|
|
Merger Agreement, dated April 3, 2006, among Health Benefits
Direct Corporation, ISG Merger Acquisition Corp., Insurance
Specialist Group Inc. and Ivan M. Spinner (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on April 6, 2006).
|
|
|
|
10.13
|
|
Employment Agreement, dated April 3, 2006, between HBDC II, Inc.
and Ivan M. Spinner (incorporated by reference to the Registrants
Current Report on Form 8-K filed with the Commission on April 6,
2006).
|
|
|
|
10.14
|
|
Health Benefits Direct Corporation 2006 Omnibus Equity
Compensation Plan (incorporated by reference to the Registrants
Current Report on Form 8-K filed with the Commission on May 2,
2006).
|
|
|
|
10.15
|
|
Health Benefits Direct Corporation 2006 Omnibus Equity
Compensation Plan Form of Nonqualified Stock Option Grant
(incorporated by reference to the Registrants Current Report on
Form 8-K filed with the Commission on May 2, 2006).
|
|
|
|
10.16
|
|
Health Benefits Direct Corporation 2008 Equity Compensation Plan
(incorporated by reference to the Registrants Current Report on
Form 8-K filed with the Commission on March 31, 2008).
|
|
|
|
10.17
|
|
Health Benefits Direct Corporation 2008 Equity Compensation Plan
Form of Nonqualified Stock Option Grant (incorporated by reference
to the Registrants Current Report on Form 8-K filed with the
Commission on March 28, 2008).
|
|
|
|
10.18
|
|
Sublease, dated March 7, 2006, between Health Benefits Direct
Corporation and World Travel Partners I, LLC Form of Nonqualified
Stock Option Grant (incorporated by reference to the Registrants
Current Report on Form 8-K filed with the Commission on May 19,
2006).
|
|
|
|
10.19
|
|
First Amendment to Sublease, dated April 18, 2006, between Health
Benefits Direct Corporation ad World Travel Partners I, LLC
(incorporated by reference to the Registrants Current Report on
Form 8-K filed with the Commission on May 19, 2006).
|
|
|
|
10.20
|
|
Letter Agreement, dated April 18, 2006, among World Travel
Partners I, LLC, Health Benefits Direct Corporation, and 1120
Avenue of the Americas, LLC (incorporated by reference to the
Registrants Current Report on Form 8-K filed with the Commission
on May 19, 2006).
|
|
|
|
10.21
|
|
Software and Services Agreement, dated May 31, 2006, among Health
Benefits Direct Corporation, Insurint Corporation, and Realtime
Solutions Group, L.L.C. (incorporated by reference to the
Registrants Current Report on Form 8-K filed with the Commission
on June 2, 2006).
|
|
|
|
10.22
|
|
Lease, dated July 7, 2006, between Health Benefits Direct
Corporation and Radnor Properties-SDC, L.P. (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on July 10, 2006).
|
133
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
10.23
|
|
Separation Agreement, dated December 7, 2006, between Health
Benefits Direct Corporation and Scott Frohman (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on December 11, 2006).
|
|
|
|
10.24
|
|
Amendment No. 1 to Option, dated as of February 15, 2007,
delivered by Health Benefits Direct Corporation to Daniel Brauser
(incorporated by reference to the Registrants Current Report on
Form 8-K filed with the Commission on February 16, 2007).
|
|
|
|
10.25
|
|
Consent and Lock-Up Agreement, dated April 5, 2007, between Health
Benefits Direct Corporation and Scott Frohman (incorporated by
reference to the Registrants Current Report on Form 8-K filed
with the Commission on April 6, 2007).
|
|
|
|
10.26
|
|
Agreement to Transfer Partnership Interests, dated October 1,
2007, by and among HBDC Acquisition, LLC and the former partners
of BileniaTech, L.P. (incorporated by reference from Exhibit 10.1
to the Companys current report on From 8-K, filed with the
Commission on October 4, 2007).
|
|
|
|
10.27
|
|
Amended and Restated Employment Agreement, dated November 27,
2007, between Health Benefits Direct Corporation and Alvin H.
Clemens (incorporated by reference to Exhibit 10.1 to the
Registrants Current Report on Form 8-K filed with the Commission
on December 3, 2007).
|
|
|
|
10.28
|
|
Amended and Restated Employment Agreement, dated November 27,
2007, between Health Benefits Direct Corporation and Anthony R.
Verdi (incorporated by reference to Exhibit 10.2 to the
Registrants Current Report on Form 8-K filed with the Commission
on December 3, 2007).
|
|
|
|
10.29
|
|
Amendment 2008-1 to Amended and Restated Employment Agreement,
dated March 31, 2008, between Health Benefits Direct Corporation
and Anthony R. Verdi (incorporated by reference to Exhibit 10.3 to
the Registrants Current Report on Form 8-K filed with the
Commission on March 31, 2008).
|
|
|
|
10.30
|
|
Amended and Restated Employment Agreement, dated November 27,
2007, between Health Benefits Direct Corporation and Ivan M.
Spinner (incorporated by reference to Exhibit 10.3 to the
Registrants Current Report on Form 8-K filed with the Commission
on December 3, 2007).
|
|
|
|
10.31**
|
|
Client Transition Agreement, between Health Benefits Direct
Corporation, HBDC II, Inc. and eHealthInsurance Services, Inc.
|
|
|
|
14
|
|
Amended and Restated Code of Business Conduct and Ethics
(incorporated by reference to Exhibit 14.1 to the Registrants
Current Report on Form 8-K filed with the Commission on February
4, 2008).
|
|
|
|
21**
|
|
Subsidiaries of Health Benefits Direct Corporation.
|
|
|
|
23.1**
|
|
Consent of Sherb & Co., LLP.
|
134
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
31.1**
|
|
Section 302 Certification of Principal Executive Officer.
|
|
|
|
31.2**
|
|
Section 302 Certification of Principal Financial Officer.
|
|
|
|
32.1**
|
|
Section 906 Certification of Principal Executive Officer and
Principal Financial Officer.
|
135